Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048856 | 0.00000 | 3.37499 | 71 | 149 | 5712 | anatomical structure development |
| GO:0007275 | 0.00000 | 3.39248 | 65 | 141 | 5227 | multicellular organism development |
| GO:0048731 | 0.00000 | 3.43667 | 57 | 131 | 4638 | system development |
| GO:0009653 | 0.00000 | 3.88304 | 33 | 94 | 2652 | anatomical structure morphogenesis |
| GO:0032502 | 0.00000 | 3.13076 | 75 | 150 | 6097 | developmental process |
| GO:0030154 | 0.00000 | 3.30119 | 51 | 118 | 4125 | cell differentiation |
| GO:0009888 | 0.00000 | 4.09788 | 23 | 75 | 1899 | tissue development |
| GO:0050793 | 0.00000 | 3.59011 | 33 | 90 | 2681 | regulation of developmental process |
| GO:0048869 | 0.00000 | 3.10293 | 54 | 118 | 4334 | cellular developmental process |
| GO:0045595 | 0.00000 | 3.93052 | 23 | 72 | 1874 | regulation of cell differentiation |
| GO:0048513 | 0.00000 | 3.20081 | 42 | 101 | 3430 | animal organ development |
| GO:0001503 | 0.00000 | 8.42125 | 5 | 32 | 369 | ossification |
| GO:2000026 | 0.00000 | 3.65295 | 26 | 76 | 2136 | regulation of multicellular organismal development |
| GO:0051239 | 0.00000 | 3.14358 | 39 | 94 | 3173 | regulation of multicellular organismal process |
| GO:0032501 | 0.00000 | 2.61491 | 100 | 166 | 8064 | multicellular organismal process |
| GO:0048583 | 0.00000 | 2.91282 | 46 | 102 | 3755 | regulation of response to stimulus |
| GO:0060429 | 0.00000 | 4.25637 | 14 | 51 | 1160 | epithelium development |
| GO:0048585 | 0.00000 | 3.76665 | 19 | 60 | 1565 | negative regulation of response to stimulus |
| GO:0009887 | 0.00000 | 4.40877 | 13 | 48 | 1048 | animal organ morphogenesis |
| GO:0051094 | 0.00000 | 3.73381 | 19 | 58 | 1516 | positive regulation of developmental process |
| GO:0010646 | 0.00000 | 2.90263 | 40 | 91 | 3256 | regulation of cell communication |
| GO:0051093 | 0.00000 | 4.30794 | 13 | 47 | 1045 | negative regulation of developmental process |
| GO:0023051 | 0.00000 | 2.88044 | 40 | 91 | 3277 | regulation of signaling |
| GO:0007155 | 0.00000 | 3.93822 | 16 | 52 | 1273 | cell adhesion |
| GO:0022610 | 0.00000 | 3.89773 | 16 | 52 | 1285 | biological adhesion |
| GO:0001649 | 0.00000 | 10.51754 | 2 | 21 | 192 | osteoblast differentiation |
| GO:0009966 | 0.00000 | 2.98372 | 33 | 80 | 2712 | regulation of signal transduction |
| GO:0030855 | 0.00000 | 5.35728 | 8 | 35 | 615 | epithelial cell differentiation |
| GO:0051240 | 0.00000 | 3.32635 | 23 | 64 | 1887 | positive regulation of multicellular organismal process |
| GO:0010648 | 0.00000 | 3.80308 | 16 | 52 | 1314 | negative regulation of cell communication |
| GO:0023057 | 0.00000 | 3.79037 | 16 | 52 | 1318 | negative regulation of signaling |
| GO:0035239 | 0.00000 | 4.45755 | 11 | 42 | 892 | tube morphogenesis |
| GO:0048519 | 0.00000 | 2.53696 | 64 | 120 | 5186 | negative regulation of biological process |
| GO:0048523 | 0.00000 | 2.59037 | 57 | 111 | 4605 | negative regulation of cellular process |
| GO:0045597 | 0.00000 | 4.04596 | 13 | 46 | 1080 | positive regulation of cell differentiation |
| GO:0045596 | 0.00000 | 4.56168 | 10 | 38 | 781 | negative regulation of cell differentiation |
| GO:0051241 | 0.00000 | 3.64735 | 16 | 50 | 1305 | negative regulation of multicellular organismal process |
| GO:0007166 | 0.00000 | 2.86639 | 31 | 72 | 2473 | cell surface receptor signaling pathway |
| GO:0048646 | 0.00000 | 3.72959 | 14 | 45 | 1135 | anatomical structure formation involved in morphogenesis |
| GO:0009968 | 0.00000 | 3.65538 | 15 | 46 | 1185 | negative regulation of signal transduction |
| GO:0048522 | 0.00000 | 2.36537 | 66 | 118 | 5349 | positive regulation of cellular process |
| GO:0035295 | 0.00000 | 3.73591 | 14 | 44 | 1105 | tube development |
| GO:0001568 | 0.00000 | 4.42842 | 9 | 34 | 710 | blood vessel development |
| GO:0045667 | 0.00000 | 10.86918 | 2 | 16 | 140 | regulation of osteoblast differentiation |
| GO:0007399 | 0.00000 | 2.82981 | 28 | 66 | 2257 | nervous system development |
| GO:0048518 | 0.00000 | 2.25826 | 75 | 126 | 6033 | positive regulation of biological process |
| GO:0048514 | 0.00000 | 4.64622 | 8 | 31 | 614 | blood vessel morphogenesis |
| GO:0001944 | 0.00000 | 4.22219 | 9 | 34 | 742 | vasculature development |
| GO:0030278 | 0.00000 | 7.78995 | 3 | 19 | 226 | regulation of ossification |
| GO:0072358 | 0.00000 | 4.14364 | 9 | 34 | 755 | cardiovascular system development |
| GO:0030182 | 0.00000 | 3.17424 | 18 | 49 | 1447 | neuron differentiation |
| GO:0072359 | 0.00000 | 3.49551 | 14 | 42 | 1115 | circulatory system development |
| GO:0022008 | 0.00000 | 2.97653 | 21 | 54 | 1712 | neurogenesis |
| GO:0050896 | 0.00000 | 2.12999 | 116 | 169 | 9397 | response to stimulus |
| GO:0065007 | 0.00000 | 2.17906 | 148 | 200 | 11983 | biological regulation |
| GO:0040011 | 0.00000 | 2.91578 | 22 | 54 | 1744 | locomotion |
| GO:0048729 | 0.00000 | 4.24208 | 8 | 31 | 668 | tissue morphogenesis |
| GO:0042221 | 0.00000 | 2.30613 | 50 | 93 | 4043 | response to chemical |
| GO:0048699 | 0.00000 | 2.95929 | 20 | 51 | 1613 | generation of neurons |
| GO:0070838 | 0.00000 | 5.03356 | 6 | 25 | 452 | divalent metal ion transport |
| GO:0051179 | 0.00000 | 2.15645 | 72 | 119 | 5794 | localization |
| GO:0006928 | 0.00000 | 2.78583 | 24 | 57 | 1932 | movement of cell or subcellular component |
| GO:0072511 | 0.00000 | 4.99778 | 6 | 25 | 455 | divalent inorganic cation transport |
| GO:0048705 | 0.00000 | 6.68095 | 3 | 19 | 260 | skeletal system morphogenesis |
| GO:0042127 | 0.00000 | 2.91321 | 20 | 51 | 1636 | regulation of cell proliferation |
| GO:0016043 | 0.00000 | 2.12056 | 73 | 120 | 5929 | cellular component organization |
| GO:0048762 | 0.00000 | 7.31013 | 3 | 17 | 213 | mesenchymal cell differentiation |
| GO:0006816 | 0.00000 | 5.14745 | 5 | 23 | 405 | calcium ion transport |
| GO:0061564 | 0.00000 | 4.68641 | 6 | 25 | 483 | axon development |
| GO:0060349 | 0.00000 | 10.52502 | 1 | 13 | 116 | bone morphogenesis |
| GO:0050789 | 0.00000 | 2.06284 | 140 | 190 | 11369 | regulation of biological process |
| GO:0000904 | 0.00000 | 3.78789 | 9 | 32 | 768 | cell morphogenesis involved in differentiation |
| GO:0071840 | 0.00000 | 2.07110 | 75 | 121 | 6096 | cellular component organization or biogenesis |
| GO:0030001 | 0.00000 | 3.64949 | 10 | 33 | 822 | metal ion transport |
| GO:0009605 | 0.00000 | 2.49826 | 30 | 64 | 2429 | response to external stimulus |
| GO:0008283 | 0.00000 | 2.64803 | 24 | 56 | 1981 | cell proliferation |
| GO:0048468 | 0.00000 | 2.51305 | 29 | 62 | 2330 | cell development |
| GO:0050794 | 0.00000 | 2.00552 | 132 | 180 | 10650 | regulation of cellular process |
| GO:0048598 | 0.00000 | 4.02051 | 8 | 28 | 629 | embryonic morphogenesis |
| GO:0001501 | 0.00000 | 4.42020 | 6 | 25 | 510 | skeletal system development |
| GO:0006811 | 0.00000 | 2.84322 | 19 | 47 | 1526 | ion transport |
| GO:0090287 | 0.00000 | 6.15099 | 3 | 18 | 265 | regulation of cellular response to growth factor stimulus |
| GO:0008285 | 0.00000 | 3.88740 | 8 | 29 | 674 | negative regulation of cell proliferation |
| GO:0045444 | 0.00000 | 6.56606 | 3 | 17 | 235 | fat cell differentiation |
| GO:0048666 | 0.00000 | 3.09566 | 15 | 40 | 1181 | neuron development |
| GO:0048870 | 0.00000 | 2.81877 | 19 | 47 | 1538 | cell motility |
| GO:0051674 | 0.00000 | 2.81877 | 19 | 47 | 1538 | localization of cell |
| GO:0007409 | 0.00000 | 4.61783 | 6 | 23 | 448 | axonogenesis |
| GO:0016477 | 0.00000 | 2.89056 | 17 | 44 | 1397 | cell migration |
| GO:0032879 | 0.00000 | 2.34770 | 34 | 68 | 2749 | regulation of localization |
| GO:0031324 | 0.00000 | 2.43303 | 30 | 62 | 2397 | negative regulation of cellular metabolic process |
| GO:0007154 | 0.00000 | 1.98595 | 82 | 126 | 6614 | cell communication |
| GO:0080090 | 0.00000 | 2.04932 | 64 | 105 | 5147 | regulation of primary metabolic process |
| GO:0060348 | 0.00000 | 6.58360 | 3 | 16 | 220 | bone development |
| GO:0006812 | 0.00000 | 3.10885 | 13 | 37 | 1080 | cation transport |
| GO:0002009 | 0.00000 | 4.10818 | 7 | 25 | 546 | morphogenesis of an epithelium |
| GO:0008544 | 0.00000 | 5.29938 | 4 | 19 | 322 | epidermis development |
| GO:0030510 | 0.00000 | 10.98127 | 1 | 11 | 94 | regulation of BMP signaling pathway |
| GO:0051960 | 0.00000 | 3.14521 | 13 | 36 | 1037 | regulation of nervous system development |
| GO:0000902 | 0.00000 | 3.12886 | 13 | 36 | 1042 | cell morphogenesis |
| GO:0051172 | 0.00000 | 2.43303 | 27 | 58 | 2222 | negative regulation of nitrogen compound metabolic process |
| GO:0030856 | 0.00000 | 8.20228 | 2 | 13 | 145 | regulation of epithelial cell differentiation |
| GO:0048667 | 0.00000 | 3.88367 | 7 | 26 | 600 | cell morphogenesis involved in neuron differentiation |
| GO:0031323 | 0.00000 | 2.00725 | 65 | 106 | 5290 | regulation of cellular metabolic process |
| GO:0022603 | 0.00000 | 3.09029 | 13 | 36 | 1054 | regulation of anatomical structure morphogenesis |
| GO:0040007 | 0.00000 | 3.02964 | 14 | 37 | 1106 | growth |
| GO:0060485 | 0.00000 | 5.67166 | 3 | 17 | 269 | mesenchyme development |
| GO:0009893 | 0.00000 | 2.16134 | 42 | 77 | 3406 | positive regulation of metabolic process |
| GO:0045668 | 0.00000 | 14.25706 | 1 | 9 | 61 | negative regulation of osteoblast differentiation |
| GO:0001657 | 0.00000 | 9.90312 | 1 | 11 | 103 | ureteric bud development |
| GO:0072163 | 0.00000 | 9.90312 | 1 | 11 | 103 | mesonephric epithelium development |
| GO:0072164 | 0.00000 | 9.90312 | 1 | 11 | 103 | mesonephric tubule development |
| GO:0061448 | 0.00000 | 5.53830 | 3 | 17 | 275 | connective tissue development |
| GO:0045926 | 0.00000 | 5.51667 | 3 | 17 | 276 | negative regulation of growth |
| GO:0001823 | 0.00000 | 9.58913 | 1 | 11 | 106 | mesonephros development |
| GO:0051270 | 0.00000 | 3.08194 | 12 | 34 | 993 | regulation of cellular component movement |
| GO:0032989 | 0.00000 | 2.92611 | 14 | 37 | 1142 | cellular component morphogenesis |
| GO:0060828 | 0.00000 | 6.24204 | 3 | 15 | 216 | regulation of canonical Wnt signaling pathway |
| GO:2000145 | 0.00000 | 3.15872 | 11 | 32 | 909 | regulation of cell motility |
| GO:0030334 | 0.00000 | 3.21545 | 11 | 31 | 864 | regulation of cell migration |
| GO:0007167 | 0.00000 | 3.21145 | 11 | 31 | 865 | enzyme linked receptor protein signaling pathway |
| GO:0023052 | 0.00000 | 1.90071 | 81 | 122 | 6550 | signaling |
| GO:0007411 | 0.00000 | 6.03012 | 3 | 15 | 223 | axon guidance |
| GO:0051171 | 0.00000 | 1.96601 | 62 | 100 | 5008 | regulation of nitrogen compound metabolic process |
| GO:0030509 | 0.00000 | 7.16423 | 2 | 13 | 164 | BMP signaling pathway |
| GO:0097485 | 0.00000 | 6.00100 | 3 | 15 | 224 | neuron projection guidance |
| GO:0009987 | 0.00000 | 2.07837 | 193 | 232 | 15608 | cellular process |
| GO:0070848 | 0.00000 | 3.68710 | 7 | 25 | 604 | response to growth factor |
| GO:0050767 | 0.00000 | 3.09987 | 11 | 32 | 925 | regulation of neurogenesis |
| GO:0065008 | 0.00000 | 2.03968 | 49 | 84 | 3955 | regulation of biological quality |
| GO:0040008 | 0.00000 | 3.38176 | 9 | 28 | 739 | regulation of growth |
| GO:0060675 | 0.00000 | 12.14878 | 1 | 9 | 70 | ureteric bud morphogenesis |
| GO:0040012 | 0.00000 | 2.99910 | 12 | 33 | 986 | regulation of locomotion |
| GO:0009790 | 0.00000 | 2.80839 | 15 | 37 | 1186 | embryo development |
| GO:0072171 | 0.00000 | 11.95231 | 1 | 9 | 71 | mesonephric tubule morphogenesis |
| GO:0019222 | 0.00000 | 1.89910 | 72 | 111 | 5833 | regulation of metabolic process |
| GO:0050673 | 0.00000 | 4.31094 | 5 | 20 | 412 | epithelial cell proliferation |
| GO:0050878 | 0.00000 | 4.74757 | 4 | 18 | 337 | regulation of body fluid levels |
| GO:0010721 | 0.00000 | 4.49987 | 5 | 19 | 375 | negative regulation of cell development |
| GO:0090090 | 0.00000 | 8.50924 | 1 | 11 | 118 | negative regulation of canonical Wnt signaling pathway |
| GO:0043066 | 0.00000 | 3.02922 | 12 | 32 | 945 | negative regulation of apoptotic process |
| GO:0009892 | 0.00000 | 2.17605 | 34 | 65 | 2787 | negative regulation of metabolic process |
| GO:0031175 | 0.00000 | 2.91350 | 13 | 34 | 1046 | neuron projection development |
| GO:0009913 | 0.00000 | 6.11116 | 3 | 14 | 205 | epidermal cell differentiation |
| GO:0071772 | 0.00000 | 6.67455 | 2 | 13 | 175 | response to BMP |
| GO:0071773 | 0.00000 | 6.67455 | 2 | 13 | 175 | cellular response to BMP stimulus |
| GO:0060070 | 0.00000 | 5.23432 | 3 | 16 | 272 | canonical Wnt signaling pathway |
| GO:0001763 | 0.00000 | 5.59546 | 3 | 15 | 239 | morphogenesis of a branching structure |
| GO:0060350 | 0.00000 | 11.39917 | 1 | 9 | 74 | endochondral bone morphogenesis |
| GO:0060394 | 0.00000 | 50.85106 | 0 | 5 | 13 | negative regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0048589 | 0.00000 | 3.25865 | 9 | 28 | 765 | developmental growth |
| GO:0051716 | 0.00000 | 1.83048 | 95 | 136 | 7705 | cellular response to stimulus |
| GO:0060284 | 0.00000 | 2.87484 | 13 | 34 | 1059 | regulation of cell development |
| GO:0071363 | 0.00000 | 3.60924 | 7 | 24 | 590 | cellular response to growth factor stimulus |
| GO:0060993 | 0.00000 | 9.37972 | 1 | 10 | 98 | kidney morphogenesis |
| GO:0043069 | 0.00000 | 2.97489 | 12 | 32 | 961 | negative regulation of programmed cell death |
| GO:0001525 | 0.00000 | 3.85386 | 6 | 22 | 506 | angiogenesis |
| GO:0050678 | 0.00000 | 4.57303 | 4 | 18 | 349 | regulation of epithelial cell proliferation |
| GO:0048754 | 0.00000 | 6.35822 | 2 | 13 | 183 | branching morphogenesis of an epithelial tube |
| GO:0010604 | 0.00000 | 2.08205 | 39 | 70 | 3149 | positive regulation of macromolecule metabolic process |
| GO:0030111 | 0.00000 | 5.01624 | 3 | 16 | 283 | regulation of Wnt signaling pathway |
| GO:0048812 | 0.00000 | 3.42560 | 8 | 25 | 647 | neuron projection morphogenesis |
| GO:0072078 | 0.00000 | 10.58263 | 1 | 9 | 79 | nephron tubule morphogenesis |
| GO:0043588 | 0.00000 | 4.95985 | 4 | 16 | 286 | skin development |
| GO:0019216 | 0.00000 | 4.64429 | 4 | 17 | 324 | regulation of lipid metabolic process |
| GO:0001837 | 0.00000 | 7.64715 | 2 | 11 | 130 | epithelial to mesenchymal transition |
| GO:0072088 | 0.00000 | 10.28777 | 1 | 9 | 81 | nephron epithelium morphogenesis |
| GO:0030335 | 0.00000 | 3.69763 | 6 | 22 | 526 | positive regulation of cell migration |
| GO:0050768 | 0.00000 | 4.59873 | 4 | 17 | 327 | negative regulation of neurogenesis |
| GO:0061430 | 0.00000 | 40.67730 | 0 | 5 | 15 | bone trabecula morphogenesis |
| GO:0072028 | 0.00000 | 10.14640 | 1 | 9 | 82 | nephron morphogenesis |
| GO:0033687 | 0.00000 | 23.31571 | 0 | 6 | 27 | osteoblast proliferation |
| GO:0120039 | 0.00000 | 3.34810 | 8 | 25 | 661 | plasma membrane bounded cell projection morphogenesis |
| GO:0042330 | 0.00000 | 3.54853 | 7 | 23 | 573 | taxis |
| GO:0031326 | 0.00000 | 2.02212 | 42 | 73 | 3386 | regulation of cellular biosynthetic process |
| GO:0010033 | 0.00000 | 2.07460 | 37 | 67 | 3005 | response to organic substance |
| GO:0046890 | 0.00000 | 6.63331 | 2 | 12 | 162 | regulation of lipid biosynthetic process |
| GO:0045664 | 0.00000 | 3.16567 | 9 | 27 | 756 | regulation of neuron differentiation |
| GO:0048858 | 0.00000 | 3.33193 | 8 | 25 | 664 | cell projection morphogenesis |
| GO:0048878 | 0.00000 | 2.71499 | 14 | 35 | 1152 | chemical homeostasis |
| GO:0009889 | 0.00000 | 2.01034 | 43 | 74 | 3456 | regulation of biosynthetic process |
| GO:0040017 | 0.00000 | 3.52228 | 7 | 23 | 577 | positive regulation of locomotion |
| GO:0062012 | 0.00000 | 4.51022 | 4 | 17 | 333 | regulation of small molecule metabolic process |
| GO:0030879 | 0.00000 | 6.54545 | 2 | 12 | 164 | mammary gland development |
| GO:0090092 | 0.00000 | 5.44884 | 3 | 14 | 228 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0008589 | 0.00000 | 9.74460 | 1 | 9 | 85 | regulation of smoothened signaling pathway |
| GO:0061333 | 0.00000 | 9.74460 | 1 | 9 | 85 | renal tubule morphogenesis |
| GO:0010647 | 0.00000 | 2.34215 | 22 | 47 | 1818 | positive regulation of cell communication |
| GO:0048584 | 0.00000 | 2.21167 | 28 | 54 | 2231 | positive regulation of response to stimulus |
| GO:0007165 | 0.00000 | 1.82319 | 74 | 111 | 6010 | signal transduction |
| GO:0023056 | 0.00000 | 2.33358 | 23 | 47 | 1824 | positive regulation of signaling |
| GO:0060411 | 0.00000 | 9.61763 | 1 | 9 | 86 | cardiac septum morphogenesis |
| GO:0001658 | 0.00000 | 11.72350 | 1 | 8 | 64 | branching involved in ureteric bud morphogenesis |
| GO:0006357 | 0.00000 | 2.29169 | 24 | 49 | 1941 | regulation of transcription by RNA polymerase II |
| GO:0048736 | 0.00000 | 5.80720 | 2 | 13 | 199 | appendage development |
| GO:0060173 | 0.00000 | 5.80720 | 2 | 13 | 199 | limb development |
| GO:0060548 | 0.00000 | 2.75398 | 13 | 33 | 1067 | negative regulation of cell death |
| GO:0001655 | 0.00000 | 4.41111 | 4 | 17 | 340 | urogenital system development |
| GO:0090288 | 0.00000 | 7.10666 | 2 | 11 | 139 | negative regulation of cellular response to growth factor stimulus |
| GO:2000147 | 0.00000 | 3.56029 | 7 | 22 | 545 | positive regulation of cell motility |
| GO:0008284 | 0.00000 | 2.82625 | 12 | 31 | 974 | positive regulation of cell proliferation |
| GO:0003198 | 0.00000 | 33.89480 | 0 | 5 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0032990 | 0.00000 | 3.21786 | 8 | 25 | 686 | cell part morphogenesis |
| GO:0021700 | 0.00000 | 4.58171 | 4 | 16 | 308 | developmental maturation |
| GO:0051173 | 0.00000 | 2.03757 | 37 | 66 | 3000 | positive regulation of nitrogen compound metabolic process |
| GO:0031325 | 0.00000 | 2.01847 | 39 | 68 | 3128 | positive regulation of cellular metabolic process |
| GO:0072073 | 0.00000 | 6.89010 | 2 | 11 | 143 | kidney epithelium development |
| GO:0035107 | 0.00000 | 6.17712 | 2 | 12 | 173 | appendage morphogenesis |
| GO:0035108 | 0.00000 | 6.17712 | 2 | 12 | 173 | limb morphogenesis |
| GO:0042981 | 0.00000 | 2.43383 | 19 | 41 | 1512 | regulation of apoptotic process |
| GO:0003007 | 0.00000 | 4.83186 | 3 | 15 | 274 | heart morphogenesis |
| GO:0051216 | 0.00000 | 5.59485 | 3 | 13 | 206 | cartilage development |
| GO:0007178 | 0.00000 | 4.27675 | 4 | 17 | 350 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0051961 | 0.00000 | 4.27675 | 4 | 17 | 350 | negative regulation of nervous system development |
| GO:0051272 | 0.00000 | 3.45214 | 7 | 22 | 561 | positive regulation of cellular component movement |
| GO:0043067 | 0.00000 | 2.40067 | 19 | 41 | 1531 | regulation of programmed cell death |
| GO:0007507 | 0.00000 | 3.31357 | 8 | 23 | 611 | heart development |
| GO:0010605 | 0.00000 | 2.09548 | 31 | 58 | 2533 | negative regulation of macromolecule metabolic process |
| GO:0030279 | 0.00000 | 8.70939 | 1 | 9 | 94 | negative regulation of ossification |
| GO:0009967 | 0.00000 | 2.42284 | 18 | 40 | 1478 | positive regulation of signal transduction |
| GO:0030178 | 0.00000 | 6.58879 | 2 | 11 | 149 | negative regulation of Wnt signaling pathway |
| GO:0031214 | 0.00000 | 6.54111 | 2 | 11 | 150 | biomineral tissue development |
| GO:0045686 | 0.00000 | 18.12970 | 0 | 6 | 33 | negative regulation of glial cell differentiation |
| GO:0006935 | 0.00000 | 3.38774 | 7 | 22 | 571 | chemotaxis |
| GO:0006366 | 0.00000 | 2.21492 | 25 | 49 | 2001 | transcription by RNA polymerase II |
| GO:0006810 | 0.00000 | 1.87164 | 53 | 85 | 4298 | transport |
| GO:0048640 | 0.00000 | 7.36204 | 2 | 10 | 122 | negative regulation of developmental growth |
| GO:0009891 | 0.00000 | 2.24432 | 23 | 47 | 1889 | positive regulation of biosynthetic process |
| GO:0072080 | 0.00000 | 8.41138 | 1 | 9 | 97 | nephron tubule development |
| GO:0051145 | 0.00000 | 10.09628 | 1 | 8 | 73 | smooth muscle cell differentiation |
| GO:0012501 | 0.00000 | 2.23246 | 23 | 47 | 1898 | programmed cell death |
| GO:0060563 | 0.00000 | 9.94287 | 1 | 8 | 74 | neuroepithelial cell differentiation |
| GO:0009110 | 0.00000 | 27.11229 | 0 | 5 | 20 | vitamin biosynthetic process |
| GO:0061138 | 0.00000 | 5.21325 | 3 | 13 | 220 | morphogenesis of a branching epithelium |
| GO:0061383 | 0.00000 | 12.44891 | 1 | 7 | 53 | trabecula morphogenesis |
| GO:0031328 | 0.00000 | 2.24025 | 23 | 46 | 1848 | positive regulation of cellular biosynthetic process |
| GO:0007267 | 0.00000 | 2.34669 | 19 | 41 | 1563 | cell-cell signaling |
| GO:1901342 | 0.00000 | 4.22925 | 4 | 16 | 332 | regulation of vasculature development |
| GO:0032101 | 0.00000 | 3.02880 | 9 | 25 | 726 | regulation of response to external stimulus |
| GO:0003279 | 0.00000 | 6.98587 | 2 | 10 | 128 | cardiac septum development |
| GO:0051253 | 0.00000 | 2.50877 | 15 | 35 | 1239 | negative regulation of RNA metabolic process |
| GO:0060840 | 0.00000 | 8.04426 | 1 | 9 | 101 | artery development |
| GO:0006915 | 0.00000 | 2.22417 | 23 | 46 | 1860 | apoptotic process |
| GO:1901576 | 0.00001 | 1.80477 | 61 | 93 | 4910 | organic substance biosynthetic process |
| GO:0010628 | 0.00001 | 2.19755 | 24 | 47 | 1925 | positive regulation of gene expression |
| GO:0016055 | 0.00001 | 3.77264 | 5 | 18 | 418 | Wnt signaling pathway |
| GO:0060560 | 0.00001 | 4.69479 | 3 | 14 | 262 | developmental growth involved in morphogenesis |
| GO:0061326 | 0.00001 | 7.87242 | 1 | 9 | 103 | renal tubule development |
| GO:0045682 | 0.00001 | 9.37307 | 1 | 8 | 78 | regulation of epidermis development |
| GO:0198738 | 0.00001 | 3.75354 | 5 | 18 | 420 | cell-cell signaling by wnt |
| GO:0045684 | 0.00001 | 15.78762 | 0 | 6 | 37 | positive regulation of epidermis development |
| GO:0044092 | 0.00001 | 2.67412 | 12 | 30 | 990 | negative regulation of molecular function |
| GO:0009058 | 0.00001 | 1.79153 | 62 | 94 | 5000 | biosynthetic process |
| GO:0048732 | 0.00001 | 3.56936 | 6 | 19 | 466 | gland development |
| GO:0045598 | 0.00001 | 6.70042 | 2 | 10 | 133 | regulation of fat cell differentiation |
| GO:0045880 | 0.00001 | 15.29359 | 0 | 6 | 38 | positive regulation of smoothened signaling pathway |
| GO:0016049 | 0.00001 | 3.41242 | 6 | 20 | 513 | cell growth |
| GO:0042060 | 0.00001 | 4.05980 | 4 | 16 | 345 | wound healing |
| GO:0120036 | 0.00001 | 2.33886 | 18 | 39 | 1485 | plasma membrane bounded cell projection organization |
| GO:0060346 | 0.00001 | 46.33014 | 0 | 4 | 11 | bone trabecula formation |
| GO:1902679 | 0.00001 | 2.52306 | 14 | 33 | 1157 | negative regulation of RNA biosynthetic process |
| GO:0030282 | 0.00001 | 7.47319 | 1 | 9 | 108 | bone mineralization |
| GO:0060255 | 0.00001 | 1.75947 | 67 | 99 | 5386 | regulation of macromolecule metabolic process |
| GO:0044249 | 0.00001 | 1.78720 | 60 | 91 | 4824 | cellular biosynthetic process |
| GO:0072009 | 0.00001 | 7.39813 | 1 | 9 | 109 | nephron epithelium development |
| GO:0034103 | 0.00001 | 8.74628 | 1 | 8 | 83 | regulation of tissue remodeling |
| GO:0009719 | 0.00001 | 2.36636 | 17 | 37 | 1388 | response to endogenous stimulus |
| GO:0009611 | 0.00001 | 3.46648 | 6 | 19 | 479 | response to wounding |
| GO:0001822 | 0.00001 | 4.45839 | 3 | 14 | 275 | kidney development |
| GO:0010941 | 0.00001 | 2.23507 | 21 | 42 | 1677 | regulation of cell death |
| GO:0051234 | 0.00001 | 1.80302 | 55 | 85 | 4428 | establishment of localization |
| GO:0003272 | 0.00001 | 21.40071 | 0 | 5 | 24 | endocardial cushion formation |
| GO:0033688 | 0.00001 | 21.40071 | 0 | 5 | 24 | regulation of osteoblast proliferation |
| GO:0090101 | 0.00001 | 7.25243 | 1 | 9 | 111 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:1905330 | 0.00001 | 7.25243 | 1 | 9 | 111 | regulation of morphogenesis of an epithelium |
| GO:0030858 | 0.00001 | 10.60093 | 1 | 7 | 61 | positive regulation of epithelial cell differentiation |
| GO:0002065 | 0.00001 | 6.24111 | 2 | 10 | 142 | columnar/cuboidal epithelial cell differentiation |
| GO:0010556 | 0.00001 | 1.89701 | 40 | 67 | 3242 | regulation of macromolecule biosynthetic process |
| GO:0030326 | 0.00001 | 6.19391 | 2 | 10 | 143 | embryonic limb morphogenesis |
| GO:0035113 | 0.00001 | 6.19391 | 2 | 10 | 143 | embryonic appendage morphogenesis |
| GO:0002573 | 0.00001 | 5.04033 | 3 | 12 | 209 | myeloid leukocyte differentiation |
| GO:0008610 | 0.00001 | 3.26344 | 7 | 20 | 535 | lipid biosynthetic process |
| GO:0031589 | 0.00001 | 4.06777 | 4 | 15 | 322 | cell-substrate adhesion |
| GO:0044260 | 0.00001 | 1.68769 | 86 | 120 | 6974 | cellular macromolecule metabolic process |
| GO:0008219 | 0.00001 | 2.09478 | 25 | 48 | 2056 | cell death |
| GO:0070887 | 0.00001 | 1.92735 | 36 | 62 | 2933 | cellular response to chemical stimulus |
| GO:0030030 | 0.00001 | 2.26190 | 19 | 39 | 1531 | cell projection organization |
| GO:0034330 | 0.00001 | 4.58644 | 3 | 13 | 248 | cell junction organization |
| GO:0045934 | 0.00001 | 2.33730 | 17 | 36 | 1363 | negative regulation of nucleobase-containing compound metabolic process |
| GO:2001141 | 0.00001 | 1.94834 | 34 | 59 | 2750 | regulation of RNA biosynthetic process |
| GO:0003206 | 0.00002 | 5.96819 | 2 | 10 | 148 | cardiac chamber morphogenesis |
| GO:0045892 | 0.00002 | 2.44387 | 14 | 32 | 1153 | negative regulation of transcription, DNA-templated |
| GO:1903507 | 0.00002 | 2.43701 | 14 | 32 | 1156 | negative regulation of nucleic acid-templated transcription |
| GO:2000112 | 0.00002 | 1.88132 | 39 | 65 | 3156 | regulation of cellular macromolecule biosynthetic process |
| GO:0045665 | 0.00002 | 4.45240 | 3 | 13 | 255 | negative regulation of neuron differentiation |
| GO:0031327 | 0.00002 | 2.27662 | 18 | 37 | 1438 | negative regulation of cellular biosynthetic process |
| GO:1905114 | 0.00002 | 3.25670 | 6 | 19 | 508 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0090596 | 0.00002 | 4.12257 | 4 | 14 | 296 | sensory organ morphogenesis |
| GO:0072507 | 0.00002 | 3.24991 | 6 | 19 | 509 | divalent inorganic cation homeostasis |
| GO:1990138 | 0.00002 | 5.18731 | 2 | 11 | 186 | neuron projection extension |
| GO:0072001 | 0.00002 | 4.10782 | 4 | 14 | 297 | renal system development |
| GO:0045669 | 0.00002 | 9.22984 | 1 | 7 | 69 | positive regulation of osteoblast differentiation |
| GO:0006355 | 0.00003 | 1.91744 | 34 | 58 | 2736 | regulation of transcription, DNA-templated |
| GO:0007610 | 0.00003 | 2.82776 | 9 | 23 | 709 | behavior |
| GO:1903506 | 0.00003 | 1.91259 | 34 | 58 | 2742 | regulation of nucleic acid-templated transcription |
| GO:0031650 | 0.00003 | 29.47767 | 0 | 4 | 15 | regulation of heat generation |
| GO:0045778 | 0.00003 | 7.28379 | 1 | 8 | 98 | positive regulation of ossification |
| GO:0001558 | 0.00003 | 3.41927 | 5 | 17 | 432 | regulation of cell growth |
| GO:0055074 | 0.00003 | 3.27910 | 6 | 18 | 477 | calcium ion homeostasis |
| GO:0060317 | 0.00003 | 16.26028 | 0 | 5 | 30 | cardiac epithelial to mesenchymal transition |
| GO:0003205 | 0.00003 | 4.95880 | 2 | 11 | 194 | cardiac chamber development |
| GO:1902106 | 0.00003 | 7.20343 | 1 | 8 | 99 | negative regulation of leukocyte differentiation |
| GO:0009890 | 0.00003 | 2.21588 | 18 | 37 | 1474 | negative regulation of biosynthetic process |
| GO:0048638 | 0.00003 | 3.54495 | 5 | 16 | 392 | regulation of developmental growth |
| GO:0048844 | 0.00003 | 8.66894 | 1 | 7 | 73 | artery morphogenesis |
| GO:0014014 | 0.00003 | 11.11679 | 1 | 6 | 50 | negative regulation of gliogenesis |
| GO:0009059 | 0.00004 | 1.76336 | 50 | 77 | 4028 | macromolecule biosynthetic process |
| GO:0051128 | 0.00004 | 1.93146 | 31 | 54 | 2513 | regulation of cellular component organization |
| GO:0071895 | 0.00004 | 80.80634 | 0 | 3 | 6 | odontoblast differentiation |
| GO:0072503 | 0.00004 | 3.22884 | 6 | 18 | 484 | cellular divalent inorganic cation homeostasis |
| GO:0007160 | 0.00004 | 4.85188 | 2 | 11 | 198 | cell-matrix adhesion |
| GO:1904018 | 0.00004 | 4.85188 | 2 | 11 | 198 | positive regulation of vasculature development |
| GO:0072132 | 0.00004 | 10.86928 | 1 | 6 | 51 | mesenchyme morphogenesis |
| GO:0042303 | 0.00004 | 6.00869 | 2 | 9 | 132 | molting cycle |
| GO:0042633 | 0.00004 | 6.00869 | 2 | 9 | 132 | hair cycle |
| GO:0032774 | 0.00004 | 1.87384 | 35 | 59 | 2844 | RNA biosynthetic process |
| GO:0048568 | 0.00004 | 3.20079 | 6 | 18 | 488 | embryonic organ development |
| GO:0098657 | 0.00004 | 2.62180 | 10 | 25 | 831 | import into cell |
| GO:0043583 | 0.00004 | 4.40766 | 3 | 12 | 237 | ear development |
| GO:0030216 | 0.00004 | 5.95997 | 2 | 9 | 133 | keratinocyte differentiation |
| GO:0048675 | 0.00004 | 5.95997 | 2 | 9 | 133 | axon extension |
| GO:0045879 | 0.00004 | 15.05450 | 0 | 5 | 32 | negative regulation of smoothened signaling pathway |
| GO:0030514 | 0.00004 | 10.63252 | 1 | 6 | 52 | negative regulation of BMP signaling pathway |
| GO:0045599 | 0.00004 | 10.63252 | 1 | 6 | 52 | negative regulation of fat cell differentiation |
| GO:0045604 | 0.00004 | 10.63252 | 1 | 6 | 52 | regulation of epidermal cell differentiation |
| GO:0044238 | 0.00004 | 1.60667 | 115 | 148 | 9296 | primary metabolic process |
| GO:0051252 | 0.00004 | 1.84876 | 37 | 61 | 2985 | regulation of RNA metabolic process |
| GO:0001667 | 0.00005 | 3.44251 | 5 | 16 | 403 | ameboidal-type cell migration |
| GO:0010558 | 0.00005 | 2.22418 | 17 | 35 | 1384 | negative regulation of macromolecule biosynthetic process |
| GO:0032102 | 0.00005 | 3.80782 | 4 | 14 | 319 | negative regulation of response to external stimulus |
| GO:0001890 | 0.00005 | 5.20815 | 2 | 10 | 168 | placenta development |
| GO:0045893 | 0.00005 | 2.17070 | 19 | 37 | 1502 | positive regulation of transcription, DNA-templated |
| GO:0051248 | 0.00005 | 2.40947 | 13 | 29 | 1052 | negative regulation of protein metabolic process |
| GO:0048841 | 0.00005 | 14.51621 | 0 | 5 | 33 | regulation of axon extension involved in axon guidance |
| GO:1903508 | 0.00005 | 2.16596 | 19 | 37 | 1505 | positive regulation of nucleic acid-templated transcription |
| GO:1902680 | 0.00005 | 2.16439 | 19 | 37 | 1506 | positive regulation of RNA biosynthetic process |
| GO:2000027 | 0.00005 | 4.65119 | 3 | 11 | 206 | regulation of animal organ morphogenesis |
| GO:0003203 | 0.00006 | 14.01504 | 0 | 5 | 34 | endocardial cushion morphogenesis |
| GO:0003002 | 0.00006 | 3.53051 | 5 | 15 | 368 | regionalization |
| GO:0007613 | 0.00006 | 5.68340 | 2 | 9 | 139 | memory |
| GO:0071310 | 0.00006 | 1.92089 | 29 | 51 | 2372 | cellular response to organic substance |
| GO:0048712 | 0.00006 | 23.15800 | 0 | 4 | 18 | negative regulation of astrocyte differentiation |
| GO:0009612 | 0.00006 | 5.04729 | 2 | 10 | 173 | response to mechanical stimulus |
| GO:0065009 | 0.00006 | 1.90817 | 30 | 52 | 2437 | regulation of molecular function |
| GO:1900084 | 0.00006 | 60.60211 | 0 | 3 | 7 | regulation of peptidyl-tyrosine autophosphorylation |
| GO:0050680 | 0.00006 | 5.63977 | 2 | 9 | 140 | negative regulation of epithelial cell proliferation |
| GO:0044237 | 0.00006 | 1.58974 | 114 | 146 | 9199 | cellular metabolic process |
| GO:1902105 | 0.00006 | 3.92687 | 4 | 13 | 287 | regulation of leukocyte differentiation |
| GO:0006351 | 0.00006 | 1.84686 | 35 | 58 | 2826 | transcription, DNA-templated |
| GO:0006874 | 0.00006 | 3.19917 | 6 | 17 | 460 | cellular calcium ion homeostasis |
| GO:0007224 | 0.00007 | 5.59680 | 2 | 9 | 141 | smoothened signaling pathway |
| GO:0072006 | 0.00007 | 5.59680 | 2 | 9 | 141 | nephron development |
| GO:2000113 | 0.00007 | 2.20587 | 17 | 34 | 1352 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0097659 | 0.00007 | 1.84232 | 35 | 58 | 2832 | nucleic acid-templated transcription |
| GO:0043269 | 0.00007 | 2.71500 | 9 | 22 | 703 | regulation of ion transport |
| GO:0045216 | 0.00007 | 5.55447 | 2 | 9 | 142 | cell-cell junction organization |
| GO:0044281 | 0.00007 | 2.06643 | 21 | 40 | 1708 | small molecule metabolic process |
| GO:0051336 | 0.00007 | 2.43177 | 12 | 27 | 967 | regulation of hydrolase activity |
| GO:0060562 | 0.00007 | 3.46078 | 5 | 15 | 375 | epithelial tube morphogenesis |
| GO:0051049 | 0.00007 | 2.01134 | 23 | 43 | 1892 | regulation of transport |
| GO:0003151 | 0.00008 | 7.52500 | 1 | 7 | 83 | outflow tract morphogenesis |
| GO:0048588 | 0.00008 | 4.12945 | 3 | 12 | 252 | developmental cell growth |
| GO:0048710 | 0.00008 | 13.10970 | 0 | 5 | 36 | regulation of astrocyte differentiation |
| GO:0001942 | 0.00008 | 6.29942 | 1 | 8 | 112 | hair follicle development |
| GO:0051130 | 0.00008 | 2.24314 | 15 | 32 | 1248 | positive regulation of cellular component organization |
| GO:1901362 | 0.00008 | 1.76532 | 43 | 67 | 3444 | organic cyclic compound biosynthetic process |
| GO:0060443 | 0.00008 | 9.40323 | 1 | 6 | 58 | mammary gland morphogenesis |
| GO:0006950 | 0.00008 | 1.75879 | 43 | 68 | 3512 | response to stress |
| GO:0007219 | 0.00008 | 4.86681 | 2 | 10 | 179 | Notch signaling pathway |
| GO:0042475 | 0.00008 | 7.42695 | 1 | 7 | 84 | odontogenesis of dentin-containing tooth |
| GO:0045766 | 0.00009 | 4.83797 | 2 | 10 | 180 | positive regulation of angiogenesis |
| GO:0098773 | 0.00009 | 6.18002 | 1 | 8 | 114 | skin epidermis development |
| GO:0048846 | 0.00009 | 12.69947 | 0 | 5 | 37 | axon extension involved in axon guidance |
| GO:1902284 | 0.00009 | 12.69947 | 0 | 5 | 37 | neuron projection extension involved in neuron projection guidance |
| GO:0046850 | 0.00009 | 9.22541 | 1 | 6 | 59 | regulation of bone remodeling |
| GO:0034645 | 0.00009 | 1.71890 | 49 | 74 | 3933 | cellular macromolecule biosynthetic process |
| GO:0022404 | 0.00009 | 6.12200 | 1 | 8 | 115 | molting cycle process |
| GO:0022405 | 0.00009 | 6.12200 | 1 | 8 | 115 | hair cycle process |
| GO:0070977 | 0.00009 | 20.26148 | 0 | 4 | 20 | bone maturation |
| GO:0072087 | 0.00009 | 20.26148 | 0 | 4 | 20 | renal vesicle development |
| GO:0003281 | 0.00010 | 7.23829 | 1 | 7 | 86 | ventricular septum development |
| GO:0010717 | 0.00010 | 7.23829 | 1 | 7 | 86 | regulation of epithelial to mesenchymal transition |
| GO:0071495 | 0.00010 | 2.24229 | 15 | 31 | 1207 | cellular response to endogenous stimulus |
| GO:1905332 | 0.00010 | 12.31410 | 0 | 5 | 38 | positive regulation of morphogenesis of an epithelium |
| GO:0045765 | 0.00010 | 3.74685 | 4 | 13 | 300 | regulation of angiogenesis |
| GO:0042592 | 0.00010 | 1.99641 | 23 | 42 | 1857 | homeostatic process |
| GO:0043086 | 0.00010 | 2.70874 | 8 | 21 | 671 | negative regulation of catalytic activity |
| GO:0001656 | 0.00010 | 7.14750 | 1 | 7 | 87 | metanephros development |
| GO:0032269 | 0.00011 | 2.37378 | 12 | 27 | 989 | negative regulation of cellular protein metabolic process |
| GO:0007595 | 0.00011 | 8.88916 | 1 | 6 | 61 | lactation |
| GO:0051924 | 0.00011 | 3.97862 | 3 | 12 | 261 | regulation of calcium ion transport |
| GO:0007420 | 0.00011 | 2.77154 | 8 | 20 | 624 | brain development |
| GO:0071704 | 0.00011 | 1.56380 | 122 | 153 | 9839 | organic substance metabolic process |
| GO:0045834 | 0.00011 | 5.20037 | 2 | 9 | 151 | positive regulation of lipid metabolic process |
| GO:0060322 | 0.00011 | 2.68325 | 8 | 21 | 677 | head development |
| GO:0048771 | 0.00012 | 4.64521 | 2 | 10 | 187 | tissue remodeling |
| GO:0051962 | 0.00012 | 2.74817 | 8 | 20 | 629 | positive regulation of nervous system development |
| GO:0010557 | 0.00012 | 2.00916 | 22 | 40 | 1752 | positive regulation of macromolecule biosynthetic process |
| GO:0030512 | 0.00013 | 8.57651 | 1 | 6 | 63 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0046889 | 0.00013 | 6.88825 | 1 | 7 | 90 | positive regulation of lipid biosynthetic process |
| GO:0060603 | 0.00013 | 11.60942 | 0 | 5 | 40 | mammary gland duct morphogenesis |
| GO:0031623 | 0.00013 | 5.79541 | 1 | 8 | 121 | receptor internalization |
| GO:1903706 | 0.00013 | 3.26699 | 5 | 15 | 396 | regulation of hemopoiesis |
| GO:0051271 | 0.00013 | 3.63149 | 4 | 13 | 309 | negative regulation of cellular component movement |
| GO:0000122 | 0.00014 | 2.46923 | 10 | 24 | 842 | negative regulation of transcription by RNA polymerase II |
| GO:0031649 | 0.00014 | 18.00864 | 0 | 4 | 22 | heat generation |
| GO:0060749 | 0.00014 | 18.00864 | 0 | 4 | 22 | mammary gland alveolus development |
| GO:0061377 | 0.00014 | 18.00864 | 0 | 4 | 22 | mammary gland lobule development |
| GO:0002761 | 0.00014 | 5.74432 | 2 | 8 | 122 | regulation of myeloid leukocyte differentiation |
| GO:0042326 | 0.00015 | 3.09970 | 5 | 16 | 445 | negative regulation of phosphorylation |
| GO:0048608 | 0.00015 | 3.09970 | 5 | 16 | 445 | reproductive structure development |
| GO:0006629 | 0.00015 | 2.18925 | 15 | 31 | 1234 | lipid metabolic process |
| GO:0042368 | 0.00015 | 40.39789 | 0 | 3 | 9 | vitamin D biosynthetic process |
| GO:0060028 | 0.00015 | 40.39789 | 0 | 3 | 9 | convergent extension involved in axis elongation |
| GO:0060556 | 0.00015 | 40.39789 | 0 | 3 | 9 | regulation of vitamin D biosynthetic process |
| GO:1903589 | 0.00015 | 40.39789 | 0 | 3 | 9 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0007417 | 0.00015 | 2.45368 | 10 | 24 | 847 | central nervous system development |
| GO:0045165 | 0.00015 | 3.82332 | 3 | 12 | 271 | cell fate commitment |
| GO:1903845 | 0.00015 | 8.28506 | 1 | 6 | 65 | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0062014 | 0.00016 | 6.64709 | 1 | 7 | 93 | negative regulation of small molecule metabolic process |
| GO:0030177 | 0.00016 | 5.64479 | 2 | 8 | 124 | positive regulation of Wnt signaling pathway |
| GO:0001933 | 0.00016 | 3.21549 | 5 | 15 | 402 | negative regulation of protein phosphorylation |
| GO:0061458 | 0.00016 | 3.07052 | 6 | 16 | 449 | reproductive system development |
| GO:0050890 | 0.00016 | 3.55839 | 4 | 13 | 315 | cognition |
| GO:0042220 | 0.00016 | 10.98093 | 1 | 5 | 42 | response to cocaine |
| GO:0060135 | 0.00016 | 10.98093 | 1 | 5 | 42 | maternal process involved in female pregnancy |
| GO:0007423 | 0.00016 | 2.75901 | 7 | 19 | 594 | sensory organ development |
| GO:0090190 | 0.00017 | 17.06007 | 0 | 4 | 23 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0097186 | 0.00017 | 17.06007 | 0 | 4 | 23 | amelogenesis |
| GO:0051254 | 0.00017 | 2.02671 | 20 | 37 | 1599 | positive regulation of RNA metabolic process |
| GO:0098660 | 0.00017 | 2.66712 | 8 | 20 | 647 | inorganic ion transmembrane transport |
| GO:0050790 | 0.00017 | 1.97177 | 22 | 40 | 1782 | regulation of catalytic activity |
| GO:0006766 | 0.00018 | 8.01272 | 1 | 6 | 67 | vitamin metabolic process |
| GO:0003416 | 0.00018 | 10.69149 | 1 | 5 | 43 | endochondral bone growth |
| GO:0019220 | 0.00018 | 2.00026 | 21 | 38 | 1665 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00019 | 1.99893 | 21 | 38 | 1666 | regulation of phosphorus metabolic process |
| GO:0098662 | 0.00019 | 2.72497 | 7 | 19 | 601 | inorganic cation transmembrane transport |
| GO:0046849 | 0.00019 | 6.42219 | 1 | 7 | 96 | bone remodeling |
| GO:0008152 | 0.00019 | 1.53693 | 128 | 158 | 10337 | metabolic process |
| GO:0019219 | 0.00019 | 1.72785 | 40 | 63 | 3276 | regulation of nucleobase-containing compound metabolic process |
| GO:0034104 | 0.00020 | 16.20636 | 0 | 4 | 24 | negative regulation of tissue remodeling |
| GO:0048799 | 0.00020 | 16.20636 | 0 | 4 | 24 | animal organ maturation |
| GO:0002521 | 0.00020 | 2.79842 | 7 | 18 | 554 | leukocyte differentiation |
| GO:0045807 | 0.00020 | 4.79263 | 2 | 9 | 163 | positive regulation of endocytosis |
| GO:0034329 | 0.00020 | 4.32491 | 2 | 10 | 200 | cell junction assembly |
| GO:0090184 | 0.00020 | 10.41689 | 1 | 5 | 44 | positive regulation of kidney development |
| GO:1901700 | 0.00021 | 2.02516 | 19 | 36 | 1554 | response to oxygen-containing compound |
| GO:0002934 | 0.00021 | 34.62525 | 0 | 3 | 10 | desmosome organization |
| GO:0031620 | 0.00021 | 34.62525 | 0 | 3 | 10 | regulation of fever generation |
| GO:1903011 | 0.00021 | 34.62525 | 0 | 3 | 10 | negative regulation of bone development |
| GO:0110110 | 0.00022 | 6.28049 | 1 | 7 | 98 | positive regulation of animal organ morphogenesis |
| GO:0006633 | 0.00022 | 5.36577 | 2 | 8 | 130 | fatty acid biosynthetic process |
| GO:0010468 | 0.00022 | 1.67955 | 47 | 70 | 3768 | regulation of gene expression |
| GO:0007389 | 0.00022 | 2.97930 | 6 | 16 | 462 | pattern specification process |
| GO:0006796 | 0.00022 | 1.75785 | 36 | 57 | 2893 | phosphate-containing compound metabolic process |
| GO:0040013 | 0.00023 | 3.43167 | 4 | 13 | 326 | negative regulation of locomotion |
| GO:0071526 | 0.00023 | 10.15603 | 1 | 5 | 45 | semaphorin-plexin signaling pathway |
| GO:0098868 | 0.00023 | 10.15603 | 1 | 5 | 45 | bone growth |
| GO:1902667 | 0.00023 | 10.15603 | 1 | 5 | 45 | regulation of axon guidance |
| GO:0010894 | 0.00023 | 15.43396 | 0 | 4 | 25 | negative regulation of steroid biosynthetic process |
| GO:0045939 | 0.00023 | 15.43396 | 0 | 4 | 25 | negative regulation of steroid metabolic process |
| GO:0061213 | 0.00023 | 15.43396 | 0 | 4 | 25 | positive regulation of mesonephros development |
| GO:0010629 | 0.00024 | 1.95473 | 22 | 39 | 1748 | negative regulation of gene expression |
| GO:0044283 | 0.00024 | 2.66849 | 8 | 19 | 613 | small molecule biosynthetic process |
| GO:0019218 | 0.00024 | 6.14489 | 1 | 7 | 100 | regulation of steroid metabolic process |
| GO:0022414 | 0.00025 | 2.04698 | 18 | 34 | 1448 | reproductive process |
| GO:0008202 | 0.00025 | 3.61163 | 4 | 12 | 286 | steroid metabolic process |
| GO:0000003 | 0.00025 | 2.04544 | 18 | 34 | 1449 | reproduction |
| GO:0048839 | 0.00026 | 4.19141 | 3 | 10 | 206 | inner ear development |
| GO:0006793 | 0.00027 | 1.74311 | 36 | 57 | 2914 | phosphorus metabolic process |
| GO:0006875 | 0.00027 | 2.72549 | 7 | 18 | 568 | cellular metal ion homeostasis |
| GO:0034654 | 0.00027 | 1.70831 | 40 | 62 | 3250 | nucleobase-containing compound biosynthetic process |
| GO:0090189 | 0.00027 | 14.73177 | 0 | 4 | 26 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0030198 | 0.00028 | 3.81986 | 3 | 11 | 248 | extracellular matrix organization |
| GO:0003197 | 0.00028 | 9.67156 | 1 | 5 | 47 | endocardial cushion development |
| GO:0051055 | 0.00028 | 9.67156 | 1 | 5 | 47 | negative regulation of lipid biosynthetic process |
| GO:0043170 | 0.00028 | 1.52483 | 103 | 132 | 8357 | macromolecule metabolic process |
| GO:0042493 | 0.00028 | 2.34136 | 11 | 24 | 885 | response to drug |
| GO:0097084 | 0.00029 | 30.29577 | 0 | 3 | 11 | vascular smooth muscle cell development |
| GO:0019438 | 0.00029 | 1.69828 | 41 | 63 | 3324 | aromatic compound biosynthetic process |
| GO:0048871 | 0.00029 | 2.90617 | 6 | 16 | 473 | multicellular organismal homeostasis |
| GO:0043062 | 0.00030 | 3.53330 | 4 | 12 | 292 | extracellular structure organization |
| GO:0050873 | 0.00031 | 9.44623 | 1 | 5 | 48 | brown fat cell differentiation |
| GO:0003006 | 0.00031 | 2.42415 | 10 | 22 | 782 | developmental process involved in reproduction |
| GO:0030900 | 0.00031 | 3.14716 | 5 | 14 | 382 | forebrain development |
| GO:0042692 | 0.00031 | 3.14716 | 5 | 14 | 382 | muscle cell differentiation |
| GO:0030316 | 0.00031 | 5.89046 | 1 | 7 | 104 | osteoclast differentiation |
| GO:0045446 | 0.00031 | 5.89046 | 1 | 7 | 104 | endothelial cell differentiation |
| GO:0003338 | 0.00032 | 14.09064 | 0 | 4 | 27 | metanephros morphogenesis |
| GO:0033561 | 0.00032 | 14.09064 | 0 | 4 | 27 | regulation of water loss via skin |
| GO:0060343 | 0.00032 | 14.09064 | 0 | 4 | 27 | trabecula formation |
| GO:0061311 | 0.00032 | 14.09064 | 0 | 4 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0035148 | 0.00033 | 4.47096 | 2 | 9 | 174 | tube formation |
| GO:0048738 | 0.00033 | 3.74012 | 3 | 11 | 253 | cardiac muscle tissue development |
| GO:0006898 | 0.00033 | 4.04563 | 3 | 10 | 213 | receptor-mediated endocytosis |
| GO:0061061 | 0.00034 | 2.52215 | 8 | 20 | 682 | muscle structure development |
| GO:0060444 | 0.00037 | 13.50294 | 0 | 4 | 28 | branching involved in mammary gland duct morphogenesis |
| GO:0061217 | 0.00037 | 13.50294 | 0 | 4 | 28 | regulation of mesonephros development |
| GO:0042362 | 0.00038 | 26.92840 | 0 | 3 | 12 | fat-soluble vitamin biosynthetic process |
| GO:0051798 | 0.00038 | 26.92840 | 0 | 3 | 12 | positive regulation of hair follicle development |
| GO:0061180 | 0.00038 | 6.88116 | 1 | 6 | 77 | mammary gland epithelium development |
| GO:0030516 | 0.00039 | 5.65619 | 1 | 7 | 108 | regulation of axon extension |
| GO:0055085 | 0.00041 | 2.07935 | 15 | 30 | 1250 | transmembrane transport |
| GO:0060351 | 0.00041 | 8.82902 | 1 | 5 | 51 | cartilage development involved in endochondral bone morphogenesis |
| GO:0060412 | 0.00041 | 8.82902 | 1 | 5 | 51 | ventricular septum morphogenesis |
| GO:0048708 | 0.00041 | 6.78529 | 1 | 6 | 78 | astrocyte differentiation |
| GO:0060976 | 0.00041 | 6.78529 | 1 | 6 | 78 | coronary vasculature development |
| GO:0051346 | 0.00041 | 3.05433 | 5 | 14 | 393 | negative regulation of hydrolase activity |
| GO:0010563 | 0.00041 | 2.71079 | 7 | 17 | 538 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00041 | 2.71079 | 7 | 17 | 538 | negative regulation of phosphate metabolic process |
| GO:0071695 | 0.00042 | 4.31295 | 2 | 9 | 180 | anatomical structure maturation |
| GO:0001958 | 0.00042 | 12.96226 | 0 | 4 | 29 | endochondral ossification |
| GO:0002092 | 0.00042 | 12.96226 | 0 | 4 | 29 | positive regulation of receptor internalization |
| GO:0036075 | 0.00042 | 12.96226 | 0 | 4 | 29 | replacement ossification |
| GO:0010979 | 0.00045 | 161.05965 | 0 | 2 | 3 | regulation of vitamin D 24-hydroxylase activity |
| GO:0010980 | 0.00045 | 161.05965 | 0 | 2 | 3 | positive regulation of vitamin D 24-hydroxylase activity |
| GO:0060300 | 0.00045 | 161.05965 | 0 | 2 | 3 | regulation of cytokine activity |
| GO:0072034 | 0.00045 | 161.05965 | 0 | 2 | 3 | renal vesicle induction |
| GO:0097187 | 0.00045 | 161.05965 | 0 | 2 | 3 | dentinogenesis |
| GO:1901329 | 0.00045 | 161.05965 | 0 | 2 | 3 | regulation of odontoblast differentiation |
| GO:0018130 | 0.00046 | 1.66986 | 41 | 62 | 3313 | heterocycle biosynthetic process |
| GO:0044255 | 0.00046 | 2.25945 | 11 | 24 | 915 | cellular lipid metabolic process |
| GO:0034220 | 0.00046 | 2.30189 | 11 | 23 | 860 | ion transmembrane transport |
| GO:0001952 | 0.00046 | 5.49231 | 1 | 7 | 111 | regulation of cell-matrix adhesion |
| GO:0060627 | 0.00047 | 2.67921 | 7 | 17 | 544 | regulation of vesicle-mediated transport |
| GO:0022612 | 0.00048 | 4.74033 | 2 | 8 | 146 | gland morphogenesis |
| GO:0048863 | 0.00048 | 3.85400 | 3 | 10 | 223 | stem cell differentiation |
| GO:0001660 | 0.00049 | 24.23451 | 0 | 3 | 13 | fever generation |
| GO:0031223 | 0.00049 | 24.23451 | 0 | 3 | 13 | auditory behavior |
| GO:0031652 | 0.00049 | 24.23451 | 0 | 3 | 13 | positive regulation of heat generation |
| GO:0033690 | 0.00049 | 24.23451 | 0 | 3 | 13 | positive regulation of osteoblast proliferation |
| GO:0042635 | 0.00049 | 24.23451 | 0 | 3 | 13 | positive regulation of hair cycle |
| GO:1903587 | 0.00049 | 24.23451 | 0 | 3 | 13 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:2001212 | 0.00049 | 24.23451 | 0 | 3 | 13 | regulation of vasculogenesis |
| GO:0042476 | 0.00049 | 5.43976 | 1 | 7 | 112 | odontogenesis |
| GO:0030534 | 0.00049 | 4.21363 | 2 | 9 | 184 | adult behavior |
| GO:0042325 | 0.00051 | 1.95819 | 19 | 34 | 1508 | regulation of phosphorylation |
| GO:0007589 | 0.00052 | 5.38821 | 1 | 7 | 113 | body fluid secretion |
| GO:0003231 | 0.00052 | 4.67220 | 2 | 8 | 148 | cardiac ventricle development |
| GO:0019217 | 0.00054 | 6.42705 | 1 | 6 | 82 | regulation of fatty acid metabolic process |
| GO:0098609 | 0.00054 | 2.42764 | 9 | 20 | 707 | cell-cell adhesion |
| GO:0045616 | 0.00055 | 12.00105 | 0 | 4 | 31 | regulation of keratinocyte differentiation |
| GO:0055065 | 0.00056 | 2.48357 | 8 | 19 | 656 | metal ion homeostasis |
| GO:0002683 | 0.00057 | 2.82808 | 6 | 15 | 454 | negative regulation of immune system process |
| GO:0015672 | 0.00057 | 2.82808 | 6 | 15 | 454 | monovalent inorganic cation transport |
| GO:0001932 | 0.00057 | 1.98613 | 17 | 32 | 1396 | regulation of protein phosphorylation |
| GO:0050731 | 0.00057 | 4.11875 | 2 | 9 | 188 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0010959 | 0.00058 | 2.94369 | 5 | 14 | 407 | regulation of metal ion transport |
| GO:0035567 | 0.00058 | 8.12128 | 1 | 5 | 55 | non-canonical Wnt signaling pathway |
| GO:0003158 | 0.00060 | 5.23922 | 1 | 7 | 116 | endothelium development |
| GO:0030656 | 0.00061 | 22.03041 | 0 | 3 | 14 | regulation of vitamin metabolic process |
| GO:0032769 | 0.00061 | 22.03041 | 0 | 3 | 14 | negative regulation of monooxygenase activity |
| GO:2000095 | 0.00061 | 22.03041 | 0 | 3 | 14 | regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0006694 | 0.00062 | 4.54162 | 2 | 8 | 152 | steroid biosynthetic process |
| GO:0001964 | 0.00062 | 11.57193 | 0 | 4 | 32 | startle response |
| GO:0006775 | 0.00062 | 11.57193 | 0 | 4 | 32 | fat-soluble vitamin metabolic process |
| GO:0048260 | 0.00063 | 7.96169 | 1 | 5 | 56 | positive regulation of receptor-mediated endocytosis |
| GO:0072347 | 0.00063 | 7.96169 | 1 | 5 | 56 | response to anesthetic |
| GO:0030155 | 0.00065 | 2.45189 | 8 | 19 | 664 | regulation of cell adhesion |
| GO:0060537 | 0.00065 | 2.78920 | 6 | 15 | 460 | muscle tissue development |
| GO:0045833 | 0.00065 | 6.18217 | 1 | 6 | 85 | negative regulation of lipid metabolic process |
| GO:0050769 | 0.00066 | 2.59352 | 7 | 17 | 561 | positive regulation of neurogenesis |
| GO:0071496 | 0.00066 | 3.42512 | 3 | 11 | 275 | cellular response to external stimulus |
| GO:2000146 | 0.00066 | 3.42512 | 3 | 11 | 275 | negative regulation of cell motility |
| GO:0030308 | 0.00067 | 4.02801 | 2 | 9 | 192 | negative regulation of cell growth |
| GO:0010565 | 0.00067 | 5.14437 | 1 | 7 | 118 | regulation of cellular ketone metabolic process |
| GO:0044271 | 0.00068 | 1.60150 | 48 | 70 | 3918 | cellular nitrogen compound biosynthetic process |
| GO:1903707 | 0.00068 | 4.47901 | 2 | 8 | 154 | negative regulation of hemopoiesis |
| GO:0010463 | 0.00069 | 7.80824 | 1 | 5 | 57 | mesenchymal cell proliferation |
| GO:0098900 | 0.00069 | 7.80824 | 1 | 5 | 57 | regulation of action potential |
| GO:0055114 | 0.00069 | 2.19031 | 12 | 24 | 942 | oxidation-reduction process |
| GO:0055080 | 0.00069 | 2.37766 | 9 | 20 | 721 | cation homeostasis |
| GO:0045685 | 0.00069 | 6.10463 | 1 | 6 | 86 | regulation of glial cell differentiation |
| GO:0097435 | 0.00069 | 2.43634 | 8 | 19 | 668 | supramolecular fiber organization |
| GO:0071634 | 0.00070 | 11.17241 | 0 | 4 | 33 | regulation of transforming growth factor beta production |
| GO:0050679 | 0.00074 | 3.96252 | 2 | 9 | 195 | positive regulation of epithelial cell proliferation |
| GO:0090183 | 0.00074 | 7.66058 | 1 | 5 | 58 | regulation of kidney development |
| GO:0098655 | 0.00075 | 2.42098 | 8 | 19 | 672 | cation transmembrane transport |
| GO:0006807 | 0.00076 | 1.47231 | 108 | 135 | 8771 | nitrogen compound metabolic process |
| GO:0042359 | 0.00076 | 20.19366 | 0 | 3 | 15 | vitamin D metabolic process |
| GO:0048715 | 0.00076 | 20.19366 | 0 | 3 | 15 | negative regulation of oligodendrocyte differentiation |
| GO:1901213 | 0.00076 | 20.19366 | 0 | 3 | 15 | regulation of transcription from RNA polymerase II promoter involved in heart development |
| GO:0034332 | 0.00078 | 5.00833 | 1 | 7 | 121 | adherens junction organization |
| GO:0045746 | 0.00079 | 10.79953 | 0 | 4 | 34 | negative regulation of Notch signaling pathway |
| GO:0046903 | 0.00080 | 2.03834 | 15 | 28 | 1184 | secretion |
| GO:0001755 | 0.00081 | 7.51839 | 1 | 5 | 59 | neural crest cell migration |
| GO:0051246 | 0.00081 | 1.69820 | 33 | 51 | 2642 | regulation of protein metabolic process |
| GO:0007611 | 0.00081 | 3.33562 | 3 | 11 | 282 | learning or memory |
| GO:0030003 | 0.00083 | 2.46327 | 8 | 18 | 625 | cellular cation homeostasis |
| GO:0001938 | 0.00083 | 5.88321 | 1 | 6 | 89 | positive regulation of endothelial cell proliferation |
| GO:0006468 | 0.00084 | 1.83418 | 22 | 38 | 1801 | protein phosphorylation |
| GO:0061387 | 0.00085 | 4.92155 | 2 | 7 | 123 | regulation of extent of cell growth |
| GO:1902652 | 0.00085 | 4.92155 | 2 | 7 | 123 | secondary alcohol metabolic process |
| GO:0014031 | 0.00088 | 5.81291 | 1 | 6 | 90 | mesenchymal cell development |
| GO:0070167 | 0.00088 | 5.81291 | 1 | 6 | 90 | regulation of biomineral tissue development |
| GO:0071604 | 0.00088 | 10.45070 | 0 | 4 | 35 | transforming growth factor beta production |
| GO:0098771 | 0.00089 | 2.32628 | 9 | 20 | 736 | inorganic ion homeostasis |
| GO:0045944 | 0.00089 | 2.02176 | 15 | 28 | 1193 | positive regulation of transcription by RNA polymerase II |
| GO:0032268 | 0.00089 | 1.71504 | 30 | 48 | 2454 | regulation of cellular protein metabolic process |
| GO:0019853 | 0.00090 | 80.52632 | 0 | 2 | 4 | L-ascorbic acid biosynthetic process |
| GO:1903964 | 0.00090 | 80.52632 | 0 | 2 | 4 | monounsaturated fatty acid metabolic process |
| GO:1903966 | 0.00090 | 80.52632 | 0 | 2 | 4 | monounsaturated fatty acid biosynthetic process |
| GO:0007638 | 0.00093 | 18.63949 | 0 | 3 | 16 | mechanosensory behavior |
| GO:0060026 | 0.00093 | 18.63949 | 0 | 3 | 16 | convergent extension |
| GO:0010171 | 0.00094 | 7.24924 | 1 | 5 | 61 | body morphogenesis |
| GO:0003417 | 0.00098 | 10.12367 | 0 | 4 | 36 | growth plate cartilage development |
| GO:0035886 | 0.00098 | 10.12367 | 0 | 4 | 36 | vascular smooth muscle cell differentiation |
| GO:0050919 | 0.00098 | 10.12367 | 0 | 4 | 36 | negative chemotaxis |
| GO:0060071 | 0.00098 | 10.12367 | 0 | 4 | 36 | Wnt signaling pathway, planar cell polarity pathway |
| GO:2000273 | 0.00098 | 10.12367 | 0 | 4 | 36 | positive regulation of signaling receptor activity |
| GO:0010975 | 0.00099 | 2.49478 | 7 | 17 | 582 | regulation of neuron projection development |
| GO:0001570 | 0.00099 | 5.67723 | 1 | 6 | 92 | vasculogenesis |
| GO:0050801 | 0.00101 | 2.25010 | 10 | 21 | 799 | ion homeostasis |
| GO:0003229 | 0.00101 | 7.12175 | 1 | 5 | 62 | ventricular cardiac muscle tissue development |
| GO:0060393 | 0.00101 | 7.12175 | 1 | 5 | 62 | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0001936 | 0.00103 | 4.75667 | 2 | 7 | 127 | regulation of endothelial cell proliferation |
| GO:0010469 | 0.00103 | 4.75667 | 2 | 7 | 127 | regulation of signaling receptor activity |
| GO:0090263 | 0.00104 | 5.61173 | 1 | 6 | 93 | positive regulation of canonical Wnt signaling pathway |
| GO:0006873 | 0.00107 | 2.40623 | 8 | 18 | 639 | cellular ion homeostasis |
| GO:0051592 | 0.00108 | 4.71715 | 2 | 7 | 128 | response to calcium ion |
| GO:0006636 | 0.00109 | 9.81647 | 0 | 4 | 37 | unsaturated fatty acid biosynthetic process |
| GO:0030513 | 0.00109 | 9.81647 | 0 | 4 | 37 | positive regulation of BMP signaling pathway |
| GO:0048709 | 0.00110 | 5.54772 | 1 | 6 | 94 | oligodendrocyte differentiation |
| GO:0046697 | 0.00111 | 17.30734 | 0 | 3 | 17 | decidualization |
| GO:0016125 | 0.00118 | 4.64004 | 2 | 7 | 130 | sterol metabolic process |
| GO:0014706 | 0.00121 | 2.71819 | 5 | 14 | 439 | striated muscle tissue development |
| GO:0042304 | 0.00121 | 9.52733 | 0 | 4 | 38 | regulation of fatty acid biosynthetic process |
| GO:0090175 | 0.00121 | 9.52733 | 0 | 4 | 38 | regulation of establishment of planar polarity |
| GO:0015893 | 0.00121 | 3.68288 | 3 | 9 | 209 | drug transport |
| GO:0060389 | 0.00125 | 6.76478 | 1 | 5 | 65 | pathway-restricted SMAD protein phosphorylation |
| GO:0050920 | 0.00125 | 3.66439 | 3 | 9 | 210 | regulation of chemotaxis |
| GO:0050730 | 0.00126 | 3.37374 | 3 | 10 | 253 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0030099 | 0.00126 | 2.82581 | 5 | 13 | 392 | myeloid cell differentiation |
| GO:1901617 | 0.00130 | 3.64609 | 3 | 9 | 211 | organic hydroxy compound biosynthetic process |
| GO:0097190 | 0.00130 | 2.42863 | 7 | 17 | 597 | apoptotic signaling pathway |
| GO:0006641 | 0.00130 | 5.36412 | 1 | 6 | 97 | triglyceride metabolic process |
| GO:0006897 | 0.00133 | 2.29765 | 9 | 19 | 706 | endocytosis |
| GO:0002076 | 0.00133 | 16.15282 | 0 | 3 | 18 | osteoblast development |
| GO:0010996 | 0.00133 | 16.15282 | 0 | 3 | 18 | response to auditory stimulus |
| GO:0046851 | 0.00133 | 16.15282 | 0 | 3 | 18 | negative regulation of bone remodeling |
| GO:0060947 | 0.00133 | 16.15282 | 0 | 3 | 18 | cardiac vascular smooth muscle cell differentiation |
| GO:0072077 | 0.00133 | 16.15282 | 0 | 3 | 18 | renal vesicle morphogenesis |
| GO:0010562 | 0.00133 | 2.01743 | 14 | 26 | 1106 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00133 | 2.01743 | 14 | 26 | 1106 | positive regulation of phosphate metabolic process |
| GO:0045637 | 0.00134 | 3.62797 | 3 | 9 | 212 | regulation of myeloid cell differentiation |
| GO:0045935 | 0.00134 | 1.79642 | 22 | 37 | 1784 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0006836 | 0.00134 | 3.12538 | 4 | 11 | 300 | neurotransmitter transport |
| GO:0042471 | 0.00141 | 4.49311 | 2 | 7 | 134 | ear morphogenesis |
| GO:0050905 | 0.00141 | 4.49311 | 2 | 7 | 134 | neuromuscular process |
| GO:0045666 | 0.00143 | 2.66702 | 6 | 14 | 447 | positive regulation of neuron differentiation |
| GO:0033993 | 0.00143 | 2.18322 | 10 | 21 | 822 | response to lipid |
| GO:1904888 | 0.00143 | 6.54598 | 1 | 5 | 67 | cranial skeletal system development |
| GO:0042310 | 0.00144 | 5.24831 | 1 | 6 | 99 | vasoconstriction |
| GO:0010976 | 0.00146 | 2.91951 | 4 | 12 | 350 | positive regulation of neuron projection development |
| GO:0015711 | 0.00148 | 2.77370 | 5 | 13 | 399 | organic anion transport |
| GO:0010957 | 0.00148 | 53.68187 | 0 | 2 | 5 | negative regulation of vitamin D biosynthetic process |
| GO:0010991 | 0.00148 | 53.68187 | 0 | 2 | 5 | negative regulation of SMAD protein complex assembly |
| GO:0015744 | 0.00148 | 53.68187 | 0 | 2 | 5 | succinate transport |
| GO:0060948 | 0.00148 | 53.68187 | 0 | 2 | 5 | cardiac vascular smooth muscle cell development |
| GO:1900003 | 0.00148 | 53.68187 | 0 | 2 | 5 | regulation of serine-type endopeptidase activity |
| GO:1900004 | 0.00148 | 53.68187 | 0 | 2 | 5 | negative regulation of serine-type endopeptidase activity |
| GO:1902571 | 0.00148 | 53.68187 | 0 | 2 | 5 | regulation of serine-type peptidase activity |
| GO:1902572 | 0.00148 | 53.68187 | 0 | 2 | 5 | negative regulation of serine-type peptidase activity |
| GO:0031400 | 0.00155 | 2.45973 | 7 | 16 | 554 | negative regulation of protein modification process |
| GO:0002043 | 0.00156 | 15.14261 | 0 | 3 | 19 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0015740 | 0.00156 | 15.14261 | 0 | 3 | 19 | C4-dicarboxylate transport |
| GO:0043931 | 0.00156 | 15.14261 | 0 | 3 | 19 | ossification involved in bone maturation |
| GO:0060231 | 0.00156 | 15.14261 | 0 | 3 | 19 | mesenchymal to epithelial transition |
| GO:0021953 | 0.00157 | 3.53998 | 3 | 9 | 217 | central nervous system neuron differentiation |
| GO:0030336 | 0.00159 | 3.26506 | 3 | 10 | 261 | negative regulation of cell migration |
| GO:0010951 | 0.00160 | 3.88872 | 2 | 8 | 176 | negative regulation of endopeptidase activity |
| GO:0017015 | 0.00160 | 5.13737 | 1 | 6 | 101 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0038083 | 0.00161 | 8.75370 | 1 | 4 | 41 | peptidyl-tyrosine autophosphorylation |
| GO:1903672 | 0.00161 | 8.75370 | 1 | 4 | 41 | positive regulation of sprouting angiogenesis |
| GO:0052547 | 0.00161 | 2.74477 | 5 | 13 | 403 | regulation of peptidase activity |
| GO:0043065 | 0.00163 | 2.37401 | 8 | 17 | 610 | positive regulation of apoptotic process |
| GO:0001659 | 0.00166 | 3.86554 | 2 | 8 | 177 | temperature homeostasis |
| GO:0051588 | 0.00166 | 3.86554 | 2 | 8 | 177 | regulation of neurotransmitter transport |
| GO:0061053 | 0.00168 | 5.08363 | 1 | 6 | 102 | somite development |
| GO:0018108 | 0.00169 | 3.02979 | 4 | 11 | 309 | peptidyl-tyrosine phosphorylation |
| GO:0061351 | 0.00172 | 3.84263 | 2 | 8 | 178 | neural precursor cell proliferation |
| GO:0010038 | 0.00173 | 3.22607 | 3 | 10 | 264 | response to metal ion |
| GO:0032768 | 0.00176 | 8.52297 | 1 | 4 | 42 | regulation of monooxygenase activity |
| GO:1903844 | 0.00177 | 5.03100 | 1 | 6 | 103 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0010001 | 0.00178 | 3.47258 | 3 | 9 | 221 | glial cell differentiation |
| GO:0043068 | 0.00181 | 2.34960 | 8 | 17 | 616 | positive regulation of programmed cell death |
| GO:0072079 | 0.00182 | 14.25124 | 0 | 3 | 20 | nephron tubule formation |
| GO:0018212 | 0.00183 | 2.99919 | 4 | 11 | 312 | peptidyl-tyrosine modification |
| GO:0010942 | 0.00186 | 2.28144 | 8 | 18 | 672 | positive regulation of cell death |
| GO:0045670 | 0.00186 | 6.14818 | 1 | 5 | 71 | regulation of osteoclast differentiation |
| GO:0050810 | 0.00186 | 6.14818 | 1 | 5 | 71 | regulation of steroid biosynthetic process |
| GO:0007043 | 0.00186 | 4.97945 | 1 | 6 | 104 | cell-cell junction assembly |
| GO:0043009 | 0.00188 | 2.17542 | 10 | 20 | 784 | chordate embryonic development |
| GO:0001935 | 0.00189 | 4.25709 | 2 | 7 | 141 | endothelial cell proliferation |
| GO:0019233 | 0.00189 | 4.25709 | 2 | 7 | 141 | sensory perception of pain |
| GO:0055082 | 0.00190 | 2.17248 | 10 | 20 | 785 | cellular chemical homeostasis |
| GO:0001709 | 0.00192 | 8.30407 | 1 | 4 | 43 | cell fate determination |
| GO:0097756 | 0.00195 | 4.92893 | 1 | 6 | 105 | negative regulation of blood vessel diameter |
| GO:2001234 | 0.00195 | 3.42367 | 3 | 9 | 224 | negative regulation of apoptotic signaling pathway |
| GO:0048562 | 0.00197 | 2.96920 | 4 | 11 | 315 | embryonic organ morphogenesis |
| GO:0051480 | 0.00202 | 2.80165 | 4 | 12 | 364 | regulation of cytosolic calcium ion concentration |
| GO:0014013 | 0.00204 | 4.19412 | 2 | 7 | 143 | regulation of gliogenesis |
| GO:0050891 | 0.00210 | 8.09611 | 1 | 4 | 44 | multicellular organismal water homeostasis |
| GO:0008015 | 0.00210 | 2.55276 | 6 | 14 | 466 | blood circulation |
| GO:0010866 | 0.00210 | 13.45892 | 0 | 3 | 21 | regulation of triglyceride biosynthetic process |
| GO:0090050 | 0.00210 | 13.45892 | 0 | 3 | 21 | positive regulation of cell migration involved in sprouting angiogenesis |
| GO:0003402 | 0.00221 | 40.25965 | 0 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
| GO:0006842 | 0.00221 | 40.25965 | 0 | 2 | 6 | tricarboxylic acid transport |
| GO:0010990 | 0.00221 | 40.25965 | 0 | 2 | 6 | regulation of SMAD protein complex assembly |
| GO:0015746 | 0.00221 | 40.25965 | 0 | 2 | 6 | citrate transport |
| GO:0031394 | 0.00221 | 40.25965 | 0 | 2 | 6 | positive regulation of prostaglandin biosynthetic process |
| GO:0032792 | 0.00221 | 40.25965 | 0 | 2 | 6 | negative regulation of CREB transcription factor activity |
| GO:0046137 | 0.00221 | 40.25965 | 0 | 2 | 6 | negative regulation of vitamin metabolic process |
| GO:0060319 | 0.00221 | 40.25965 | 0 | 2 | 6 | primitive erythrocyte differentiation |
| GO:0060745 | 0.00221 | 40.25965 | 0 | 2 | 6 | mammary gland branching involved in pregnancy |
| GO:0060842 | 0.00221 | 40.25965 | 0 | 2 | 6 | arterial endothelial cell differentiation |
| GO:0061302 | 0.00221 | 40.25965 | 0 | 2 | 6 | smooth muscle cell-matrix adhesion |
| GO:0061312 | 0.00221 | 40.25965 | 0 | 2 | 6 | BMP signaling pathway involved in heart development |
| GO:0072174 | 0.00221 | 40.25965 | 0 | 2 | 6 | metanephric tubule formation |
| GO:1900086 | 0.00221 | 40.25965 | 0 | 2 | 6 | positive regulation of peptidyl-tyrosine autophosphorylation |
| GO:0010464 | 0.00228 | 7.89830 | 1 | 4 | 45 | regulation of mesenchymal cell proliferation |
| GO:0001505 | 0.00231 | 2.75397 | 5 | 12 | 370 | regulation of neurotransmitter levels |
| GO:0044706 | 0.00234 | 3.64798 | 2 | 8 | 187 | multi-multicellular organism process |
| GO:0008344 | 0.00236 | 4.73669 | 1 | 6 | 109 | adult locomotory behavior |
| GO:2000177 | 0.00236 | 4.73669 | 1 | 6 | 109 | regulation of neural precursor cell proliferation |
| GO:0019229 | 0.00237 | 5.79585 | 1 | 5 | 75 | regulation of vasoconstriction |
| GO:0030500 | 0.00237 | 5.79585 | 1 | 5 | 75 | regulation of bone mineralization |
| GO:0045606 | 0.00241 | 12.75000 | 0 | 3 | 22 | positive regulation of epidermal cell differentiation |
| GO:0045723 | 0.00241 | 12.75000 | 0 | 3 | 22 | positive regulation of fatty acid biosynthetic process |
| GO:0051797 | 0.00241 | 12.75000 | 0 | 3 | 22 | regulation of hair follicle development |
| GO:0072273 | 0.00241 | 12.75000 | 0 | 3 | 22 | metanephric nephron morphogenesis |
| GO:0014070 | 0.00243 | 2.17042 | 9 | 19 | 745 | response to organic cyclic compound |
| GO:0009792 | 0.00244 | 2.12362 | 10 | 20 | 802 | embryo development ending in birth or egg hatching |
| GO:0030100 | 0.00245 | 3.06724 | 3 | 10 | 277 | regulation of endocytosis |
| GO:0021772 | 0.00247 | 7.70991 | 1 | 4 | 46 | olfactory bulb development |
| GO:0006813 | 0.00247 | 3.29969 | 3 | 9 | 232 | potassium ion transport |
| GO:1903522 | 0.00247 | 3.29969 | 3 | 9 | 232 | regulation of blood circulation |
| GO:0003013 | 0.00250 | 2.50192 | 6 | 14 | 475 | circulatory system process |
| GO:0010720 | 0.00252 | 2.27165 | 8 | 17 | 636 | positive regulation of cell development |
| GO:0010631 | 0.00252 | 3.05566 | 3 | 10 | 278 | epithelial cell migration |
| GO:0007169 | 0.00261 | 2.40259 | 7 | 15 | 530 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0090132 | 0.00265 | 3.03276 | 3 | 10 | 280 | epithelium migration |
| GO:0001892 | 0.00270 | 4.60203 | 1 | 6 | 112 | embryonic placenta development |
| GO:0042472 | 0.00270 | 4.60203 | 1 | 6 | 112 | inner ear morphogenesis |
| GO:0030162 | 0.00270 | 2.19831 | 9 | 18 | 696 | regulation of proteolysis |
| GO:0003018 | 0.00275 | 3.54808 | 2 | 8 | 192 | vascular process in circulatory system |
| GO:0050866 | 0.00275 | 3.54808 | 2 | 8 | 192 | negative regulation of cell activation |
| GO:0061436 | 0.00275 | 12.11197 | 0 | 3 | 23 | establishment of skin barrier |
| GO:0052548 | 0.00275 | 2.83673 | 4 | 11 | 329 | regulation of endopeptidase activity |
| GO:0090130 | 0.00279 | 3.01019 | 3 | 10 | 282 | tissue migration |
| GO:0015918 | 0.00281 | 5.55693 | 1 | 5 | 78 | sterol transport |
| GO:0030301 | 0.00281 | 5.55693 | 1 | 5 | 78 | cholesterol transport |
| GO:0051050 | 0.00287 | 1.95214 | 13 | 24 | 1049 | positive regulation of transport |
| GO:0002762 | 0.00289 | 7.35882 | 1 | 4 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:0021545 | 0.00289 | 7.35882 | 1 | 4 | 48 | cranial nerve development |
| GO:0021988 | 0.00289 | 7.35882 | 1 | 4 | 48 | olfactory lobe development |
| GO:0045104 | 0.00289 | 7.35882 | 1 | 4 | 48 | intermediate filament cytoskeleton organization |
| GO:0043542 | 0.00293 | 3.50962 | 2 | 8 | 194 | endothelial cell migration |
| GO:0002040 | 0.00295 | 4.51641 | 1 | 6 | 114 | sprouting angiogenesis |
| GO:0006942 | 0.00297 | 5.48160 | 1 | 5 | 79 | regulation of striated muscle contraction |
| GO:0021675 | 0.00297 | 5.48160 | 1 | 5 | 79 | nerve development |
| GO:0043279 | 0.00297 | 5.48160 | 1 | 5 | 79 | response to alkaloid |
| GO:0051341 | 0.00297 | 5.48160 | 1 | 5 | 79 | regulation of oxidoreductase activity |
| GO:0019852 | 0.00306 | 32.20632 | 0 | 2 | 7 | L-ascorbic acid metabolic process |
| GO:0038030 | 0.00306 | 32.20632 | 0 | 2 | 7 | non-canonical Wnt signaling pathway via MAPK cascade |
| GO:0060558 | 0.00306 | 32.20632 | 0 | 2 | 7 | regulation of calcidiol 1-monooxygenase activity |
| GO:0060676 | 0.00306 | 32.20632 | 0 | 2 | 7 | ureteric bud formation |
| GO:0061314 | 0.00306 | 32.20632 | 0 | 2 | 7 | Notch signaling involved in heart development |
| GO:1990034 | 0.00306 | 32.20632 | 0 | 2 | 7 | calcium ion export across plasma membrane |
| GO:2000096 | 0.00306 | 32.20632 | 0 | 2 | 7 | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0003181 | 0.00311 | 11.53471 | 0 | 3 | 24 | atrioventricular valve morphogenesis |
| GO:0042474 | 0.00311 | 11.53471 | 0 | 3 | 24 | middle ear morphogenesis |
| GO:0043112 | 0.00312 | 3.47197 | 2 | 8 | 196 | receptor metabolic process |
| GO:0030104 | 0.00312 | 7.19497 | 1 | 4 | 49 | water homeostasis |
| GO:0045103 | 0.00312 | 7.19497 | 1 | 4 | 49 | intermediate filament-based process |
| GO:0048483 | 0.00312 | 7.19497 | 1 | 4 | 49 | autonomic nervous system development |
| GO:0051247 | 0.00313 | 1.75381 | 20 | 33 | 1616 | positive regulation of protein metabolic process |
| GO:0034762 | 0.00316 | 2.35119 | 7 | 15 | 541 | regulation of transmembrane transport |
| GO:0010466 | 0.00319 | 3.17043 | 3 | 9 | 241 | negative regulation of peptidase activity |
| GO:0008593 | 0.00331 | 5.33688 | 1 | 5 | 81 | regulation of Notch signaling pathway |
| GO:0034333 | 0.00331 | 5.33688 | 1 | 5 | 81 | adherens junction assembly |
| GO:1901888 | 0.00331 | 5.33688 | 1 | 5 | 81 | regulation of cell junction assembly |
| GO:0035137 | 0.00336 | 7.03825 | 1 | 4 | 50 | hindlimb morphogenesis |
| GO:0043392 | 0.00336 | 7.03825 | 1 | 4 | 50 | negative regulation of DNA binding |
| GO:0070542 | 0.00336 | 7.03825 | 1 | 4 | 50 | response to fatty acid |
| GO:0080134 | 0.00342 | 1.84982 | 15 | 27 | 1247 | regulation of response to stress |
| GO:0007565 | 0.00344 | 3.80033 | 2 | 7 | 157 | female pregnancy |
| GO:0042632 | 0.00349 | 5.26734 | 1 | 5 | 82 | cholesterol homeostasis |
| GO:0048148 | 0.00351 | 11.00992 | 0 | 3 | 25 | behavioral response to cocaine |
| GO:1903010 | 0.00351 | 11.00992 | 0 | 3 | 25 | regulation of bone development |
| GO:2000050 | 0.00351 | 11.00992 | 0 | 3 | 25 | regulation of non-canonical Wnt signaling pathway |
| GO:0001701 | 0.00354 | 2.40085 | 6 | 14 | 494 | in utero embryonic development |
| GO:0043433 | 0.00357 | 3.77500 | 2 | 7 | 158 | negative regulation of DNA-binding transcription factor activity |
| GO:0002520 | 0.00357 | 1.94500 | 12 | 23 | 1007 | immune system development |
| GO:0032103 | 0.00357 | 2.90217 | 4 | 10 | 292 | positive regulation of response to external stimulus |
| GO:0016126 | 0.00361 | 6.88820 | 1 | 4 | 51 | sterol biosynthetic process |
| GO:0061614 | 0.00361 | 6.88820 | 1 | 4 | 51 | pri-miRNA transcription by RNA polymerase II |
| GO:0050770 | 0.00363 | 3.38128 | 2 | 8 | 201 | regulation of axonogenesis |
| GO:0008203 | 0.00365 | 4.31562 | 1 | 6 | 119 | cholesterol metabolic process |
| GO:0055092 | 0.00368 | 5.19958 | 1 | 5 | 83 | sterol homeostasis |
| GO:0048534 | 0.00378 | 1.96585 | 12 | 22 | 952 | hematopoietic or lymphoid organ development |
| GO:0006639 | 0.00380 | 4.27758 | 1 | 6 | 120 | acylglycerol metabolic process |
| GO:0048565 | 0.00380 | 4.27758 | 1 | 6 | 120 | digestive tract development |
| GO:0032787 | 0.00381 | 2.30190 | 7 | 15 | 552 | monocarboxylic acid metabolic process |
| GO:0046942 | 0.00384 | 2.87124 | 4 | 10 | 295 | carboxylic acid transport |
| GO:0072330 | 0.00385 | 3.07662 | 3 | 9 | 248 | monocarboxylic acid biosynthetic process |
| GO:0046394 | 0.00386 | 2.70715 | 4 | 11 | 344 | carboxylic acid biosynthetic process |
| GO:0001954 | 0.00387 | 6.74441 | 1 | 4 | 52 | positive regulation of cell-matrix adhesion |
| GO:0010712 | 0.00387 | 6.74441 | 1 | 4 | 52 | regulation of collagen metabolic process |
| GO:0031295 | 0.00393 | 10.53077 | 0 | 3 | 26 | T cell costimulation |
| GO:0045109 | 0.00393 | 10.53077 | 0 | 3 | 26 | intermediate filament organization |
| GO:0060716 | 0.00393 | 10.53077 | 0 | 3 | 26 | labyrinthine layer blood vessel development |
| GO:2000178 | 0.00393 | 10.53077 | 0 | 3 | 26 | negative regulation of neural precursor cell proliferation |
| GO:0015849 | 0.00393 | 2.86107 | 4 | 10 | 296 | organic acid transport |
| GO:0090066 | 0.00394 | 2.29316 | 7 | 15 | 554 | regulation of anatomical structure size |
| GO:0016053 | 0.00394 | 2.69893 | 4 | 11 | 345 | organic acid biosynthetic process |
| GO:0016070 | 0.00397 | 1.49951 | 46 | 63 | 3688 | RNA metabolic process |
| GO:0032906 | 0.00405 | 26.83743 | 0 | 2 | 8 | transforming growth factor beta2 production |
| GO:0032909 | 0.00405 | 26.83743 | 0 | 2 | 8 | regulation of transforming growth factor beta2 production |
| GO:0042363 | 0.00405 | 26.83743 | 0 | 2 | 8 | fat-soluble vitamin catabolic process |
| GO:0042364 | 0.00405 | 26.83743 | 0 | 2 | 8 | water-soluble vitamin biosynthetic process |
| GO:0043696 | 0.00405 | 26.83743 | 0 | 2 | 8 | dedifferentiation |
| GO:0043697 | 0.00405 | 26.83743 | 0 | 2 | 8 | cell dedifferentiation |
| GO:0045654 | 0.00405 | 26.83743 | 0 | 2 | 8 | positive regulation of megakaryocyte differentiation |
| GO:0051581 | 0.00405 | 26.83743 | 0 | 2 | 8 | negative regulation of neurotransmitter uptake |
| GO:0060363 | 0.00405 | 26.83743 | 0 | 2 | 8 | cranial suture morphogenesis |
| GO:0070561 | 0.00405 | 26.83743 | 0 | 2 | 8 | vitamin D receptor signaling pathway |
| GO:0072033 | 0.00405 | 26.83743 | 0 | 2 | 8 | renal vesicle formation |
| GO:0072050 | 0.00405 | 26.83743 | 0 | 2 | 8 | S-shaped body morphogenesis |
| GO:2001280 | 0.00405 | 26.83743 | 0 | 2 | 8 | positive regulation of unsaturated fatty acid biosynthetic process |
| GO:0007626 | 0.00405 | 3.05082 | 3 | 9 | 250 | locomotory behavior |
| GO:0014032 | 0.00407 | 5.06915 | 1 | 5 | 85 | neural crest cell development |
| GO:0001666 | 0.00409 | 3.31205 | 3 | 8 | 205 | response to hypoxia |
| GO:0010810 | 0.00409 | 3.31205 | 3 | 8 | 205 | regulation of cell-substrate adhesion |
| GO:0071559 | 0.00409 | 3.31205 | 3 | 8 | 205 | response to transforming growth factor beta |
| GO:0006638 | 0.00412 | 4.20346 | 2 | 6 | 122 | neutral lipid metabolic process |
| GO:0046165 | 0.00412 | 4.20346 | 2 | 6 | 122 | alcohol biosynthetic process |
| GO:0045620 | 0.00415 | 6.60648 | 1 | 4 | 53 | negative regulation of lymphocyte differentiation |
| GO:0048546 | 0.00415 | 6.60648 | 1 | 4 | 53 | digestive tract morphogenesis |
| GO:0051930 | 0.00415 | 6.60648 | 1 | 4 | 53 | regulation of sensory perception of pain |
| GO:0055010 | 0.00415 | 6.60648 | 1 | 4 | 53 | ventricular cardiac muscle tissue morphogenesis |
| GO:0030097 | 0.00420 | 1.98014 | 11 | 21 | 901 | hemopoiesis |
| GO:0009628 | 0.00421 | 1.91649 | 13 | 23 | 1021 | response to abiotic stimulus |
| GO:1903034 | 0.00423 | 3.65321 | 2 | 7 | 163 | regulation of response to wounding |
| GO:1903524 | 0.00428 | 5.00635 | 1 | 5 | 86 | positive regulation of blood circulation |
| GO:0051100 | 0.00437 | 3.62978 | 2 | 7 | 164 | negative regulation of binding |
| GO:0003171 | 0.00438 | 10.09155 | 0 | 3 | 27 | atrioventricular valve development |
| GO:0048843 | 0.00438 | 10.09155 | 0 | 3 | 27 | negative regulation of axon extension involved in axon guidance |
| GO:0051354 | 0.00438 | 10.09155 | 0 | 3 | 27 | negative regulation of oxidoreductase activity |
| GO:0060536 | 0.00438 | 10.09155 | 0 | 3 | 27 | cartilage morphogenesis |
| GO:0034765 | 0.00439 | 2.42747 | 6 | 13 | 453 | regulation of ion transmembrane transport |
| GO:0035019 | 0.00444 | 6.47406 | 1 | 4 | 54 | somatic stem cell population maintenance |
| GO:0051931 | 0.00444 | 6.47406 | 1 | 4 | 54 | regulation of sensory perception |
| GO:0042063 | 0.00452 | 2.80154 | 4 | 10 | 302 | gliogenesis |
| GO:0035265 | 0.00459 | 3.24556 | 3 | 8 | 209 | organ growth |
| GO:0010243 | 0.00466 | 1.99648 | 10 | 20 | 850 | response to organonitrogen compound |
| GO:2001233 | 0.00467 | 2.51132 | 5 | 12 | 404 | regulation of apoptotic signaling pathway |
| GO:0002042 | 0.00474 | 6.34684 | 1 | 4 | 55 | cell migration involved in sprouting angiogenesis |
| GO:0050922 | 0.00474 | 6.34684 | 1 | 4 | 55 | negative regulation of chemotaxis |
| GO:0050729 | 0.00482 | 4.06263 | 2 | 6 | 126 | positive regulation of inflammatory response |
| GO:0007369 | 0.00482 | 3.56125 | 2 | 7 | 167 | gastrulation |
| GO:2000241 | 0.00482 | 3.56125 | 2 | 7 | 167 | regulation of reproductive process |
| GO:0031668 | 0.00486 | 3.21331 | 3 | 8 | 211 | cellular response to extracellular stimulus |
| GO:0001893 | 0.00486 | 9.68746 | 0 | 3 | 28 | maternal placenta development |
| GO:0003413 | 0.00486 | 9.68746 | 0 | 3 | 28 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0008045 | 0.00486 | 9.68746 | 0 | 3 | 28 | motor neuron axon guidance |
| GO:0010719 | 0.00486 | 9.68746 | 0 | 3 | 28 | negative regulation of epithelial to mesenchymal transition |
| GO:0031294 | 0.00486 | 9.68746 | 0 | 3 | 28 | lymphocyte costimulation |
| GO:0033137 | 0.00486 | 9.68746 | 0 | 3 | 28 | negative regulation of peptidyl-serine phosphorylation |
| GO:0060037 | 0.00486 | 9.68746 | 0 | 3 | 28 | pharyngeal system development |
| GO:1902668 | 0.00486 | 9.68746 | 0 | 3 | 28 | negative regulation of axon guidance |
| GO:0007612 | 0.00498 | 3.53898 | 2 | 7 | 168 | learning |
| GO:0001736 | 0.00506 | 6.22452 | 1 | 4 | 56 | establishment of planar polarity |
| GO:0043536 | 0.00506 | 6.22452 | 1 | 4 | 56 | positive regulation of blood vessel endothelial cell migration |
| GO:0003223 | 0.00517 | 23.00251 | 0 | 2 | 9 | ventricular compact myocardium morphogenesis |
| GO:0031392 | 0.00517 | 23.00251 | 0 | 2 | 9 | regulation of prostaglandin biosynthetic process |
| GO:0031622 | 0.00517 | 23.00251 | 0 | 2 | 9 | positive regulation of fever generation |
| GO:0033689 | 0.00517 | 23.00251 | 0 | 2 | 9 | negative regulation of osteoblast proliferation |
| GO:0035878 | 0.00517 | 23.00251 | 0 | 2 | 9 | nail development |
| GO:0043587 | 0.00517 | 23.00251 | 0 | 2 | 9 | tongue morphogenesis |
| GO:0046533 | 0.00517 | 23.00251 | 0 | 2 | 9 | negative regulation of photoreceptor cell differentiation |
| GO:0060837 | 0.00517 | 23.00251 | 0 | 2 | 9 | blood vessel endothelial cell differentiation |
| GO:0060896 | 0.00517 | 23.00251 | 0 | 2 | 9 | neural plate pattern specification |
| GO:0061042 | 0.00517 | 23.00251 | 0 | 2 | 9 | vascular wound healing |
| GO:0061101 | 0.00517 | 23.00251 | 0 | 2 | 9 | neuroendocrine cell differentiation |
| GO:0070862 | 0.00517 | 23.00251 | 0 | 2 | 9 | negative regulation of protein exit from endoplasmic reticulum |
| GO:0071305 | 0.00517 | 23.00251 | 0 | 2 | 9 | cellular response to vitamin D |
| GO:0071635 | 0.00517 | 23.00251 | 0 | 2 | 9 | negative regulation of transforming growth factor beta production |
| GO:0090037 | 0.00517 | 23.00251 | 0 | 2 | 9 | positive regulation of protein kinase C signaling |
| GO:0090269 | 0.00517 | 23.00251 | 0 | 2 | 9 | fibroblast growth factor production |
| GO:0090270 | 0.00517 | 23.00251 | 0 | 2 | 9 | regulation of fibroblast growth factor production |
| GO:2001214 | 0.00517 | 23.00251 | 0 | 2 | 9 | positive regulation of vasculogenesis |
| GO:0002682 | 0.00521 | 1.75032 | 17 | 29 | 1414 | regulation of immune system process |
| GO:0031399 | 0.00522 | 1.67680 | 21 | 34 | 1737 | regulation of protein modification process |
| GO:0003148 | 0.00537 | 9.31446 | 0 | 3 | 29 | outflow tract septum morphogenesis |
| GO:0010939 | 0.00537 | 9.31446 | 0 | 3 | 29 | regulation of necrotic cell death |
| GO:0048820 | 0.00537 | 9.31446 | 0 | 3 | 29 | hair follicle maturation |
| GO:0061037 | 0.00537 | 9.31446 | 0 | 3 | 29 | negative regulation of cartilage development |
| GO:0007164 | 0.00538 | 6.10681 | 1 | 4 | 57 | establishment of tissue polarity |
| GO:0001101 | 0.00540 | 2.58122 | 4 | 11 | 360 | response to acid chemical |
| GO:0048864 | 0.00544 | 4.71425 | 1 | 5 | 91 | stem cell development |
| GO:0043436 | 0.00557 | 1.92770 | 11 | 21 | 924 | oxoacid metabolic process |
| GO:0120035 | 0.00560 | 2.03984 | 9 | 18 | 747 | regulation of plasma membrane bounded cell projection organization |
| GO:0061041 | 0.00561 | 3.93089 | 2 | 6 | 130 | regulation of wound healing |
| GO:0071453 | 0.00561 | 3.93089 | 2 | 6 | 130 | cellular response to oxygen levels |
| GO:0016310 | 0.00561 | 1.60466 | 26 | 40 | 2144 | phosphorylation |
| GO:0002695 | 0.00565 | 3.45258 | 2 | 7 | 172 | negative regulation of leukocyte activation |
| GO:0008016 | 0.00565 | 3.45258 | 2 | 7 | 172 | regulation of heart contraction |
| GO:0001704 | 0.00570 | 4.65986 | 1 | 5 | 92 | formation of primary germ layer |
| GO:0014033 | 0.00570 | 4.65986 | 1 | 5 | 92 | neural crest cell differentiation |
| GO:0044319 | 0.00591 | 8.96909 | 0 | 3 | 30 | wound healing, spreading of cells |
| GO:0090505 | 0.00591 | 8.96909 | 0 | 3 | 30 | epiboly involved in wound healing |
| GO:0071456 | 0.00596 | 4.60671 | 1 | 5 | 93 | cellular response to hypoxia |
| GO:1902531 | 0.00596 | 1.67295 | 21 | 33 | 1687 | regulation of intracellular signal transduction |
| GO:0060711 | 0.00609 | 5.88423 | 1 | 4 | 59 | labyrinthine layer development |
| GO:0060021 | 0.00623 | 4.55475 | 1 | 5 | 94 | roof of mouth development |
| GO:0060359 | 0.00623 | 4.55475 | 1 | 5 | 94 | response to ammonium ion |
| GO:0055123 | 0.00625 | 3.83753 | 2 | 6 | 133 | digestive system development |
| GO:0031344 | 0.00631 | 2.01414 | 9 | 18 | 756 | regulation of cell projection organization |
| GO:0070588 | 0.00633 | 2.83655 | 3 | 9 | 268 | calcium ion transmembrane transport |
| GO:0009410 | 0.00638 | 3.06110 | 3 | 8 | 221 | response to xenobiotic stimulus |
| GO:0003149 | 0.00641 | 20.12632 | 0 | 2 | 10 | membranous septum morphogenesis |
| GO:0021612 | 0.00641 | 20.12632 | 0 | 2 | 10 | facial nerve structural organization |
| GO:0045741 | 0.00641 | 20.12632 | 0 | 2 | 10 | positive regulation of epidermal growth factor-activated receptor activity |
| GO:0045759 | 0.00641 | 20.12632 | 0 | 2 | 10 | negative regulation of action potential |
| GO:0051001 | 0.00641 | 20.12632 | 0 | 2 | 10 | negative regulation of nitric-oxide synthase activity |
| GO:0060215 | 0.00641 | 20.12632 | 0 | 2 | 10 | primitive hemopoiesis |
| GO:0060710 | 0.00641 | 20.12632 | 0 | 2 | 10 | chorio-allantoic fusion |
| GO:0072173 | 0.00641 | 20.12632 | 0 | 2 | 10 | metanephric tubule morphogenesis |
| GO:0072203 | 0.00641 | 20.12632 | 0 | 2 | 10 | cell proliferation involved in metanephros development |
| GO:0032967 | 0.00649 | 8.64839 | 0 | 3 | 31 | positive regulation of collagen biosynthetic process |
| GO:0042634 | 0.00649 | 8.64839 | 0 | 3 | 31 | regulation of hair cycle |
| GO:0090504 | 0.00649 | 8.64839 | 0 | 3 | 31 | epiboly |
| GO:2000352 | 0.00649 | 8.64839 | 0 | 3 | 31 | negative regulation of endothelial cell apoptotic process |
| GO:0010595 | 0.00651 | 4.50394 | 1 | 5 | 95 | positive regulation of endothelial cell migration |
| GO:0006631 | 0.00671 | 2.50113 | 5 | 11 | 371 | fatty acid metabolic process |
| GO:0046486 | 0.00672 | 2.63678 | 4 | 10 | 320 | glycerolipid metabolic process |
| GO:0050804 | 0.00674 | 2.09533 | 8 | 16 | 645 | modulation of chemical synaptic transmission |
| GO:0010035 | 0.00680 | 2.29441 | 6 | 13 | 478 | response to inorganic substance |
| GO:0045639 | 0.00680 | 4.45425 | 1 | 5 | 96 | positive regulation of myeloid cell differentiation |
| GO:0099177 | 0.00684 | 2.09191 | 8 | 16 | 646 | regulation of trans-synaptic signaling |
| GO:0045600 | 0.00685 | 5.67727 | 1 | 4 | 61 | positive regulation of fat cell differentiation |
| GO:1901360 | 0.00698 | 1.40600 | 63 | 81 | 5097 | organic cyclic compound metabolic process |
| GO:0019752 | 0.00700 | 1.91727 | 11 | 20 | 883 | carboxylic acid metabolic process |
| GO:0022607 | 0.00706 | 1.52238 | 34 | 48 | 2723 | cellular component assembly |
| GO:0002026 | 0.00710 | 8.34981 | 0 | 3 | 32 | regulation of the force of heart contraction |
| GO:0040036 | 0.00710 | 8.34981 | 0 | 3 | 32 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:1901890 | 0.00710 | 8.34981 | 0 | 3 | 32 | positive regulation of cell junction assembly |
| GO:0032963 | 0.00710 | 4.40564 | 1 | 5 | 97 | collagen metabolic process |
| GO:0032270 | 0.00720 | 1.68989 | 19 | 30 | 1513 | positive regulation of cellular protein metabolic process |
| GO:0035051 | 0.00720 | 3.29176 | 2 | 7 | 180 | cardiocyte differentiation |
| GO:0006082 | 0.00737 | 1.87575 | 12 | 21 | 948 | organic acid metabolic process |
| GO:0050772 | 0.00741 | 4.35808 | 1 | 5 | 98 | positive regulation of axonogenesis |
| GO:0048706 | 0.00745 | 3.69136 | 2 | 6 | 138 | embryonic skeletal system development |
| GO:0007162 | 0.00761 | 2.75059 | 3 | 9 | 276 | negative regulation of cell adhesion |
| GO:0009952 | 0.00764 | 2.96279 | 3 | 8 | 228 | anterior/posterior pattern specification |
| GO:0003407 | 0.00767 | 5.48434 | 1 | 4 | 63 | neural retina development |
| GO:2000242 | 0.00767 | 5.48434 | 1 | 4 | 63 | negative regulation of reproductive process |
| GO:0086091 | 0.00773 | 8.07113 | 0 | 3 | 33 | regulation of heart rate by cardiac conduction |
| GO:0009111 | 0.00777 | 17.88928 | 0 | 2 | 11 | vitamin catabolic process |
| GO:0033080 | 0.00777 | 17.88928 | 0 | 2 | 11 | immature T cell proliferation in thymus |
| GO:0035630 | 0.00777 | 17.88928 | 0 | 2 | 11 | bone mineralization involved in bone maturation |
| GO:0038063 | 0.00777 | 17.88928 | 0 | 2 | 11 | collagen-activated tyrosine kinase receptor signaling pathway |
| GO:0046532 | 0.00777 | 17.88928 | 0 | 2 | 11 | regulation of photoreceptor cell differentiation |
| GO:0048262 | 0.00777 | 17.88928 | 0 | 2 | 11 | determination of dorsal/ventral asymmetry |
| GO:0048263 | 0.00777 | 17.88928 | 0 | 2 | 11 | determination of dorsal identity |
| GO:0060056 | 0.00777 | 17.88928 | 0 | 2 | 11 | mammary gland involution |
| GO:0060405 | 0.00777 | 17.88928 | 0 | 2 | 11 | regulation of penile erection |
| GO:0060872 | 0.00777 | 17.88928 | 0 | 2 | 11 | semicircular canal development |
| GO:0072172 | 0.00777 | 17.88928 | 0 | 2 | 11 | mesonephric tubule formation |
| GO:0086103 | 0.00777 | 17.88928 | 0 | 2 | 11 | G protein-coupled receptor signaling pathway involved in heart process |
| GO:2001279 | 0.00777 | 17.88928 | 0 | 2 | 11 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0042180 | 0.00785 | 3.23523 | 2 | 7 | 183 | cellular ketone metabolic process |
| GO:0036293 | 0.00803 | 2.93584 | 3 | 8 | 230 | response to decreased oxygen levels |
| GO:0033559 | 0.00805 | 4.26596 | 1 | 5 | 100 | unsaturated fatty acid metabolic process |
| GO:0031669 | 0.00808 | 3.21681 | 2 | 7 | 184 | cellular response to nutrient levels |
| GO:0051259 | 0.00813 | 2.10481 | 7 | 15 | 601 | protein complex oligomerization |
| GO:0033002 | 0.00823 | 2.92255 | 3 | 8 | 231 | muscle cell proliferation |
| GO:0010634 | 0.00824 | 3.60886 | 2 | 6 | 141 | positive regulation of epithelial cell migration |
| GO:0055007 | 0.00824 | 3.60886 | 2 | 6 | 141 | cardiac muscle cell differentiation |
| GO:0048609 | 0.00829 | 1.91834 | 10 | 19 | 837 | multicellular organismal reproductive process |
| GO:0010714 | 0.00841 | 7.81043 | 0 | 3 | 34 | positive regulation of collagen metabolic process |
| GO:0014003 | 0.00841 | 7.81043 | 0 | 3 | 34 | oligodendrocyte development |
| GO:0031069 | 0.00841 | 7.81043 | 0 | 3 | 34 | hair follicle morphogenesis |
| GO:0031424 | 0.00841 | 7.81043 | 0 | 3 | 34 | keratinization |
| GO:0030029 | 0.00849 | 1.99269 | 9 | 17 | 720 | actin filament-based process |
| GO:0006855 | 0.00855 | 5.30406 | 1 | 4 | 65 | drug transmembrane transport |
| GO:0055117 | 0.00855 | 5.30406 | 1 | 4 | 65 | regulation of cardiac muscle contraction |
| GO:0042136 | 0.00874 | 4.17763 | 1 | 5 | 102 | neurotransmitter biosynthetic process |
| GO:0010769 | 0.00877 | 2.52920 | 4 | 10 | 333 | regulation of cell morphogenesis involved in differentiation |
| GO:0061035 | 0.00901 | 5.21828 | 1 | 4 | 66 | regulation of cartilage development |
| GO:0062013 | 0.00909 | 3.52994 | 2 | 6 | 144 | positive regulation of small molecule metabolic process |
| GO:0009953 | 0.00909 | 4.13482 | 1 | 5 | 103 | dorsal/ventral pattern formation |
| GO:1903825 | 0.00909 | 4.13482 | 1 | 5 | 103 | organic acid transmembrane transport |
| GO:1905039 | 0.00909 | 4.13482 | 1 | 5 | 103 | carboxylic acid transmembrane transport |
| GO:0009954 | 0.00911 | 7.56602 | 0 | 3 | 35 | proximal/distal pattern formation |
| GO:0019432 | 0.00911 | 7.56602 | 0 | 3 | 35 | triglyceride biosynthetic process |
| GO:0001840 | 0.00924 | 16.09965 | 0 | 2 | 12 | neural plate development |
| GO:0021561 | 0.00924 | 16.09965 | 0 | 2 | 12 | facial nerve development |
| GO:0021610 | 0.00924 | 16.09965 | 0 | 2 | 12 | facial nerve morphogenesis |
| GO:0032353 | 0.00924 | 16.09965 | 0 | 2 | 12 | negative regulation of hormone biosynthetic process |
| GO:0036315 | 0.00924 | 16.09965 | 0 | 2 | 12 | cellular response to sterol |
| GO:0048570 | 0.00924 | 16.09965 | 0 | 2 | 12 | notochord morphogenesis |
| GO:0060430 | 0.00924 | 16.09965 | 0 | 2 | 12 | lung saccule development |
| GO:1901660 | 0.00924 | 16.09965 | 0 | 2 | 12 | calcium ion export |
| GO:1902287 | 0.00924 | 16.09965 | 0 | 2 | 12 | semaphorin-plexin signaling pathway involved in axon guidance |
| GO:0019725 | 0.00935 | 1.86119 | 11 | 20 | 908 | cellular homeostasis |
| GO:0032504 | 0.00944 | 1.89194 | 10 | 19 | 848 | multicellular organism reproduction |
| GO:0002090 | 0.00950 | 5.13523 | 1 | 4 | 67 | regulation of receptor internalization |
| GO:0006029 | 0.00950 | 5.13523 | 1 | 4 | 67 | proteoglycan metabolic process |
| GO:0050771 | 0.00950 | 5.13523 | 1 | 4 | 67 | negative regulation of axonogenesis |
| GO:0060688 | 0.00950 | 5.13523 | 1 | 4 | 67 | regulation of morphogenesis of a branching structure |
| GO:0006066 | 0.00968 | 2.64047 | 4 | 9 | 287 | alcohol metabolic process |
| GO:0048469 | 0.00980 | 3.09348 | 2 | 7 | 191 | cell maturation |
| GO:0071804 | 0.00980 | 3.09348 | 2 | 7 | 191 | cellular potassium ion transport |
| GO:0071805 | 0.00980 | 3.09348 | 2 | 7 | 191 | potassium ion transmembrane transport |
| GO:0043085 | 0.00982 | 1.79612 | 13 | 22 | 1036 | positive regulation of catalytic activity |
| GO:0048259 | 0.00983 | 4.05177 | 1 | 5 | 105 | regulation of receptor-mediated endocytosis |
| GO:0003401 | 0.00985 | 7.33643 | 0 | 3 | 36 | axis elongation |
| GO:0045601 | 0.00985 | 7.33643 | 0 | 3 | 36 | regulation of endothelial cell differentiation |
| GO:0046470 | 0.00985 | 7.33643 | 0 | 3 | 36 | phosphatidylcholine metabolic process |
| GO:0051098 | 0.00991 | 2.36107 | 5 | 11 | 392 | regulation of binding |
| GO:0042327 | 0.00993 | 1.79427 | 13 | 22 | 1037 | positive regulation of phosphorylation |
| GO:0015850 | 0.00998 | 2.82034 | 3 | 8 | 239 | organic hydroxy compound transport |
| GO:1903670 | 0.00999 | 5.05477 | 1 | 4 | 68 | regulation of sprouting angiogenesis |
| GO:0035556 | 0.01026 | 1.50365 | 32 | 45 | 2571 | intracellular signal transduction |
| GO:0006937 | 0.01032 | 3.42990 | 2 | 6 | 148 | regulation of muscle contraction |
| GO:0002064 | 0.01046 | 2.79588 | 3 | 8 | 241 | epithelial cell development |
| GO:0002053 | 0.01062 | 7.12034 | 0 | 3 | 37 | positive regulation of mesenchymal cell proliferation |
| GO:0006692 | 0.01062 | 7.12034 | 0 | 3 | 37 | prostanoid metabolic process |
| GO:0006693 | 0.01062 | 7.12034 | 0 | 3 | 37 | prostaglandin metabolic process |
| GO:0030225 | 0.01062 | 7.12034 | 0 | 3 | 37 | macrophage differentiation |
| GO:0060674 | 0.01062 | 7.12034 | 0 | 3 | 37 | placenta blood vessel development |
| GO:0006644 | 0.01064 | 2.45216 | 4 | 10 | 343 | phospholipid metabolic process |
| GO:0071248 | 0.01065 | 3.40577 | 2 | 6 | 149 | cellular response to metal ion |
| GO:1901701 | 0.01066 | 1.73639 | 14 | 24 | 1170 | cellular response to oxygen-containing compound |
| GO:0007183 | 0.01084 | 14.63541 | 0 | 2 | 13 | SMAD protein complex assembly |
| GO:0021604 | 0.01084 | 14.63541 | 0 | 2 | 13 | cranial nerve structural organization |
| GO:0021877 | 0.01084 | 14.63541 | 0 | 2 | 13 | forebrain neuron fate commitment |
| GO:0032351 | 0.01084 | 14.63541 | 0 | 2 | 13 | negative regulation of hormone metabolic process |
| GO:0033079 | 0.01084 | 14.63541 | 0 | 2 | 13 | immature T cell proliferation |
| GO:0033280 | 0.01084 | 14.63541 | 0 | 2 | 13 | response to vitamin D |
| GO:0038065 | 0.01084 | 14.63541 | 0 | 2 | 13 | collagen-activated signaling pathway |
| GO:0042891 | 0.01084 | 14.63541 | 0 | 2 | 13 | antibiotic transport |
| GO:0045906 | 0.01084 | 14.63541 | 0 | 2 | 13 | negative regulation of vasoconstriction |
| GO:0071295 | 0.01084 | 14.63541 | 0 | 2 | 13 | cellular response to vitamin |
| GO:0071679 | 0.01084 | 14.63541 | 0 | 2 | 13 | commissural neuron axon guidance |
| GO:1902285 | 0.01084 | 14.63541 | 0 | 2 | 13 | semaphorin-plexin signaling pathway involved in neuron projection guidance |
| GO:2000052 | 0.01084 | 14.63541 | 0 | 2 | 13 | positive regulation of non-canonical Wnt signaling pathway |
| GO:0045861 | 0.01084 | 2.44471 | 4 | 10 | 344 | negative regulation of proteolysis |
| GO:1901615 | 0.01091 | 2.23260 | 6 | 12 | 452 | organic hydroxy compound metabolic process |
| GO:0033135 | 0.01098 | 3.38197 | 2 | 6 | 150 | regulation of peptidyl-serine phosphorylation |
| GO:0043087 | 0.01098 | 2.58400 | 4 | 9 | 293 | regulation of GTPase activity |
| GO:0008217 | 0.01119 | 3.01098 | 2 | 7 | 196 | regulation of blood pressure |
| GO:0031346 | 0.01127 | 2.22230 | 6 | 12 | 454 | positive regulation of cell projection organization |
| GO:0043267 | 0.01143 | 6.91660 | 0 | 3 | 38 | negative regulation of potassium ion transport |
| GO:0046460 | 0.01143 | 6.91660 | 0 | 3 | 38 | neutral lipid biosynthetic process |
| GO:0046463 | 0.01143 | 6.91660 | 0 | 3 | 38 | acylglycerol biosynthetic process |
| GO:0046885 | 0.01143 | 6.91660 | 0 | 3 | 38 | regulation of hormone biosynthetic process |
| GO:0072210 | 0.01143 | 6.91660 | 0 | 3 | 38 | metanephric nephron development |
| GO:0086004 | 0.01143 | 6.91660 | 0 | 3 | 38 | regulation of cardiac muscle cell contraction |
| GO:0002376 | 0.01146 | 1.49236 | 32 | 45 | 2588 | immune system process |
| GO:0044085 | 0.01152 | 1.46453 | 36 | 50 | 2940 | cellular component biogenesis |
| GO:0001934 | 0.01153 | 1.79295 | 12 | 21 | 989 | positive regulation of protein phosphorylation |
| GO:0045453 | 0.01159 | 4.82780 | 1 | 4 | 71 | bone resorption |
| GO:0006941 | 0.01166 | 3.33535 | 2 | 6 | 152 | striated muscle contraction |
| GO:0051051 | 0.01200 | 2.12613 | 6 | 13 | 514 | negative regulation of transport |
| GO:0001838 | 0.01202 | 3.31251 | 2 | 6 | 153 | embryonic epithelial tube formation |
| GO:0010594 | 0.01202 | 3.31251 | 2 | 6 | 153 | regulation of endothelial cell migration |
| GO:0008543 | 0.01215 | 4.75660 | 1 | 4 | 72 | fibroblast growth factor receptor signaling pathway |
| GO:0043627 | 0.01215 | 4.75660 | 1 | 4 | 72 | response to estrogen |
| GO:0048730 | 0.01227 | 6.72418 | 0 | 3 | 39 | epidermis morphogenesis |
| GO:0090049 | 0.01227 | 6.72418 | 0 | 3 | 39 | regulation of cell migration involved in sprouting angiogenesis |
| GO:0098739 | 0.01230 | 3.82142 | 1 | 5 | 111 | import across plasma membrane |
| GO:0002575 | 0.01235 | Inf | 0 | 1 | 1 | basophil chemotaxis |
| GO:0002785 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of antimicrobial peptide production |
| GO:0002787 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of antibacterial peptide production |
| GO:0007497 | 0.01235 | Inf | 0 | 1 | 1 | posterior midgut development |
| GO:0007634 | 0.01235 | Inf | 0 | 1 | 1 | optokinetic behavior |
| GO:0008348 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of antimicrobial humoral response |
| GO:0009447 | 0.01235 | Inf | 0 | 1 | 1 | putrescine catabolic process |
| GO:0010157 | 0.01235 | Inf | 0 | 1 | 1 | response to chlorate |
| GO:0010335 | 0.01235 | Inf | 0 | 1 | 1 | response to non-ionic osmotic stress |
| GO:0010849 | 0.01235 | Inf | 0 | 1 | 1 | regulation of proton-transporting ATPase activity, rotational mechanism |
| GO:0010868 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of triglyceride biosynthetic process |
| GO:0010967 | 0.01235 | Inf | 0 | 1 | 1 | regulation of polyamine biosynthetic process |
| GO:0014861 | 0.01235 | Inf | 0 | 1 | 1 | regulation of skeletal muscle contraction via regulation of action potential |
| GO:0021793 | 0.01235 | Inf | 0 | 1 | 1 | chemorepulsion of branchiomotor axon |
| GO:0030704 | 0.01235 | Inf | 0 | 1 | 1 | vitelline membrane formation |
| GO:0031945 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of glucocorticoid metabolic process |
| GO:0031948 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of glucocorticoid biosynthetic process |
| GO:0032599 | 0.01235 | Inf | 0 | 1 | 1 | protein transport out of membrane raft |
| GO:0032600 | 0.01235 | Inf | 0 | 1 | 1 | chemokine receptor transport out of membrane raft |
| GO:0032913 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of transforming growth factor beta3 production |
| GO:0033606 | 0.01235 | Inf | 0 | 1 | 1 | chemokine receptor transport within lipid bilayer |
| GO:0034102 | 0.01235 | Inf | 0 | 1 | 1 | erythrocyte clearance |
| GO:0034106 | 0.01235 | Inf | 0 | 1 | 1 | regulation of erythrocyte clearance |
| GO:0034107 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte clearance |
| GO:0034119 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte aggregation |
| GO:0035490 | 0.01235 | Inf | 0 | 1 | 1 | regulation of leukotriene production involved in inflammatory response |
| GO:0035491 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of leukotriene production involved in inflammatory response |
| GO:0035645 | 0.01235 | Inf | 0 | 1 | 1 | enteric smooth muscle cell differentiation |
| GO:0036275 | 0.01235 | Inf | 0 | 1 | 1 | response to 5-fluorouracil |
| GO:0036316 | 0.01235 | Inf | 0 | 1 | 1 | SREBP-SCAP complex retention in endoplasmic reticulum |
| GO:0036378 | 0.01235 | Inf | 0 | 1 | 1 | calcitriol biosynthetic process from calciol |
| GO:0038098 | 0.01235 | Inf | 0 | 1 | 1 | sequestering of BMP from receptor via BMP binding |
| GO:0042103 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of T cell homeostatic proliferation |
| GO:0044333 | 0.01235 | Inf | 0 | 1 | 1 | Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:0046014 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of T cell homeostatic proliferation |
| GO:0048074 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of eye pigmentation |
| GO:0048086 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of developmental pigmentation |
| GO:0051352 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of ligase activity |
| GO:0060007 | 0.01235 | Inf | 0 | 1 | 1 | linear vestibuloocular reflex |
| GO:0060183 | 0.01235 | Inf | 0 | 1 | 1 | apelin receptor signaling pathway |
| GO:0060806 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of cell differentiation involved in embryonic placenta development |
| GO:0061044 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of vascular wound healing |
| GO:0061369 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of testicular blood vessel morphogenesis |
| GO:0061682 | 0.01235 | Inf | 0 | 1 | 1 | seminal vesicle morphogenesis |
| GO:0061889 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of astrocyte activation |
| GO:0061914 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of growth plate cartilage chondrocyte proliferation |
| GO:0061975 | 0.01235 | Inf | 0 | 1 | 1 | articular cartilage development |
| GO:0061976 | 0.01235 | Inf | 0 | 1 | 1 | temporomandibular joint articular cartilage development |
| GO:0061978 | 0.01235 | Inf | 0 | 1 | 1 | mandibular condyle articular cartilage development |
| GO:0071471 | 0.01235 | Inf | 0 | 1 | 1 | cellular response to non-ionic osmotic stress |
| GO:0086100 | 0.01235 | Inf | 0 | 1 | 1 | endothelin receptor signaling pathway |
| GO:0090119 | 0.01235 | Inf | 0 | 1 | 1 | vesicle-mediated cholesterol transport |
| GO:0090291 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of osteoclast proliferation |
| GO:0100001 | 0.01235 | Inf | 0 | 1 | 1 | regulation of skeletal muscle contraction by action potential |
| GO:0106016 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of inflammatory response to wounding |
| GO:0140196 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process |
| GO:1900085 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of peptidyl-tyrosine autophosphorylation |
| GO:1901148 | 0.01235 | Inf | 0 | 1 | 1 | gene expression involved in extracellular matrix organization |
| GO:1901229 | 0.01235 | Inf | 0 | 1 | 1 | regulation of non-canonical Wnt signaling pathway via JNK cascade |
| GO:1901231 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of non-canonical Wnt signaling pathway via JNK cascade |
| GO:1901232 | 0.01235 | Inf | 0 | 1 | 1 | regulation of convergent extension involved in axis elongation |
| GO:1901233 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of convergent extension involved in axis elongation |
| GO:1901304 | 0.01235 | Inf | 0 | 1 | 1 | regulation of spermidine biosynthetic process |
| GO:1901307 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of spermidine biosynthetic process |
| GO:1901331 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of odontoblast differentiation |
| GO:1902178 | 0.01235 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor apoptotic signaling pathway |
| GO:1903570 | 0.01235 | Inf | 0 | 1 | 1 | regulation of protein kinase D signaling |
| GO:1903572 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of protein kinase D signaling |
| GO:1903610 | 0.01235 | Inf | 0 | 1 | 1 | regulation of calcium-dependent ATPase activity |
| GO:1903611 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of calcium-dependent ATPase activity |
| GO:1903627 | 0.01235 | Inf | 0 | 1 | 1 | regulation of dUTP diphosphatase activity |
| GO:1903629 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of dUTP diphosphatase activity |
| GO:1903631 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of aminoacyl-tRNA ligase activity |
| GO:1903633 | 0.01235 | Inf | 0 | 1 | 1 | regulation of leucine-tRNA ligase activity |
| GO:1903634 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of leucine-tRNA ligase activity |
| GO:1904022 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of G protein-coupled receptor internalization |
| GO:1904145 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of meiotic cell cycle process involved in oocyte maturation |
| GO:1905043 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of epithelium regeneration |
| GO:1905239 | 0.01235 | Inf | 0 | 1 | 1 | regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1905240 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1990697 | 0.01235 | Inf | 0 | 1 | 1 | protein depalmitoleylation |
| GO:2000056 | 0.01235 | Inf | 0 | 1 | 1 | regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:2000057 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:2000066 | 0.01235 | Inf | 0 | 1 | 1 | positive regulation of cortisol biosynthetic process |
| GO:2000180 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of androgen biosynthetic process |
| GO:2000639 | 0.01235 | Inf | 0 | 1 | 1 | negative regulation of SREBP signaling pathway |
| GO:0071560 | 0.01240 | 2.94806 | 2 | 7 | 200 | cellular response to transforming growth factor beta stimulus |
| GO:0014819 | 0.01254 | 13.41520 | 0 | 2 | 14 | regulation of skeletal muscle contraction |
| GO:0031340 | 0.01254 | 13.41520 | 0 | 2 | 14 | positive regulation of vesicle fusion |
| GO:0042159 | 0.01254 | 13.41520 | 0 | 2 | 14 | lipoprotein catabolic process |
| GO:0045618 | 0.01254 | 13.41520 | 0 | 2 | 14 | positive regulation of keratinocyte differentiation |
| GO:0048484 | 0.01254 | 13.41520 | 0 | 2 | 14 | enteric nervous system development |
| GO:0048537 | 0.01254 | 13.41520 | 0 | 2 | 14 | mucosal-associated lymphoid tissue development |
| GO:0048541 | 0.01254 | 13.41520 | 0 | 2 | 14 | Peyer's patch development |
| GO:0097154 | 0.01254 | 13.41520 | 0 | 2 | 14 | GABAergic neuron differentiation |
| GO:0098911 | 0.01254 | 13.41520 | 0 | 2 | 14 | regulation of ventricular cardiac muscle cell action potential |
| GO:0106070 | 0.01254 | 13.41520 | 0 | 2 | 14 | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:1903430 | 0.01254 | 13.41520 | 0 | 2 | 14 | negative regulation of cell maturation |
| GO:0060341 | 0.01257 | 1.80406 | 12 | 20 | 935 | regulation of cellular localization |
| GO:0007422 | 0.01273 | 4.68746 | 1 | 4 | 73 | peripheral nervous system development |
| GO:0061097 | 0.01273 | 4.68746 | 1 | 4 | 73 | regulation of protein tyrosine kinase activity |
| GO:0044057 | 0.01302 | 2.03935 | 7 | 14 | 577 | regulation of system process |
| GO:0035296 | 0.01313 | 3.24584 | 2 | 6 | 156 | regulation of tube diameter |
| GO:0097746 | 0.01313 | 3.24584 | 2 | 6 | 156 | regulation of blood vessel diameter |
| GO:0021983 | 0.01315 | 6.54216 | 0 | 3 | 40 | pituitary gland development |
| GO:0045923 | 0.01315 | 6.54216 | 0 | 3 | 40 | positive regulation of fatty acid metabolic process |
| GO:0046621 | 0.01315 | 6.54216 | 0 | 3 | 40 | negative regulation of organ growth |
| GO:2000181 | 0.01321 | 3.75033 | 1 | 5 | 113 | negative regulation of blood vessel morphogenesis |
| GO:0010467 | 0.01324 | 1.37370 | 58 | 74 | 4707 | gene expression |
| GO:1901698 | 0.01325 | 1.79384 | 12 | 20 | 940 | response to nitrogen compound |
| GO:0016192 | 0.01326 | 1.63315 | 18 | 28 | 1453 | vesicle-mediated transport |
| GO:0006809 | 0.01334 | 4.62029 | 1 | 4 | 74 | nitric oxide biosynthetic process |
| GO:0021879 | 0.01334 | 4.62029 | 1 | 4 | 74 | forebrain neuron differentiation |
| GO:0051966 | 0.01334 | 4.62029 | 1 | 4 | 74 | regulation of synaptic transmission, glutamatergic |
| GO:0007596 | 0.01351 | 3.22420 | 2 | 6 | 157 | blood coagulation |
| GO:0044703 | 0.01359 | 1.76252 | 12 | 21 | 1005 | multi-organism reproductive process |
| GO:0043534 | 0.01368 | 3.71576 | 1 | 5 | 114 | blood vessel endothelial cell migration |
| GO:0045732 | 0.01370 | 2.88769 | 3 | 7 | 204 | positive regulation of protein catabolic process |
| GO:0001738 | 0.01395 | 4.55502 | 1 | 4 | 75 | morphogenesis of a polarized epithelium |
| GO:0006953 | 0.01406 | 6.36972 | 1 | 3 | 41 | acute-phase response |
| GO:0110111 | 0.01406 | 6.36972 | 1 | 3 | 41 | negative regulation of animal organ morphogenesis |
| GO:0006139 | 0.01409 | 1.36888 | 58 | 74 | 4720 | nucleobase-containing compound metabolic process |
| GO:0007599 | 0.01430 | 3.18177 | 2 | 6 | 159 | hemostasis |
| GO:0043129 | 0.01435 | 12.38273 | 0 | 2 | 15 | surfactant homeostasis |
| GO:0045779 | 0.01435 | 12.38273 | 0 | 2 | 15 | negative regulation of bone resorption |
| GO:0050930 | 0.01435 | 12.38273 | 0 | 2 | 15 | induction of positive chemotaxis |
| GO:0060055 | 0.01435 | 12.38273 | 0 | 2 | 15 | angiogenesis involved in wound healing |
| GO:0060134 | 0.01435 | 12.38273 | 0 | 2 | 15 | prepulse inhibition |
| GO:0070166 | 0.01435 | 12.38273 | 0 | 2 | 15 | enamel mineralization |
| GO:0070593 | 0.01435 | 12.38273 | 0 | 2 | 15 | dendrite self-avoidance |
| GO:0071243 | 0.01435 | 12.38273 | 0 | 2 | 15 | cellular response to arsenic-containing substance |
| GO:0071404 | 0.01435 | 12.38273 | 0 | 2 | 15 | cellular response to low-density lipoprotein particle stimulus |
| GO:0072498 | 0.01435 | 12.38273 | 0 | 2 | 15 | embryonic skeletal joint development |
| GO:0098917 | 0.01435 | 12.38273 | 0 | 2 | 15 | retrograde trans-synaptic signaling |
| GO:0008361 | 0.01438 | 2.85842 | 3 | 7 | 206 | regulation of cell size |
| GO:0060047 | 0.01438 | 2.85842 | 3 | 7 | 206 | heart contraction |
| GO:0031401 | 0.01440 | 1.68674 | 15 | 24 | 1202 | positive regulation of protein modification process |
| GO:0030193 | 0.01459 | 4.49156 | 1 | 4 | 76 | regulation of blood coagulation |
| GO:0055008 | 0.01459 | 4.49156 | 1 | 4 | 76 | cardiac muscle tissue morphogenesis |
| GO:0071277 | 0.01459 | 4.49156 | 1 | 4 | 76 | cellular response to calcium ion |
| GO:0072175 | 0.01471 | 3.16097 | 2 | 6 | 160 | epithelial tube formation |
| GO:0006024 | 0.01501 | 6.20612 | 1 | 3 | 42 | glycosaminoglycan biosynthetic process |
| GO:0061098 | 0.01501 | 6.20612 | 1 | 3 | 42 | positive regulation of protein tyrosine kinase activity |
| GO:0070830 | 0.01501 | 6.20612 | 1 | 3 | 42 | bicellular tight junction assembly |
| GO:0007179 | 0.01513 | 3.14044 | 2 | 6 | 161 | transforming growth factor beta receptor signaling pathway |
| GO:0031644 | 0.01513 | 3.14044 | 2 | 6 | 161 | regulation of neurological system process |
| GO:0050817 | 0.01513 | 3.14044 | 2 | 6 | 161 | coagulation |
| GO:0002062 | 0.01516 | 3.61575 | 1 | 5 | 117 | chondrocyte differentiation |
| GO:0036294 | 0.01516 | 3.61575 | 1 | 5 | 117 | cellular response to decreased oxygen levels |
| GO:0006835 | 0.01524 | 4.42984 | 1 | 4 | 77 | dicarboxylic acid transport |
| GO:0046209 | 0.01524 | 4.42984 | 1 | 4 | 77 | nitric oxide metabolic process |
| GO:1900046 | 0.01524 | 4.42984 | 1 | 4 | 77 | regulation of hemostasis |
| GO:0006820 | 0.01554 | 2.05075 | 7 | 13 | 532 | anion transport |
| GO:0006695 | 0.01599 | 6.05070 | 1 | 3 | 43 | cholesterol biosynthetic process |
| GO:0033344 | 0.01599 | 6.05070 | 1 | 3 | 43 | cholesterol efflux |
| GO:0086002 | 0.01599 | 6.05070 | 1 | 3 | 43 | cardiac muscle cell action potential involved in contraction |
| GO:0120192 | 0.01599 | 6.05070 | 1 | 3 | 43 | tight junction assembly |
| GO:1902893 | 0.01599 | 6.05070 | 1 | 3 | 43 | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0006814 | 0.01620 | 2.78775 | 3 | 7 | 211 | sodium ion transport |
| GO:0010817 | 0.01621 | 2.03869 | 7 | 13 | 535 | regulation of hormone levels |
| GO:0001886 | 0.01627 | 11.49774 | 0 | 2 | 16 | endothelial cell morphogenesis |
| GO:0003414 | 0.01627 | 11.49774 | 0 | 2 | 16 | chondrocyte morphogenesis involved in endochondral bone morphogenesis |
| GO:0003429 | 0.01627 | 11.49774 | 0 | 2 | 16 | growth plate cartilage chondrocyte morphogenesis |
| GO:0008272 | 0.01627 | 11.49774 | 0 | 2 | 16 | sulfate transport |
| GO:0035235 | 0.01627 | 11.49774 | 0 | 2 | 16 | ionotropic glutamate receptor signaling pathway |
| GO:0042640 | 0.01627 | 11.49774 | 0 | 2 | 16 | anagen |
| GO:0043084 | 0.01627 | 11.49774 | 0 | 2 | 16 | penile erection |
| GO:0045603 | 0.01627 | 11.49774 | 0 | 2 | 16 | positive regulation of endothelial cell differentiation |
| GO:0090171 | 0.01627 | 11.49774 | 0 | 2 | 16 | chondrocyte morphogenesis |
| GO:0097094 | 0.01627 | 11.49774 | 0 | 2 | 16 | craniofacial suture morphogenesis |
| GO:2001053 | 0.01627 | 11.49774 | 0 | 2 | 16 | regulation of mesenchymal cell apoptotic process |
| GO:0003208 | 0.01661 | 4.31133 | 1 | 4 | 79 | cardiac ventricle morphogenesis |
| GO:0060113 | 0.01661 | 4.31133 | 1 | 4 | 79 | inner ear receptor cell differentiation |
| GO:0043271 | 0.01688 | 3.06090 | 2 | 6 | 165 | negative regulation of ion transport |
| GO:0002063 | 0.01700 | 5.90287 | 1 | 3 | 44 | chondrocyte development |
| GO:0045581 | 0.01700 | 5.90287 | 1 | 3 | 44 | negative regulation of T cell differentiation |
| GO:0090207 | 0.01700 | 5.90287 | 1 | 3 | 44 | regulation of triglyceride metabolic process |
| GO:0090279 | 0.01700 | 5.90287 | 1 | 3 | 44 | regulation of calcium ion import |
| GO:1902653 | 0.01700 | 5.90287 | 1 | 3 | 44 | secondary alcohol biosynthetic process |
| GO:0034641 | 0.01707 | 1.33796 | 67 | 83 | 5435 | cellular nitrogen compound metabolic process |
| GO:0046530 | 0.01731 | 4.25442 | 1 | 4 | 80 | photoreceptor cell differentiation |
| GO:0050818 | 0.01731 | 4.25442 | 1 | 4 | 80 | regulation of coagulation |
| GO:0006725 | 0.01732 | 1.34894 | 61 | 76 | 4913 | cellular aromatic compound metabolic process |
| GO:0003015 | 0.01737 | 2.74698 | 3 | 7 | 214 | heart process |
| GO:0048659 | 0.01780 | 3.02261 | 2 | 6 | 167 | smooth muscle cell proliferation |
| GO:0050727 | 0.01783 | 2.37232 | 4 | 9 | 318 | regulation of inflammatory response |
| GO:0007268 | 0.01789 | 1.79243 | 10 | 18 | 844 | chemical synaptic transmission |
| GO:0098916 | 0.01789 | 1.79243 | 10 | 18 | 844 | anterograde trans-synaptic signaling |
| GO:1901564 | 0.01802 | 1.32162 | 76 | 92 | 6130 | organonitrogen compound metabolic process |
| GO:0048663 | 0.01804 | 4.19898 | 1 | 4 | 81 | neuron fate commitment |
| GO:0033554 | 0.01804 | 1.55220 | 21 | 31 | 1692 | cellular response to stress |
| GO:0031952 | 0.01805 | 5.76207 | 1 | 3 | 45 | regulation of protein autophosphorylation |
| GO:0032965 | 0.01805 | 5.76207 | 1 | 3 | 45 | regulation of collagen biosynthetic process |
| GO:0044848 | 0.01805 | 5.76207 | 1 | 3 | 45 | biological phase |
| GO:0060323 | 0.01805 | 5.76207 | 1 | 3 | 45 | head morphogenesis |
| GO:0070169 | 0.01805 | 5.76207 | 1 | 3 | 45 | positive regulation of biomineral tissue development |
| GO:1902373 | 0.01805 | 5.76207 | 1 | 3 | 45 | negative regulation of mRNA catabolic process |
| GO:1903115 | 0.01805 | 5.76207 | 1 | 3 | 45 | regulation of actin filament-based movement |
| GO:0002237 | 0.01812 | 2.24652 | 5 | 10 | 373 | response to molecule of bacterial origin |
| GO:0050880 | 0.01828 | 3.00382 | 2 | 6 | 168 | regulation of blood vessel size |
| GO:0003184 | 0.01829 | 10.73076 | 0 | 2 | 17 | pulmonary valve morphogenesis |
| GO:0003422 | 0.01829 | 10.73076 | 0 | 2 | 17 | growth plate cartilage morphogenesis |
| GO:0006448 | 0.01829 | 10.73076 | 0 | 2 | 17 | regulation of translational elongation |
| GO:0010867 | 0.01829 | 10.73076 | 0 | 2 | 17 | positive regulation of triglyceride biosynthetic process |
| GO:0032780 | 0.01829 | 10.73076 | 0 | 2 | 17 | negative regulation of ATPase activity |
| GO:0035988 | 0.01829 | 10.73076 | 0 | 2 | 17 | chondrocyte proliferation |
| GO:0045019 | 0.01829 | 10.73076 | 0 | 2 | 17 | negative regulation of nitric oxide biosynthetic process |
| GO:0045836 | 0.01829 | 10.73076 | 0 | 2 | 17 | positive regulation of meiotic nuclear division |
| GO:0048875 | 0.01829 | 10.73076 | 0 | 2 | 17 | chemical homeostasis within a tissue |
| GO:0060644 | 0.01829 | 10.73076 | 0 | 2 | 17 | mammary gland epithelial cell differentiation |
| GO:0071636 | 0.01829 | 10.73076 | 0 | 2 | 17 | positive regulation of transforming growth factor beta production |
| GO:0090036 | 0.01829 | 10.73076 | 0 | 2 | 17 | regulation of protein kinase C signaling |
| GO:0097152 | 0.01829 | 10.73076 | 0 | 2 | 17 | mesenchymal cell apoptotic process |
| GO:0099171 | 0.01829 | 10.73076 | 0 | 2 | 17 | presynaptic modulation of chemical synaptic transmission |
| GO:1904406 | 0.01829 | 10.73076 | 0 | 2 | 17 | negative regulation of nitric oxide metabolic process |
| GO:0035150 | 0.01876 | 2.98526 | 2 | 6 | 169 | regulation of tube size |
| GO:1903035 | 0.01879 | 4.14497 | 1 | 4 | 82 | negative regulation of response to wounding |
| GO:2001057 | 0.01879 | 4.14497 | 1 | 4 | 82 | reactive nitrogen species metabolic process |
| GO:0010811 | 0.01902 | 3.40202 | 2 | 5 | 124 | positive regulation of cell-substrate adhesion |
| GO:0001504 | 0.01914 | 5.62783 | 1 | 3 | 46 | neurotransmitter uptake |
| GO:0003382 | 0.01914 | 5.62783 | 1 | 3 | 46 | epithelial cell morphogenesis |
| GO:0030517 | 0.01914 | 5.62783 | 1 | 3 | 46 | negative regulation of axon extension |
| GO:0045907 | 0.01914 | 5.62783 | 1 | 3 | 46 | positive regulation of vasoconstriction |
| GO:0048713 | 0.01914 | 5.62783 | 1 | 3 | 46 | regulation of oligodendrocyte differentiation |
| GO:0090102 | 0.01914 | 5.62783 | 1 | 3 | 46 | cochlea development |
| GO:0120193 | 0.01914 | 5.62783 | 1 | 3 | 46 | tight junction organization |
| GO:1901343 | 0.01962 | 3.37352 | 2 | 5 | 125 | negative regulation of vasculature development |
| GO:0099537 | 0.01967 | 1.77239 | 11 | 18 | 853 | trans-synaptic signaling |
| GO:0090304 | 0.01972 | 1.36023 | 52 | 66 | 4198 | nucleic acid metabolic process |
| GO:1904062 | 0.01986 | 2.32652 | 4 | 9 | 324 | regulation of cation transmembrane transport |
| GO:0008277 | 0.02023 | 3.34550 | 2 | 5 | 126 | regulation of G protein-coupled receptor signaling pathway |
| GO:0051101 | 0.02023 | 3.34550 | 2 | 5 | 126 | regulation of DNA binding |
| GO:0003179 | 0.02026 | 5.49968 | 1 | 3 | 47 | heart valve morphogenesis |
| GO:0038066 | 0.02026 | 5.49968 | 1 | 3 | 47 | p38MAPK cascade |
| GO:0051353 | 0.02026 | 5.49968 | 1 | 3 | 47 | positive regulation of oxidoreductase activity |
| GO:0060612 | 0.02026 | 5.49968 | 1 | 3 | 47 | adipose tissue development |
| GO:1904036 | 0.02026 | 5.49968 | 1 | 3 | 47 | negative regulation of epithelial cell apoptotic process |
| GO:0003012 | 0.02031 | 2.20334 | 5 | 10 | 380 | muscle system process |
| GO:0009991 | 0.02031 | 2.20334 | 5 | 10 | 380 | response to extracellular stimulus |
| GO:0010632 | 0.02032 | 2.65631 | 3 | 7 | 221 | regulation of epithelial cell migration |
| GO:0070509 | 0.02034 | 4.04099 | 1 | 4 | 84 | calcium ion import |
| GO:0005980 | 0.02041 | 10.05965 | 0 | 2 | 18 | glycogen catabolic process |
| GO:0009251 | 0.02041 | 10.05965 | 0 | 2 | 18 | glucan catabolic process |
| GO:0010002 | 0.02041 | 10.05965 | 0 | 2 | 18 | cardioblast differentiation |
| GO:0021783 | 0.02041 | 10.05965 | 0 | 2 | 18 | preganglionic parasympathetic fiber development |
| GO:0022010 | 0.02041 | 10.05965 | 0 | 2 | 18 | central nervous system myelination |
| GO:0032291 | 0.02041 | 10.05965 | 0 | 2 | 18 | axon ensheathment in central nervous system |
| GO:0034111 | 0.02041 | 10.05965 | 0 | 2 | 18 | negative regulation of homotypic cell-cell adhesion |
| GO:0036314 | 0.02041 | 10.05965 | 0 | 2 | 18 | response to sterol |
| GO:0060707 | 0.02041 | 10.05965 | 0 | 2 | 18 | trophoblast giant cell differentiation |
| GO:0071605 | 0.02041 | 10.05965 | 0 | 2 | 18 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.02041 | 10.05965 | 0 | 2 | 18 | regulation of monocyte chemotactic protein-1 production |
| GO:0086011 | 0.02041 | 10.05965 | 0 | 2 | 18 | membrane repolarization during action potential |
| GO:2000678 | 0.02041 | 10.05965 | 0 | 2 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0050900 | 0.02057 | 2.31163 | 4 | 9 | 326 | leukocyte migration |
| GO:0042490 | 0.02114 | 3.99093 | 1 | 4 | 85 | mechanoreceptor differentiation |
| GO:0099536 | 0.02136 | 1.75494 | 11 | 18 | 861 | synaptic signaling |
| GO:0061005 | 0.02142 | 5.37723 | 1 | 3 | 48 | cell differentiation involved in kidney development |
| GO:1902930 | 0.02142 | 5.37723 | 1 | 3 | 48 | regulation of alcohol biosynthetic process |
| GO:0021872 | 0.02196 | 3.94208 | 1 | 4 | 86 | forebrain generation of neurons |
| GO:0044344 | 0.02196 | 3.94208 | 1 | 4 | 86 | cellular response to fibroblast growth factor stimulus |
| GO:0019538 | 0.02207 | 1.32331 | 65 | 80 | 5268 | protein metabolic process |
| GO:0045995 | 0.02214 | 3.26413 | 2 | 5 | 129 | regulation of embryonic development |
| GO:1903364 | 0.02214 | 3.26413 | 2 | 5 | 129 | positive regulation of cellular protein catabolic process |
| GO:0010770 | 0.02239 | 2.86146 | 2 | 6 | 176 | positive regulation of cell morphogenesis involved in differentiation |
| GO:0042491 | 0.02262 | 5.26010 | 1 | 3 | 49 | inner ear auditory receptor cell differentiation |
| GO:0045124 | 0.02262 | 5.26010 | 1 | 3 | 49 | regulation of bone resorption |
| GO:0045646 | 0.02262 | 5.26010 | 1 | 3 | 49 | regulation of erythrocyte differentiation |
| GO:0002863 | 0.02263 | 9.46749 | 0 | 2 | 19 | positive regulation of inflammatory response to antigenic stimulus |
| GO:0010666 | 0.02263 | 9.46749 | 0 | 2 | 19 | positive regulation of cardiac muscle cell apoptotic process |
| GO:0040037 | 0.02263 | 9.46749 | 0 | 2 | 19 | negative regulation of fibroblast growth factor receptor signaling pathway |
| GO:0051546 | 0.02263 | 9.46749 | 0 | 2 | 19 | keratinocyte migration |
| GO:0070208 | 0.02263 | 9.46749 | 0 | 2 | 19 | protein heterotrimerization |
| GO:1905331 | 0.02263 | 9.46749 | 0 | 2 | 19 | negative regulation of morphogenesis of an epithelium |
| GO:0051928 | 0.02280 | 3.23787 | 2 | 5 | 130 | positive regulation of calcium ion transport |
| GO:0021954 | 0.02280 | 3.89442 | 1 | 4 | 87 | central nervous system neuron development |
| GO:1903305 | 0.02294 | 2.84460 | 2 | 6 | 177 | regulation of regulated secretory pathway |
| GO:0045619 | 0.02351 | 2.82794 | 2 | 6 | 178 | regulation of lymphocyte differentiation |
| GO:1902533 | 0.02353 | 1.68302 | 12 | 20 | 998 | positive regulation of intracellular signal transduction |
| GO:0006936 | 0.02357 | 2.39089 | 3 | 8 | 280 | muscle contraction |
| GO:0009798 | 0.02367 | 3.84789 | 1 | 4 | 88 | axis specification |
| GO:0071774 | 0.02367 | 3.84789 | 1 | 4 | 88 | response to fibroblast growth factor |
| GO:0008038 | 0.02384 | 5.14796 | 1 | 3 | 50 | neuron recognition |
| GO:0048701 | 0.02384 | 5.14796 | 1 | 3 | 50 | embryonic cranial skeleton morphogenesis |
| GO:0070482 | 0.02401 | 2.38203 | 3 | 8 | 281 | response to oxygen levels |
| GO:0001508 | 0.02416 | 3.18660 | 2 | 5 | 132 | action potential |
| GO:0060415 | 0.02455 | 3.80245 | 1 | 4 | 89 | muscle tissue morphogenesis |
| GO:0001830 | 0.02455 | 80.24825 | 0 | 1 | 2 | trophectodermal cell fate commitment |
| GO:0001966 | 0.02455 | 80.24825 | 0 | 1 | 2 | thigmotaxis |
| GO:0002041 | 0.02455 | 80.24825 | 0 | 1 | 2 | intussusceptive angiogenesis |
| GO:0002842 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of T cell mediated immune response to tumor cell |
| GO:0003169 | 0.02455 | 80.24825 | 0 | 1 | 2 | coronary vein morphogenesis |
| GO:0006011 | 0.02455 | 80.24825 | 0 | 1 | 2 | UDP-glucose metabolic process |
| GO:0006452 | 0.02455 | 80.24825 | 0 | 1 | 2 | translational frameshifting |
| GO:0007352 | 0.02455 | 80.24825 | 0 | 1 | 2 | zygotic specification of dorsal/ventral axis |
| GO:0007493 | 0.02455 | 80.24825 | 0 | 1 | 2 | endodermal cell fate determination |
| GO:0010142 | 0.02455 | 80.24825 | 0 | 1 | 2 | farnesyl diphosphate biosynthetic process, mevalonate pathway |
| GO:0010899 | 0.02455 | 80.24825 | 0 | 1 | 2 | regulation of phosphatidylcholine catabolic process |
| GO:0015881 | 0.02455 | 80.24825 | 0 | 1 | 2 | creatine transmembrane transport |
| GO:0019255 | 0.02455 | 80.24825 | 0 | 1 | 2 | glucose 1-phosphate metabolic process |
| GO:0019417 | 0.02455 | 80.24825 | 0 | 1 | 2 | sulfur oxidation |
| GO:0019566 | 0.02455 | 80.24825 | 0 | 1 | 2 | arabinose metabolic process |
| GO:0021560 | 0.02455 | 80.24825 | 0 | 1 | 2 | abducens nerve development |
| GO:0021598 | 0.02455 | 80.24825 | 0 | 1 | 2 | abducens nerve morphogenesis |
| GO:0021599 | 0.02455 | 80.24825 | 0 | 1 | 2 | abducens nerve formation |
| GO:0021644 | 0.02455 | 80.24825 | 0 | 1 | 2 | vagus nerve morphogenesis |
| GO:0021754 | 0.02455 | 80.24825 | 0 | 1 | 2 | facial nucleus development |
| GO:0021762 | 0.02455 | 80.24825 | 0 | 1 | 2 | substantia nigra development |
| GO:0021784 | 0.02455 | 80.24825 | 0 | 1 | 2 | postganglionic parasympathetic fiber development |
| GO:0021893 | 0.02455 | 80.24825 | 0 | 1 | 2 | cerebral cortex GABAergic interneuron fate commitment |
| GO:0021935 | 0.02455 | 80.24825 | 0 | 1 | 2 | cerebellar granule cell precursor tangential migration |
| GO:0021997 | 0.02455 | 80.24825 | 0 | 1 | 2 | neural plate axis specification |
| GO:0030237 | 0.02455 | 80.24825 | 0 | 1 | 2 | female sex determination |
| GO:0032912 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of transforming growth factor beta2 production |
| GO:0032915 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of transforming growth factor beta2 production |
| GO:0033484 | 0.02455 | 80.24825 | 0 | 1 | 2 | nitric oxide homeostasis |
| GO:0034117 | 0.02455 | 80.24825 | 0 | 1 | 2 | erythrocyte aggregation |
| GO:0034118 | 0.02455 | 80.24825 | 0 | 1 | 2 | regulation of erythrocyte aggregation |
| GO:0035803 | 0.02455 | 80.24825 | 0 | 1 | 2 | egg coat formation |
| GO:0035854 | 0.02455 | 80.24825 | 0 | 1 | 2 | eosinophil fate commitment |
| GO:0035981 | 0.02455 | 80.24825 | 0 | 1 | 2 | tongue muscle cell differentiation |
| GO:0036304 | 0.02455 | 80.24825 | 0 | 1 | 2 | umbilical cord morphogenesis |
| GO:0036305 | 0.02455 | 80.24825 | 0 | 1 | 2 | ameloblast differentiation |
| GO:0038183 | 0.02455 | 80.24825 | 0 | 1 | 2 | bile acid signaling pathway |
| GO:0038190 | 0.02455 | 80.24825 | 0 | 1 | 2 | VEGF-activated neuropilin signaling pathway |
| GO:0042369 | 0.02455 | 80.24825 | 0 | 1 | 2 | vitamin D catabolic process |
| GO:0045905 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of translational termination |
| GO:0046203 | 0.02455 | 80.24825 | 0 | 1 | 2 | spermidine catabolic process |
| GO:0046373 | 0.02455 | 80.24825 | 0 | 1 | 2 | L-arabinose metabolic process |
| GO:0048073 | 0.02455 | 80.24825 | 0 | 1 | 2 | regulation of eye pigmentation |
| GO:0060031 | 0.02455 | 80.24825 | 0 | 1 | 2 | mediolateral intercalation |
| GO:0060220 | 0.02455 | 80.24825 | 0 | 1 | 2 | camera-type eye photoreceptor cell fate commitment |
| GO:0060302 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of cytokine activity |
| GO:0060364 | 0.02455 | 80.24825 | 0 | 1 | 2 | frontal suture morphogenesis |
| GO:0060775 | 0.02455 | 80.24825 | 0 | 1 | 2 | planar cell polarity pathway involved in gastrula mediolateral intercalation |
| GO:0060876 | 0.02455 | 80.24825 | 0 | 1 | 2 | semicircular canal formation |
| GO:0061027 | 0.02455 | 80.24825 | 0 | 1 | 2 | umbilical cord development |
| GO:0061075 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of neural retina development |
| GO:0061107 | 0.02455 | 80.24825 | 0 | 1 | 2 | seminal vesicle development |
| GO:0061723 | 0.02455 | 80.24825 | 0 | 1 | 2 | glycophagy |
| GO:0062044 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of cardiac epithelial to mesenchymal transition |
| GO:0070564 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of vitamin D receptor signaling pathway |
| GO:0070778 | 0.02455 | 80.24825 | 0 | 1 | 2 | L-aspartate transmembrane transport |
| GO:0071279 | 0.02455 | 80.24825 | 0 | 1 | 2 | cellular response to cobalt ion |
| GO:0071460 | 0.02455 | 80.24825 | 0 | 1 | 2 | cellular response to cell-matrix adhesion |
| GO:0071642 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of macrophage inflammatory protein 1 alpha production |
| GO:0071874 | 0.02455 | 80.24825 | 0 | 1 | 2 | cellular response to norepinephrine stimulus |
| GO:0071879 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0086098 | 0.02455 | 80.24825 | 0 | 1 | 2 | angiotensin-activated signaling pathway involved in heart process |
| GO:0090076 | 0.02455 | 80.24825 | 0 | 1 | 2 | relaxation of skeletal muscle |
| GO:0090362 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of platelet-derived growth factor production |
| GO:0090678 | 0.02455 | 80.24825 | 0 | 1 | 2 | cell dedifferentiation involved in phenotypic switching |
| GO:0097532 | 0.02455 | 80.24825 | 0 | 1 | 2 | stress response to acid chemical |
| GO:0097533 | 0.02455 | 80.24825 | 0 | 1 | 2 | cellular stress response to acid chemical |
| GO:0098923 | 0.02455 | 80.24825 | 0 | 1 | 2 | retrograde trans-synaptic signaling by soluble gas |
| GO:0098924 | 0.02455 | 80.24825 | 0 | 1 | 2 | retrograde trans-synaptic signaling by nitric oxide |
| GO:0099148 | 0.02455 | 80.24825 | 0 | 1 | 2 | regulation of synaptic vesicle docking |
| GO:0140009 | 0.02455 | 80.24825 | 0 | 1 | 2 | L-aspartate import across plasma membrane |
| GO:1900138 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of phospholipase A2 activity |
| GO:1900154 | 0.02455 | 80.24825 | 0 | 1 | 2 | regulation of bone trabecula formation |
| GO:1900155 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of bone trabecula formation |
| GO:1900924 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of glycine import across plasma membrane |
| GO:1901303 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of cargo loading into COPII-coated vesicle |
| GO:1902767 | 0.02455 | 80.24825 | 0 | 1 | 2 | isoprenoid biosynthetic process via mevalonate |
| GO:1902868 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of retina development in camera-type eye |
| GO:1902871 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of amacrine cell differentiation |
| GO:1902913 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of neuroepithelial cell differentiation |
| GO:1903609 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of inward rectifier potassium channel activity |
| GO:1903699 | 0.02455 | 80.24825 | 0 | 1 | 2 | tarsal gland development |
| GO:1904456 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of neuronal action potential |
| GO:1905006 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:1905167 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of lysosomal protein catabolic process |
| GO:1905174 | 0.02455 | 80.24825 | 0 | 1 | 2 | regulation of vascular smooth muscle cell dedifferentiation |
| GO:1990927 | 0.02455 | 80.24825 | 0 | 1 | 2 | calcium ion regulated lysosome exocytosis |
| GO:1990936 | 0.02455 | 80.24825 | 0 | 1 | 2 | vascular smooth muscle cell dedifferentiation |
| GO:2000098 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000225 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of testosterone biosynthetic process |
| GO:2000276 | 0.02455 | 80.24825 | 0 | 1 | 2 | negative regulation of oxidative phosphorylation uncoupler activity |
| GO:2000638 | 0.02455 | 80.24825 | 0 | 1 | 2 | regulation of SREBP signaling pathway |
| GO:2001035 | 0.02455 | 80.24825 | 0 | 1 | 2 | regulation of tongue muscle cell differentiation |
| GO:2001037 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of tongue muscle cell differentiation |
| GO:2001247 | 0.02455 | 80.24825 | 0 | 1 | 2 | positive regulation of phosphatidylcholine biosynthetic process |
| GO:0050806 | 0.02481 | 2.23302 | 4 | 9 | 337 | positive regulation of synaptic transmission |
| GO:0046928 | 0.02486 | 3.16157 | 2 | 5 | 133 | regulation of neurotransmitter secretion |
| GO:0048593 | 0.02486 | 3.16157 | 2 | 5 | 133 | camera-type eye morphogenesis |
| GO:0002115 | 0.02494 | 8.94113 | 0 | 2 | 20 | store-operated calcium entry |
| GO:0003177 | 0.02494 | 8.94113 | 0 | 2 | 20 | pulmonary valve development |
| GO:0010663 | 0.02494 | 8.94113 | 0 | 2 | 20 | positive regulation of striated muscle cell apoptotic process |
| GO:0044247 | 0.02494 | 8.94113 | 0 | 2 | 20 | cellular polysaccharide catabolic process |
| GO:0045649 | 0.02494 | 8.94113 | 0 | 2 | 20 | regulation of macrophage differentiation |
| GO:0048557 | 0.02494 | 8.94113 | 0 | 2 | 20 | embryonic digestive tract morphogenesis |
| GO:0072170 | 0.02494 | 8.94113 | 0 | 2 | 20 | metanephric tubule development |
| GO:0022604 | 0.02509 | 1.97154 | 6 | 12 | 509 | regulation of cell morphogenesis |
| GO:0043297 | 0.02511 | 5.04049 | 1 | 3 | 51 | apical junction assembly |
| GO:0090257 | 0.02512 | 2.53661 | 3 | 7 | 231 | regulation of muscle system process |
| GO:0016331 | 0.02525 | 2.77910 | 2 | 6 | 181 | morphogenesis of embryonic epithelium |
| GO:0022408 | 0.02525 | 2.77910 | 2 | 6 | 181 | negative regulation of cell-cell adhesion |
| GO:0046483 | 0.02526 | 1.32287 | 60 | 74 | 4848 | heterocycle metabolic process |
| GO:0043535 | 0.02545 | 3.75807 | 1 | 4 | 90 | regulation of blood vessel endothelial cell migration |
| GO:0055088 | 0.02557 | 3.13692 | 2 | 5 | 134 | lipid homeostasis |
| GO:0007015 | 0.02605 | 2.11051 | 5 | 10 | 396 | actin filament organization |
| GO:0002027 | 0.02637 | 3.71472 | 1 | 4 | 91 | regulation of heart rate |
| GO:0014909 | 0.02637 | 3.71472 | 1 | 4 | 91 | smooth muscle cell migration |
| GO:0006023 | 0.02641 | 4.93741 | 1 | 3 | 52 | aminoglycan biosynthetic process |
| GO:0045773 | 0.02641 | 4.93741 | 1 | 3 | 52 | positive regulation of axon extension |
| GO:2000351 | 0.02641 | 4.93741 | 1 | 3 | 52 | regulation of endothelial cell apoptotic process |
| GO:0023061 | 0.02643 | 1.95545 | 6 | 12 | 513 | signal release |
| GO:0031330 | 0.02670 | 2.50275 | 3 | 7 | 234 | negative regulation of cellular catabolic process |
| GO:0045785 | 0.02724 | 2.09396 | 5 | 10 | 399 | positive regulation of cell adhesion |
| GO:0003433 | 0.02735 | 8.47018 | 0 | 2 | 21 | chondrocyte development involved in endochondral bone morphogenesis |
| GO:0031290 | 0.02735 | 8.47018 | 0 | 2 | 21 | retinal ganglion cell axon guidance |
| GO:0032366 | 0.02735 | 8.47018 | 0 | 2 | 21 | intracellular sterol transport |
| GO:0032367 | 0.02735 | 8.47018 | 0 | 2 | 21 | intracellular cholesterol transport |
| GO:0043586 | 0.02735 | 8.47018 | 0 | 2 | 21 | tongue development |
| GO:0046475 | 0.02735 | 8.47018 | 0 | 2 | 21 | glycerophospholipid catabolic process |
| GO:0048486 | 0.02735 | 8.47018 | 0 | 2 | 21 | parasympathetic nervous system development |
| GO:0051450 | 0.02735 | 8.47018 | 0 | 2 | 21 | myoblast proliferation |
| GO:0072111 | 0.02735 | 8.47018 | 0 | 2 | 21 | cell proliferation involved in kidney development |
| GO:1901522 | 0.02735 | 8.47018 | 0 | 2 | 21 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| GO:0010517 | 0.02775 | 4.83845 | 1 | 3 | 53 | regulation of phospholipase activity |
| GO:0030850 | 0.02775 | 4.83845 | 1 | 3 | 53 | prostate gland development |
| GO:0032350 | 0.02775 | 4.83845 | 1 | 3 | 53 | regulation of hormone metabolic process |
| GO:0070265 | 0.02775 | 4.83845 | 1 | 3 | 53 | necrotic cell death |
| GO:1902369 | 0.02775 | 4.83845 | 1 | 3 | 53 | negative regulation of RNA catabolic process |
| GO:0035270 | 0.02779 | 3.06523 | 2 | 5 | 137 | endocrine system development |
| GO:0046888 | 0.02827 | 3.63092 | 1 | 4 | 93 | negative regulation of hormone secretion |
| GO:0007269 | 0.02835 | 2.70130 | 2 | 6 | 186 | neurotransmitter secretion |
| GO:0099643 | 0.02835 | 2.70130 | 2 | 6 | 186 | signal release from synapse |
| GO:0009267 | 0.02855 | 3.04205 | 2 | 5 | 138 | cellular response to starvation |
| GO:0031347 | 0.02857 | 1.87652 | 7 | 13 | 579 | regulation of defense response |
| GO:0030036 | 0.02862 | 1.82895 | 8 | 14 | 640 | actin cytoskeleton organization |
| GO:0097193 | 0.02875 | 2.29685 | 4 | 8 | 291 | intrinsic apoptotic signaling pathway |
| GO:0016051 | 0.02900 | 2.68626 | 2 | 6 | 187 | carbohydrate biosynthetic process |
| GO:0032964 | 0.02912 | 4.74337 | 1 | 3 | 54 | collagen biosynthetic process |
| GO:0035315 | 0.02912 | 4.74337 | 1 | 3 | 54 | hair cell differentiation |
| GO:0086001 | 0.02912 | 4.74337 | 1 | 3 | 54 | cardiac muscle cell action potential |
| GO:0016042 | 0.02977 | 2.28053 | 4 | 8 | 293 | lipid catabolic process |
| GO:0003418 | 0.02984 | 8.04632 | 0 | 2 | 22 | growth plate cartilage chondrocyte differentiation |
| GO:0010874 | 0.02984 | 8.04632 | 0 | 2 | 22 | regulation of cholesterol efflux |
| GO:0014912 | 0.02984 | 8.04632 | 0 | 2 | 22 | negative regulation of smooth muscle cell migration |
| GO:0034505 | 0.02984 | 8.04632 | 0 | 2 | 22 | tooth mineralization |
| GO:0043153 | 0.02984 | 8.04632 | 0 | 2 | 22 | entrainment of circadian clock by photoperiod |
| GO:0044851 | 0.02984 | 8.04632 | 0 | 2 | 22 | hair cycle phase |
| GO:0045922 | 0.02984 | 8.04632 | 0 | 2 | 22 | negative regulation of fatty acid metabolic process |
| GO:0048532 | 0.02984 | 8.04632 | 0 | 2 | 22 | anatomical structure arrangement |
| GO:0048857 | 0.02984 | 8.04632 | 0 | 2 | 22 | neural nucleus development |
| GO:0071711 | 0.02984 | 8.04632 | 0 | 2 | 22 | basement membrane organization |
| GO:0007568 | 0.03006 | 2.43766 | 3 | 7 | 240 | aging |
| GO:0031333 | 0.03012 | 2.99672 | 2 | 5 | 140 | negative regulation of protein complex assembly |
| GO:0034101 | 0.03012 | 2.99672 | 2 | 5 | 140 | erythrocyte homeostasis |
| GO:0072577 | 0.03052 | 4.65195 | 1 | 3 | 55 | endothelial cell apoptotic process |
| GO:0035637 | 0.03092 | 2.97455 | 2 | 5 | 141 | multicellular organismal signaling |
| GO:0009617 | 0.03096 | 1.67636 | 11 | 18 | 899 | response to bacterium |
| GO:2001243 | 0.03126 | 3.51206 | 1 | 4 | 96 | negative regulation of intrinsic apoptotic signaling pathway |
| GO:0043933 | 0.03142 | 1.45876 | 24 | 33 | 1910 | protein-containing complex subunit organization |
| GO:0007292 | 0.03174 | 2.95271 | 2 | 5 | 142 | female gamete generation |
| GO:0001754 | 0.03196 | 4.56398 | 1 | 3 | 56 | eye photoreceptor cell differentiation |
| GO:0002067 | 0.03196 | 4.56398 | 1 | 3 | 56 | glandular epithelial cell differentiation |
| GO:0051445 | 0.03196 | 4.56398 | 1 | 3 | 56 | regulation of meiotic cell cycle |
| GO:0051893 | 0.03196 | 4.56398 | 1 | 3 | 56 | regulation of focal adhesion assembly |
| GO:0090109 | 0.03196 | 4.56398 | 1 | 3 | 56 | regulation of cell-substrate junction assembly |
| GO:0045638 | 0.03230 | 3.47414 | 1 | 4 | 97 | negative regulation of myeloid cell differentiation |
| GO:0048644 | 0.03230 | 3.47414 | 1 | 4 | 97 | muscle organ morphogenesis |
| GO:0000272 | 0.03242 | 7.66282 | 0 | 2 | 23 | polysaccharide catabolic process |
| GO:0009648 | 0.03242 | 7.66282 | 0 | 2 | 23 | photoperiodism |
| GO:0031954 | 0.03242 | 7.66282 | 0 | 2 | 23 | positive regulation of protein autophosphorylation |
| GO:0051580 | 0.03242 | 7.66282 | 0 | 2 | 23 | regulation of neurotransmitter uptake |
| GO:0055094 | 0.03242 | 7.66282 | 0 | 2 | 23 | response to lipoprotein particle |
| GO:0070861 | 0.03242 | 7.66282 | 0 | 2 | 23 | regulation of protein exit from endoplasmic reticulum |
| GO:0071870 | 0.03242 | 7.66282 | 0 | 2 | 23 | cellular response to catecholamine stimulus |
| GO:0072202 | 0.03242 | 7.66282 | 0 | 2 | 23 | cell differentiation involved in metanephros development |
| GO:0072207 | 0.03242 | 7.66282 | 0 | 2 | 23 | metanephric epithelium development |
| GO:1900120 | 0.03242 | 7.66282 | 0 | 2 | 23 | regulation of receptor binding |
| GO:0032496 | 0.03304 | 2.11517 | 4 | 9 | 355 | response to lipopolysaccharide |
| GO:0021782 | 0.03336 | 3.43703 | 1 | 4 | 98 | glial cell development |
| GO:0055024 | 0.03336 | 3.43703 | 1 | 4 | 98 | regulation of cardiac muscle tissue development |
| GO:0003170 | 0.03344 | 4.47926 | 1 | 3 | 57 | heart valve development |
| GO:0051146 | 0.03410 | 2.21748 | 4 | 8 | 301 | striated muscle cell differentiation |
| GO:0051704 | 0.03415 | 1.40728 | 29 | 39 | 2346 | multi-organism process |
| GO:0042133 | 0.03427 | 2.88906 | 2 | 5 | 145 | neurotransmitter metabolic process |
| GO:0043410 | 0.03439 | 1.87503 | 7 | 12 | 534 | positive regulation of MAPK cascade |
| GO:0010771 | 0.03444 | 3.40071 | 1 | 4 | 99 | negative regulation of cell morphogenesis involved in differentiation |
| GO:0055001 | 0.03454 | 2.57165 | 2 | 6 | 195 | muscle cell development |
| GO:0009894 | 0.03465 | 1.70771 | 10 | 16 | 783 | regulation of catabolic process |
| GO:0002011 | 0.03495 | 4.39763 | 1 | 3 | 58 | morphogenesis of an epithelial sheet |
| GO:0043462 | 0.03495 | 4.39763 | 1 | 3 | 58 | regulation of ATPase activity |
| GO:0045744 | 0.03495 | 4.39763 | 1 | 3 | 58 | negative regulation of G protein-coupled receptor signaling pathway |
| GO:0061337 | 0.03495 | 4.39763 | 1 | 3 | 58 | cardiac conduction |
| GO:0021537 | 0.03497 | 2.35591 | 3 | 7 | 248 | telencephalon development |
| GO:0001516 | 0.03509 | 7.31419 | 0 | 2 | 24 | prostaglandin biosynthetic process |
| GO:0001829 | 0.03509 | 7.31419 | 0 | 2 | 24 | trophectodermal cell differentiation |
| GO:0010575 | 0.03509 | 7.31419 | 0 | 2 | 24 | positive regulation of vascular endothelial growth factor production |
| GO:0021889 | 0.03509 | 7.31419 | 0 | 2 | 24 | olfactory bulb interneuron differentiation |
| GO:0021895 | 0.03509 | 7.31419 | 0 | 2 | 24 | cerebral cortex neuron differentiation |
| GO:0030728 | 0.03509 | 7.31419 | 0 | 2 | 24 | ovulation |
| GO:0032365 | 0.03509 | 7.31419 | 0 | 2 | 24 | intracellular lipid transport |
| GO:0046457 | 0.03509 | 7.31419 | 0 | 2 | 24 | prostanoid biosynthetic process |
| GO:0046685 | 0.03509 | 7.31419 | 0 | 2 | 24 | response to arsenic-containing substance |
| GO:0071868 | 0.03509 | 7.31419 | 0 | 2 | 24 | cellular response to monoamine stimulus |
| GO:0071869 | 0.03509 | 7.31419 | 0 | 2 | 24 | response to catecholamine |
| GO:0090280 | 0.03509 | 7.31419 | 0 | 2 | 24 | positive regulation of calcium ion import |
| GO:1900273 | 0.03509 | 7.31419 | 0 | 2 | 24 | positive regulation of long-term synaptic potentiation |
| GO:0051260 | 0.03509 | 2.09063 | 4 | 9 | 359 | protein homooligomerization |
| GO:0046677 | 0.03524 | 2.20225 | 4 | 8 | 303 | response to antibiotic |
| GO:0060541 | 0.03562 | 2.34607 | 3 | 7 | 249 | respiratory system development |
| GO:0031329 | 0.03568 | 1.77074 | 8 | 14 | 660 | regulation of cellular catabolic process |
| GO:0051250 | 0.03603 | 2.84812 | 2 | 5 | 147 | negative regulation of lymphocyte activation |
| GO:0007517 | 0.03621 | 1.98980 | 5 | 10 | 419 | muscle organ development |
| GO:0009100 | 0.03642 | 2.18722 | 4 | 8 | 305 | glycoprotein metabolic process |
| GO:0045776 | 0.03650 | 4.31891 | 1 | 3 | 59 | negative regulation of blood pressure |
| GO:0048286 | 0.03650 | 4.31891 | 1 | 3 | 59 | lung alveolus development |
| GO:0002540 | 0.03660 | 40.12238 | 0 | 1 | 3 | leukotriene production involved in inflammatory response |
| GO:0003420 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of growth plate cartilage chondrocyte proliferation |
| GO:0009449 | 0.03660 | 40.12238 | 0 | 1 | 3 | gamma-aminobutyric acid biosynthetic process |
| GO:0010725 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of primitive erythrocyte differentiation |
| GO:0010956 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of calcidiol 1-monooxygenase activity |
| GO:0015709 | 0.03660 | 40.12238 | 0 | 1 | 3 | thiosulfate transport |
| GO:0015729 | 0.03660 | 40.12238 | 0 | 1 | 3 | oxaloacetate transport |
| GO:0015743 | 0.03660 | 40.12238 | 0 | 1 | 3 | malate transport |
| GO:0016539 | 0.03660 | 40.12238 | 0 | 1 | 3 | intein-mediated protein splicing |
| GO:0019065 | 0.03660 | 40.12238 | 0 | 1 | 3 | receptor-mediated endocytosis of virus by host cell |
| GO:0019287 | 0.03660 | 40.12238 | 0 | 1 | 3 | isopentenyl diphosphate biosynthetic process, mevalonate pathway |
| GO:0019371 | 0.03660 | 40.12238 | 0 | 1 | 3 | cyclooxygenase pathway |
| GO:0021564 | 0.03660 | 40.12238 | 0 | 1 | 3 | vagus nerve development |
| GO:0021570 | 0.03660 | 40.12238 | 0 | 1 | 3 | rhombomere 4 development |
| GO:0021882 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
| GO:0021898 | 0.03660 | 40.12238 | 0 | 1 | 3 | commitment of multipotent stem cells to neuronal lineage in forebrain |
| GO:0021934 | 0.03660 | 40.12238 | 0 | 1 | 3 | hindbrain tangential cell migration |
| GO:0030200 | 0.03660 | 40.12238 | 0 | 1 | 3 | heparan sulfate proteoglycan catabolic process |
| GO:0030908 | 0.03660 | 40.12238 | 0 | 1 | 3 | protein splicing |
| GO:0032025 | 0.03660 | 40.12238 | 0 | 1 | 3 | response to cobalt ion |
| GO:0032346 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of aldosterone metabolic process |
| GO:0032349 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of aldosterone biosynthetic process |
| GO:0035880 | 0.03660 | 40.12238 | 0 | 1 | 3 | embryonic nail plate morphogenesis |
| GO:0038086 | 0.03660 | 40.12238 | 0 | 1 | 3 | VEGF-activated platelet-derived growth factor receptor signaling pathway |
| GO:0038091 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
| GO:0038189 | 0.03660 | 40.12238 | 0 | 1 | 3 | neuropilin signaling pathway |
| GO:0042706 | 0.03660 | 40.12238 | 0 | 1 | 3 | eye photoreceptor cell fate commitment |
| GO:0044107 | 0.03660 | 40.12238 | 0 | 1 | 3 | cellular alcohol metabolic process |
| GO:0044108 | 0.03660 | 40.12238 | 0 | 1 | 3 | cellular alcohol biosynthetic process |
| GO:0044339 | 0.03660 | 40.12238 | 0 | 1 | 3 | canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:0045337 | 0.03660 | 40.12238 | 0 | 1 | 3 | farnesyl diphosphate biosynthetic process |
| GO:0046061 | 0.03660 | 40.12238 | 0 | 1 | 3 | dATP catabolic process |
| GO:0046208 | 0.03660 | 40.12238 | 0 | 1 | 3 | spermine catabolic process |
| GO:0046552 | 0.03660 | 40.12238 | 0 | 1 | 3 | photoreceptor cell fate commitment |
| GO:0050968 | 0.03660 | 40.12238 | 0 | 1 | 3 | detection of chemical stimulus involved in sensory perception of pain |
| GO:0051344 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of cyclic-nucleotide phosphodiesterase activity |
| GO:0051466 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of corticotropin-releasing hormone secretion |
| GO:0051795 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of timing of catagen |
| GO:0060166 | 0.03660 | 40.12238 | 0 | 1 | 3 | olfactory pit development |
| GO:0060741 | 0.03660 | 40.12238 | 0 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0060748 | 0.03660 | 40.12238 | 0 | 1 | 3 | tertiary branching involved in mammary gland duct morphogenesis |
| GO:0060825 | 0.03660 | 40.12238 | 0 | 1 | 3 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation |
| GO:0061144 | 0.03660 | 40.12238 | 0 | 1 | 3 | alveolar secondary septum development |
| GO:0061146 | 0.03660 | 40.12238 | 0 | 1 | 3 | Peyer's patch morphogenesis |
| GO:0061184 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of dermatome development |
| GO:0061366 | 0.03660 | 40.12238 | 0 | 1 | 3 | behavioral response to chemical pain |
| GO:0061368 | 0.03660 | 40.12238 | 0 | 1 | 3 | behavioral response to formalin induced pain |
| GO:0061771 | 0.03660 | 40.12238 | 0 | 1 | 3 | response to caloric restriction |
| GO:0070268 | 0.03660 | 40.12238 | 0 | 1 | 3 | cornification |
| GO:0070368 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of hepatocyte differentiation |
| GO:0070640 | 0.03660 | 40.12238 | 0 | 1 | 3 | vitamin D3 metabolic process |
| GO:0071422 | 0.03660 | 40.12238 | 0 | 1 | 3 | succinate transmembrane transport |
| GO:0071423 | 0.03660 | 40.12238 | 0 | 1 | 3 | malate transmembrane transport |
| GO:0071691 | 0.03660 | 40.12238 | 0 | 1 | 3 | cardiac muscle thin filament assembly |
| GO:0071873 | 0.03660 | 40.12238 | 0 | 1 | 3 | response to norepinephrine |
| GO:0072138 | 0.03660 | 40.12238 | 0 | 1 | 3 | mesenchymal cell proliferation involved in ureteric bud development |
| GO:0075509 | 0.03660 | 40.12238 | 0 | 1 | 3 | endocytosis involved in viral entry into host cell |
| GO:0090360 | 0.03660 | 40.12238 | 0 | 1 | 3 | platelet-derived growth factor production |
| GO:0090361 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of platelet-derived growth factor production |
| GO:0090673 | 0.03660 | 40.12238 | 0 | 1 | 3 | endothelial cell-matrix adhesion |
| GO:0097021 | 0.03660 | 40.12238 | 0 | 1 | 3 | lymphocyte migration into lymphoid organs |
| GO:0097037 | 0.03660 | 40.12238 | 0 | 1 | 3 | heme export |
| GO:0097116 | 0.03660 | 40.12238 | 0 | 1 | 3 | gephyrin clustering involved in postsynaptic density assembly |
| GO:0099163 | 0.03660 | 40.12238 | 0 | 1 | 3 | synaptic signaling by nitric oxide |
| GO:0099543 | 0.03660 | 40.12238 | 0 | 1 | 3 | trans-synaptic signaling by soluble gas |
| GO:0099548 | 0.03660 | 40.12238 | 0 | 1 | 3 | trans-synaptic signaling by nitric oxide |
| GO:0106014 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of inflammatory response to wounding |
| GO:0106015 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of inflammatory response to wounding |
| GO:0110021 | 0.03660 | 40.12238 | 0 | 1 | 3 | cardiac muscle myoblast proliferation |
| GO:0110022 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of cardiac muscle myoblast proliferation |
| GO:0110024 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of cardiac muscle myoblast proliferation |
| GO:0110025 | 0.03660 | 40.12238 | 0 | 1 | 3 | DNA strand resection involved in replication fork processing |
| GO:1900923 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of glycine import across plasma membrane |
| GO:1901301 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of cargo loading into COPII-coated vesicle |
| GO:1901318 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of flagellated sperm motility |
| GO:1901492 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of lymphangiogenesis |
| GO:1901671 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of superoxide dismutase activity |
| GO:1901844 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of cell communication by electrical coupling involved in cardiac conduction |
| GO:1902309 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of peptidyl-serine dephosphorylation |
| GO:1902336 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of retinal ganglion cell axon guidance |
| GO:1902445 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death |
| GO:1902731 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of chondrocyte proliferation |
| GO:1902811 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of skeletal muscle fiber differentiation |
| GO:1903537 | 0.03660 | 40.12238 | 0 | 1 | 3 | meiotic cell cycle process involved in oocyte maturation |
| GO:1903538 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of meiotic cell cycle process involved in oocyte maturation |
| GO:1903598 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of gap junction assembly |
| GO:1903630 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of aminoacyl-tRNA ligase activity |
| GO:1903979 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of microglial cell activation |
| GO:1904020 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of G protein-coupled receptor internalization |
| GO:1904057 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of sensory perception of pain |
| GO:1904217 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity |
| GO:1904219 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity |
| GO:1904222 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of serine C-palmitoyltransferase activity |
| GO:1904352 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of protein catabolic process in the vacuole |
| GO:1904425 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of GTP binding |
| GO:1904833 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of removal of superoxide radicals |
| GO:1905041 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of epithelium regeneration |
| GO:1905319 | 0.03660 | 40.12238 | 0 | 1 | 3 | mesenchymal stem cell migration |
| GO:1905320 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of mesenchymal stem cell migration |
| GO:1905322 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of mesenchymal stem cell migration |
| GO:1905907 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of amyloid fibril formation |
| GO:1990399 | 0.03660 | 40.12238 | 0 | 1 | 3 | epithelium regeneration |
| GO:1990523 | 0.03660 | 40.12238 | 0 | 1 | 3 | bone regeneration |
| GO:1990926 | 0.03660 | 40.12238 | 0 | 1 | 3 | short-term synaptic potentiation |
| GO:2000019 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of male gonad development |
| GO:2000040 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of planar cell polarity pathway involved in axis elongation |
| GO:2000041 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of planar cell polarity pathway involved in axis elongation |
| GO:2000286 | 0.03660 | 40.12238 | 0 | 1 | 3 | receptor internalization involved in canonical Wnt signaling pathway |
| GO:2000313 | 0.03660 | 40.12238 | 0 | 1 | 3 | regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation |
| GO:2000820 | 0.03660 | 40.12238 | 0 | 1 | 3 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
| GO:2001055 | 0.03660 | 40.12238 | 0 | 1 | 3 | positive regulation of mesenchymal cell apoptotic process |
| GO:2000300 | 0.03666 | 3.33030 | 1 | 4 | 101 | regulation of synaptic vesicle exocytosis |
| GO:0097529 | 0.03678 | 2.53114 | 2 | 6 | 198 | myeloid leukocyte migration |
| GO:0008360 | 0.03693 | 2.82808 | 2 | 5 | 148 | regulation of cell shape |
| GO:0043270 | 0.03761 | 2.17240 | 4 | 8 | 307 | positive regulation of ion transport |
| GO:0035249 | 0.03780 | 3.29617 | 1 | 4 | 102 | synaptic transmission, glutamatergic |
| GO:0009649 | 0.03783 | 6.99588 | 0 | 2 | 25 | entrainment of circadian clock |
| GO:0030194 | 0.03783 | 6.99588 | 0 | 2 | 25 | positive regulation of blood coagulation |
| GO:0030903 | 0.03783 | 6.99588 | 0 | 2 | 25 | notochord development |
| GO:0036342 | 0.03783 | 6.99588 | 0 | 2 | 25 | post-anal tail morphogenesis |
| GO:0045648 | 0.03783 | 6.99588 | 0 | 2 | 25 | positive regulation of erythrocyte differentiation |
| GO:0051894 | 0.03783 | 6.99588 | 0 | 2 | 25 | positive regulation of focal adhesion assembly |
| GO:0071402 | 0.03783 | 6.99588 | 0 | 2 | 25 | cellular response to lipoprotein particle stimulus |
| GO:0071867 | 0.03783 | 6.99588 | 0 | 2 | 25 | response to monoamine |
| GO:1900048 | 0.03783 | 6.99588 | 0 | 2 | 25 | positive regulation of hemostasis |
| GO:1901532 | 0.03783 | 6.99588 | 0 | 2 | 25 | regulation of hematopoietic progenitor cell differentiation |
| GO:1902230 | 0.03783 | 6.99588 | 0 | 2 | 25 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:2000738 | 0.03783 | 6.99588 | 0 | 2 | 25 | positive regulation of stem cell differentiation |
| GO:0044267 | 0.03800 | 1.29968 | 56 | 68 | 4494 | cellular protein metabolic process |
| GO:0002763 | 0.03808 | 4.24296 | 1 | 3 | 60 | positive regulation of myeloid leukocyte differentiation |
| GO:0086003 | 0.03808 | 4.24296 | 1 | 3 | 60 | cardiac muscle cell contraction |
| GO:1905207 | 0.03808 | 4.24296 | 1 | 3 | 60 | regulation of cardiocyte differentiation |
| GO:1904064 | 0.03877 | 2.78882 | 2 | 5 | 150 | positive regulation of cation transmembrane transport |
| GO:0055006 | 0.03896 | 3.26273 | 1 | 4 | 103 | cardiac cell development |
| GO:0031348 | 0.03912 | 2.49187 | 2 | 6 | 201 | negative regulation of defense response |
| GO:0071407 | 0.03948 | 1.89000 | 6 | 11 | 485 | cellular response to organic cyclic compound |
| GO:0071702 | 0.03956 | 1.38420 | 30 | 40 | 2444 | organic substance transport |
| GO:0090398 | 0.03970 | 4.16962 | 1 | 3 | 61 | cellular senescence |
| GO:2000736 | 0.03970 | 4.16962 | 1 | 3 | 61 | regulation of stem cell differentiation |
| GO:0022600 | 0.04014 | 3.22996 | 1 | 4 | 104 | digestive system process |
| GO:0043266 | 0.04014 | 3.22996 | 1 | 4 | 104 | regulation of potassium ion transport |
| GO:0042391 | 0.04032 | 1.95093 | 5 | 10 | 427 | regulation of membrane potential |
| GO:0007176 | 0.04066 | 6.70409 | 0 | 2 | 26 | regulation of epidermal growth factor-activated receptor activity |
| GO:0007263 | 0.04066 | 6.70409 | 0 | 2 | 26 | nitric oxide mediated signal transduction |
| GO:0007620 | 0.04066 | 6.70409 | 0 | 2 | 26 | copulation |
| GO:0045742 | 0.04066 | 6.70409 | 0 | 2 | 26 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0050927 | 0.04066 | 6.70409 | 0 | 2 | 26 | positive regulation of positive chemotaxis |
| GO:0051560 | 0.04066 | 6.70409 | 0 | 2 | 26 | mitochondrial calcium ion homeostasis |
| GO:0060219 | 0.04066 | 6.70409 | 0 | 2 | 26 | camera-type eye photoreceptor cell differentiation |
| GO:0089718 | 0.04066 | 6.70409 | 0 | 2 | 26 | amino acid import across plasma membrane |
| GO:0090025 | 0.04066 | 6.70409 | 0 | 2 | 26 | regulation of monocyte chemotaxis |
| GO:0090208 | 0.04066 | 6.70409 | 0 | 2 | 26 | positive regulation of triglyceride metabolic process |
| GO:0098901 | 0.04066 | 6.70409 | 0 | 2 | 26 | regulation of cardiac muscle cell action potential |
| GO:1901380 | 0.04066 | 6.70409 | 0 | 2 | 26 | negative regulation of potassium ion transmembrane transport |
| GO:0014812 | 0.04134 | 3.19784 | 1 | 4 | 105 | muscle cell migration |
| GO:0042752 | 0.04134 | 3.19784 | 1 | 4 | 105 | regulation of circadian rhythm |
| GO:0048704 | 0.04134 | 3.19784 | 1 | 4 | 105 | embryonic skeletal system morphogenesis |
| GO:1902803 | 0.04134 | 3.19784 | 1 | 4 | 105 | regulation of synaptic vesicle transport |
| GO:0001707 | 0.04135 | 4.09877 | 1 | 3 | 62 | mesoderm formation |
| GO:0002673 | 0.04135 | 4.09877 | 1 | 3 | 62 | regulation of acute inflammatory response |
| GO:0035904 | 0.04135 | 4.09877 | 1 | 3 | 62 | aorta development |
| GO:0060042 | 0.04135 | 4.09877 | 1 | 3 | 62 | retina morphogenesis in camera-type eye |
| GO:1903391 | 0.04135 | 4.09877 | 1 | 3 | 62 | regulation of adherens junction organization |
| GO:1903708 | 0.04154 | 2.45379 | 3 | 6 | 204 | positive regulation of hemopoiesis |
| GO:0006464 | 0.04178 | 1.32670 | 42 | 53 | 3400 | cellular protein modification process |
| GO:0036211 | 0.04178 | 1.32670 | 42 | 53 | 3400 | protein modification process |
| GO:0009880 | 0.04303 | 4.03028 | 1 | 3 | 63 | embryonic pattern specification |
| GO:0007204 | 0.04333 | 2.10809 | 4 | 8 | 316 | positive regulation of cytosolic calcium ion concentration |
| GO:0021533 | 0.04356 | 6.43565 | 0 | 2 | 27 | cell differentiation in hindbrain |
| GO:0046639 | 0.04356 | 6.43565 | 0 | 2 | 27 | negative regulation of alpha-beta T cell differentiation |
| GO:0050926 | 0.04356 | 6.43565 | 0 | 2 | 27 | regulation of positive chemotaxis |
| GO:0051446 | 0.04356 | 6.43565 | 0 | 2 | 27 | positive regulation of meiotic cell cycle |
| GO:0060713 | 0.04356 | 6.43565 | 0 | 2 | 27 | labyrinthine layer morphogenesis |
| GO:0090200 | 0.04356 | 6.43565 | 0 | 2 | 27 | positive regulation of release of cytochrome c from mitochondria |
| GO:1900745 | 0.04356 | 6.43565 | 0 | 2 | 27 | positive regulation of p38MAPK cascade |
| GO:0001885 | 0.04475 | 3.96404 | 1 | 3 | 64 | endothelial cell development |
| GO:0007566 | 0.04475 | 3.96404 | 1 | 3 | 64 | embryo implantation |
| GO:0071260 | 0.04475 | 3.96404 | 1 | 3 | 64 | cellular response to mechanical stimulus |
| GO:0090278 | 0.04475 | 3.96404 | 1 | 3 | 64 | negative regulation of peptide hormone secretion |
| GO:0043408 | 0.04492 | 1.67636 | 9 | 15 | 746 | regulation of MAPK cascade |
| GO:0042594 | 0.04564 | 2.65957 | 2 | 5 | 157 | response to starvation |
| GO:0051046 | 0.04597 | 1.61546 | 11 | 17 | 878 | regulation of secretion |
| GO:0032970 | 0.04607 | 1.98131 | 5 | 9 | 378 | regulation of actin filament-based process |
| GO:0005976 | 0.04634 | 3.07548 | 1 | 4 | 109 | polysaccharide metabolic process |
| GO:0007156 | 0.04634 | 3.07548 | 1 | 4 | 109 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0014074 | 0.04634 | 3.07548 | 1 | 4 | 109 | response to purine-containing compound |
| GO:0090100 | 0.04634 | 3.07548 | 1 | 4 | 109 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0009064 | 0.04650 | 3.89993 | 1 | 3 | 65 | glutamine family amino acid metabolic process |
| GO:0051591 | 0.04650 | 3.89993 | 1 | 3 | 65 | response to cAMP |
| GO:0021952 | 0.04654 | 6.18785 | 0 | 2 | 28 | central nervous system projection neuron axonogenesis |
| GO:0030224 | 0.04654 | 6.18785 | 0 | 2 | 28 | monocyte differentiation |
| GO:0035162 | 0.04654 | 6.18785 | 0 | 2 | 28 | embryonic hemopoiesis |
| GO:0045671 | 0.04654 | 6.18785 | 0 | 2 | 28 | negative regulation of osteoclast differentiation |
| GO:0050820 | 0.04654 | 6.18785 | 0 | 2 | 28 | positive regulation of coagulation |
| GO:0051589 | 0.04654 | 6.18785 | 0 | 2 | 28 | negative regulation of neurotransmitter transport |
| GO:0055022 | 0.04654 | 6.18785 | 0 | 2 | 28 | negative regulation of cardiac muscle tissue growth |
| GO:0060384 | 0.04654 | 6.18785 | 0 | 2 | 28 | innervation |
| GO:0061117 | 0.04654 | 6.18785 | 0 | 2 | 28 | negative regulation of heart growth |
| GO:0086005 | 0.04654 | 6.18785 | 0 | 2 | 28 | ventricular cardiac muscle cell action potential |
| GO:1901186 | 0.04654 | 6.18785 | 0 | 2 | 28 | positive regulation of ERBB signaling pathway |
| GO:1902042 | 0.04654 | 6.18785 | 0 | 2 | 28 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:1903131 | 0.04654 | 6.18785 | 0 | 2 | 28 | mononuclear cell differentiation |
| GO:0009725 | 0.04663 | 1.70024 | 8 | 14 | 686 | response to hormone |
| GO:0007010 | 0.04682 | 1.50239 | 16 | 23 | 1281 | cytoskeleton organization |
| GO:0002688 | 0.04764 | 3.04634 | 1 | 4 | 110 | regulation of leukocyte chemotaxis |
| GO:0007498 | 0.04764 | 3.04634 | 1 | 4 | 110 | mesoderm development |
| GO:0016525 | 0.04764 | 3.04634 | 1 | 4 | 110 | negative regulation of angiogenesis |
| GO:1903052 | 0.04764 | 3.04634 | 1 | 4 | 110 | positive regulation of proteolysis involved in cellular protein catabolic process |
| GO:0051147 | 0.04773 | 2.62480 | 2 | 5 | 159 | regulation of muscle cell differentiation |
| GO:0006869 | 0.04815 | 2.06060 | 4 | 8 | 323 | lipid transport |
| GO:0007405 | 0.04828 | 3.83786 | 1 | 3 | 66 | neuroblast proliferation |
| GO:0007492 | 0.04828 | 3.83786 | 1 | 3 | 66 | endoderm development |
| GO:0045428 | 0.04828 | 3.83786 | 1 | 3 | 66 | regulation of nitric oxide biosynthetic process |
| GO:0048332 | 0.04828 | 3.83786 | 1 | 3 | 66 | mesoderm morphogenesis |
| GO:1903036 | 0.04828 | 3.83786 | 1 | 3 | 66 | positive regulation of response to wounding |
| GO:2000179 | 0.04828 | 3.83786 | 1 | 3 | 66 | positive regulation of neural precursor cell proliferation |
| GO:2000378 | 0.04828 | 3.83786 | 1 | 3 | 66 | negative regulation of reactive oxygen species metabolic process |
| GO:0051345 | 0.04840 | 1.82319 | 6 | 11 | 502 | positive regulation of hydrolase activity |
| GO:0002424 | 0.04850 | 26.74709 | 0 | 1 | 4 | T cell mediated immune response to tumor cell |
| GO:0002538 | 0.04850 | 26.74709 | 0 | 1 | 4 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0002840 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of T cell mediated immune response to tumor cell |
| GO:0003166 | 0.04850 | 26.74709 | 0 | 1 | 4 | bundle of His development |
| GO:0003257 | 0.04850 | 26.74709 | 0 | 1 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
| GO:0006203 | 0.04850 | 26.74709 | 0 | 1 | 4 | dGTP catabolic process |
| GO:0006528 | 0.04850 | 26.74709 | 0 | 1 | 4 | asparagine metabolic process |
| GO:0006537 | 0.04850 | 26.74709 | 0 | 1 | 4 | glutamate biosynthetic process |
| GO:0006598 | 0.04850 | 26.74709 | 0 | 1 | 4 | polyamine catabolic process |
| GO:0006931 | 0.04850 | 26.74709 | 0 | 1 | 4 | substrate-dependent cell migration, cell attachment to substrate |
| GO:0009597 | 0.04850 | 26.74709 | 0 | 1 | 4 | detection of virus |
| GO:0009957 | 0.04850 | 26.74709 | 0 | 1 | 4 | epidermal cell fate specification |
| GO:0014826 | 0.04850 | 26.74709 | 0 | 1 | 4 | vein smooth muscle contraction |
| GO:0016103 | 0.04850 | 26.74709 | 0 | 1 | 4 | diterpenoid catabolic process |
| GO:0016182 | 0.04850 | 26.74709 | 0 | 1 | 4 | synaptic vesicle budding from endosome |
| GO:0021569 | 0.04850 | 26.74709 | 0 | 1 | 4 | rhombomere 3 development |
| GO:0021571 | 0.04850 | 26.74709 | 0 | 1 | 4 | rhombomere 5 development |
| GO:0021615 | 0.04850 | 26.74709 | 0 | 1 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0030167 | 0.04850 | 26.74709 | 0 | 1 | 4 | proteoglycan catabolic process |
| GO:0031296 | 0.04850 | 26.74709 | 0 | 1 | 4 | B cell costimulation |
| GO:0032907 | 0.04850 | 26.74709 | 0 | 1 | 4 | transforming growth factor beta3 production |
| GO:0032910 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of transforming growth factor beta3 production |
| GO:0032911 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of transforming growth factor beta1 production |
| GO:0033540 | 0.04850 | 26.74709 | 0 | 1 | 4 | fatty acid beta-oxidation using acyl-CoA oxidase |
| GO:0034653 | 0.04850 | 26.74709 | 0 | 1 | 4 | retinoic acid catabolic process |
| GO:0035926 | 0.04850 | 26.74709 | 0 | 1 | 4 | chemokine (C-C motif) ligand 2 secretion |
| GO:0042998 | 0.04850 | 26.74709 | 0 | 1 | 4 | positive regulation of Golgi to plasma membrane protein transport |
| GO:0043152 | 0.04850 | 26.74709 | 0 | 1 | 4 | induction of bacterial agglutination |
| GO:0043396 | 0.04850 | 26.74709 | 0 | 1 | 4 | corticotropin-releasing hormone secretion |
| GO:0043397 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of corticotropin-releasing hormone secretion |
| GO:0045338 | 0.04850 | 26.74709 | 0 | 1 | 4 | farnesyl diphosphate metabolic process |
| GO:0045578 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of B cell differentiation |
| GO:0045900 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of translational elongation |
| GO:0045901 | 0.04850 | 26.74709 | 0 | 1 | 4 | positive regulation of translational elongation |
| GO:0046013 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of T cell homeostatic proliferation |
| GO:0048014 | 0.04850 | 26.74709 | 0 | 1 | 4 | Tie signaling pathway |
| GO:0050923 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of negative chemotaxis |
| GO:0051612 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of serotonin uptake |
| GO:0051725 | 0.04850 | 26.74709 | 0 | 1 | 4 | protein de-ADP-ribosylation |
| GO:0051794 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of timing of catagen |
| GO:0060018 | 0.04850 | 26.74709 | 0 | 1 | 4 | astrocyte fate commitment |
| GO:0060125 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of growth hormone secretion |
| GO:0060126 | 0.04850 | 26.74709 | 0 | 1 | 4 | somatotropin secreting cell differentiation |
| GO:0060129 | 0.04850 | 26.74709 | 0 | 1 | 4 | thyroid-stimulating hormone-secreting cell differentiation |
| GO:0060221 | 0.04850 | 26.74709 | 0 | 1 | 4 | retinal rod cell differentiation |
| GO:0060486 | 0.04850 | 26.74709 | 0 | 1 | 4 | Clara cell differentiation |
| GO:0060800 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of cell differentiation involved in embryonic placenta development |
| GO:0061030 | 0.04850 | 26.74709 | 0 | 1 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
| GO:0061031 | 0.04850 | 26.74709 | 0 | 1 | 4 | endodermal digestive tract morphogenesis |
| GO:0061054 | 0.04850 | 26.74709 | 0 | 1 | 4 | dermatome development |
| GO:0061183 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of dermatome development |
| GO:0061209 | 0.04850 | 26.74709 | 0 | 1 | 4 | cell proliferation involved in mesonephros development |
| GO:0061643 | 0.04850 | 26.74709 | 0 | 1 | 4 | chemorepulsion of axon |
| GO:0061817 | 0.04850 | 26.74709 | 0 | 1 | 4 | endoplasmic reticulum-plasma membrane tethering |
| GO:0061888 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of astrocyte activation |
| GO:0070175 | 0.04850 | 26.74709 | 0 | 1 | 4 | positive regulation of enamel mineralization |
| GO:0070366 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of hepatocyte differentiation |
| GO:0070836 | 0.04850 | 26.74709 | 0 | 1 | 4 | caveola assembly |
| GO:0070837 | 0.04850 | 26.74709 | 0 | 1 | 4 | dehydroascorbic acid transport |
| GO:0071896 | 0.04850 | 26.74709 | 0 | 1 | 4 | protein localization to adherens junction |
| GO:0071963 | 0.04850 | 26.74709 | 0 | 1 | 4 | establishment or maintenance of cell polarity regulating cell shape |
| GO:0072162 | 0.04850 | 26.74709 | 0 | 1 | 4 | metanephric mesenchymal cell differentiation |
| GO:0072180 | 0.04850 | 26.74709 | 0 | 1 | 4 | mesonephric duct morphogenesis |
| GO:0072197 | 0.04850 | 26.74709 | 0 | 1 | 4 | ureter morphogenesis |
| GO:0072289 | 0.04850 | 26.74709 | 0 | 1 | 4 | metanephric nephron tubule formation |
| GO:0089700 | 0.04850 | 26.74709 | 0 | 1 | 4 | protein kinase D signaling |
| GO:0090154 | 0.04850 | 26.74709 | 0 | 1 | 4 | positive regulation of sphingolipid biosynthetic process |
| GO:0090191 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:0090271 | 0.04850 | 26.74709 | 0 | 1 | 4 | positive regulation of fibroblast growth factor production |
| GO:0090289 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of osteoclast proliferation |
| GO:0090427 | 0.04850 | 26.74709 | 0 | 1 | 4 | activation of meiosis |
| GO:0097118 | 0.04850 | 26.74709 | 0 | 1 | 4 | neuroligin clustering involved in postsynaptic membrane assembly |
| GO:0098989 | 0.04850 | 26.74709 | 0 | 1 | 4 | NMDA selective glutamate receptor signaling pathway |
| GO:0099552 | 0.04850 | 26.74709 | 0 | 1 | 4 | trans-synaptic signaling by lipid, modulating synaptic transmission |
| GO:0099553 | 0.04850 | 26.74709 | 0 | 1 | 4 | trans-synaptic signaling by endocannabinoid, modulating synaptic transmission |
| GO:0140192 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process |
| GO:0150079 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of neuroinflammatory response |
| GO:1900158 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of bone mineralization involved in bone maturation |
| GO:1901668 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of superoxide dismutase activity |
| GO:1901979 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of inward rectifier potassium channel activity |
| GO:1902109 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:1902219 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:1902809 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of skeletal muscle fiber differentiation |
| GO:1902869 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of amacrine cell differentiation |
| GO:1903596 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of gap junction assembly |
| GO:1903625 | 0.04850 | 26.74709 | 0 | 1 | 4 | negative regulation of DNA catabolic process |
| GO:1903804 | 0.04850 | 26.74709 | 0 | 1 | 4 | glycine import across plasma membrane |
| GO:1904220 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of serine C-palmitoyltransferase activity |
| GO:1990410 | 0.04850 | 26.74709 | 0 | 1 | 4 | adrenomedullin receptor signaling pathway |
| GO:1990839 | 0.04850 | 26.74709 | 0 | 1 | 4 | response to endothelin |
| GO:2000097 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of smooth muscle cell-matrix adhesion |
| GO:2000304 | 0.04850 | 26.74709 | 0 | 1 | 4 | positive regulation of ceramide biosynthetic process |
| GO:2000503 | 0.04850 | 26.74709 | 0 | 1 | 4 | positive regulation of natural killer cell chemotaxis |
| GO:2001245 | 0.04850 | 26.74709 | 0 | 1 | 4 | regulation of phosphatidylcholine biosynthetic process |
| GO:0022407 | 0.04864 | 1.95972 | 5 | 9 | 382 | regulation of cell-cell adhesion |
| GO:0051707 | 0.04873 | 1.52459 | 14 | 21 | 1151 | response to other organism |
| GO:0060041 | 0.04879 | 2.60776 | 2 | 5 | 160 | retina development in camera-type eye |
| GO:0043207 | 0.04946 | 1.52176 | 14 | 21 | 1153 | response to external biotic stimulus |
| GO:0002931 | 0.04959 | 5.95841 | 0 | 2 | 29 | response to ischemia |
| GO:0009225 | 0.04959 | 5.95841 | 0 | 2 | 29 | nucleotide-sugar metabolic process |
| GO:0034110 | 0.04959 | 5.95841 | 0 | 2 | 29 | regulation of homotypic cell-cell adhesion |
| GO:0043114 | 0.04959 | 5.95841 | 0 | 2 | 29 | regulation of vascular permeability |
| GO:0045672 | 0.04959 | 5.95841 | 0 | 2 | 29 | positive regulation of osteoclast differentiation |
| GO:0060218 | 0.04959 | 5.95841 | 0 | 2 | 29 | hematopoietic stem cell differentiation |
| GO:0071709 | 0.04959 | 5.95841 | 0 | 2 | 29 | membrane assembly |
| GO:1905314 | 0.04959 | 5.95841 | 0 | 2 | 29 | semi-lunar valve development |
| GO:0030902 | 0.04987 | 2.59093 | 2 | 5 | 161 | hindbrain development |
| GO:0071897 | 0.04987 | 2.59093 | 2 | 5 | 161 | DNA biosynthetic process |